TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-1236977	Endosomal/Vacuolar pathway	4.49323572479807e-06	-12.312937464352	11	7	0.0108527131782946	645	8202	1514,3106,3107,3133,3134,1515,3105	CTSL,HLA-B,HLA-C,HLA-E,HLA-F,CTSV,HLA-A
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	6.00089158987203e-06	-12.0236025014639	24	10	0.0155038759689922	645	8202	3106,10484,6892,3133,3134,6890,51752,3107,3105,64167	HLA-B,SEC23A,TAPBP,HLA-E,HLA-F,TAP1,ERAP1,HLA-C,HLA-A,ERAP2
R-HSA-1474244	Extracellular matrix organization	9.62991444341852e-06	-11.5506362165739	267	42	0.0651162790697674	645	8202	4052,1299,3339,55214,3655,4038,6385,80781,1287,6382,780,2192,5154,3696,999,655,1291,8751,59277,10491,10516,7077,1292,5045,1294,4017,1605,1303,1514,4324,5352,4326,1515,649,140766,5650,4053,3685,1307,823,7093,170690	LTBP1,COL9A3,HSPG2,P3H2,ITGA6,LRP4,SDC4,COL18A1,COL4A5,SDC1,DDR1,FBLN1,PDGFA,ITGB8,CDH1,BMP7,COL6A1,ADAM15,NTN4,CRTAP,FBLN5,TIMP2,COL6A2,FURIN,COL7A1,LOXL2,DAG1,COL12A1,CTSL,MMP15,PLOD2,MMP17,CTSV,BMP1,ADAMTS14,KLK7,LTBP2,ITGAV,COL16A1,CAPN1,TLL2,ADAMTS16
R-HSA-422475	Axon guidance	4.1541640178646e-05	-10.088814255976	516	66	0.102325581395349	645	8202	10398,5721,6195,8826,2043,2064,9542,5720,5361,6710,5154,6196,9048,53358,1808,11221,7220,59277,2050,6326,1741,221002,7074,10125,6328,10817,1292,5588,1846,214,10627,8660,3984,1946,3084,219699,103910,1299,6331,5922,808,5716,1287,9965,1947,8828,4756,1291,2065,56896,64283,9693,801,2902,2041,7525,10048,5921,8851,8506,10507,2263,5306,3685,10371,56963	MYL9,PSME2,RPS6KA1,IQGAP1,EPHA4,ERBB2,NRG2,PSME1,PLXNA1,SPTB,PDGFA,RPS6KA2,ARTN,SHC3,DPYSL2,DUSP10,TRPC1,NTN4,EPHB4,SCN2A,DLG3,RASGEF1A,TIAM1,RASGRP1,SCN3A,FRS3,COL6A2,PRKCQ,DUSP4,ALCAM,MYL12A,IRS2,LIMK1,EFNA5,NRG1,UNC5B,MYL12B,COL9A3,SCN5A,RASA2,CALM3,PSMD10,COL4A5,FGF19,EFNB1,NRP2,NEO1,COL6A1,ERBB3,DPYSL5,ARHGEF28,RAPGEF2,CALM1,GRIN1,EPHA1,YES1,RANBP9,RASA1,CDK5R1,CNTNAP1,SEMA4D,FGFR2,PITPNA,ITGAV,SEMA3A,RGMA
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	6.33960131281178e-05	-9.66610958291295	36	11	0.0170542635658915	645	8202	118788,5336,801,5295,7220,808,3709,5293,3710,6850,30011	PIK3AP1,PLCG2,CALM1,PIK3R1,TRPC1,CALM3,ITPR2,PIK3CD,ITPR3,SYK,SH3KBP1
R-HSA-1280218	Adaptive Immune System	6.58850540106387e-05	-9.62759894019599	668	80	0.124031007751938	645	8202	5721,6890,26232,2064,9542,221687,5720,29126,3709,5566,30011,5154,10053,999,5336,5290,1027,7220,5293,10125,64167,10484,207,83737,5588,192670,958,79754,3710,127544,9021,8660,6892,5795,3084,2549,9902,90293,3133,3134,140462,9493,808,5716,23239,9965,3105,151636,92912,118788,1075,51465,147700,5592,6737,11059,2065,3107,6850,10112,3164,801,5295,7319,7525,3832,10235,1514,3106,2263,5819,4792,1515,51752,5476,3685,1062,126433,11065,945	PSME2,TAP1,FBXO2,ERBB2,NRG2,RNF182,PSME1,CD274,ITPR2,PRKACA,SH3KBP1,PDGFA,AP1M2,CDH1,PLCG2,PIK3CA,CDKN1B,TRPC1,PIK3CD,RASGRP1,ERAP2,SEC23A,AKT1,ITCH,PRKCQ,AGO4,CD40,ASB13,ITPR3,RNF19B,SOCS3,IRS2,TAPBP,PTPRJ,NRG1,GAB1,MRC2,KLHL13,HLA-E,HLA-F,ASB9,KIF23,CALM3,PSMD10,PHLPP1,FGF19,HLA-A,DTX3L,UBE2Q2,PIK3AP1,CTSC,UBE2J1,KLC3,PRKG1,TRIM21,WWP1,ERBB3,HLA-C,SYK,KIF20A,NR4A1,CALM1,PIK3R1,UBE2A,YES1,KIF11,RASGRP2,CTSL,HLA-B,FGFR2,PVRL2,NFKBIA,CTSV,ERAP1,CTSA,ITGAV,CENPE,FBXO27,UBE2C,CD33
R-HSA-1474290	Collagen formation	9.88904723535438e-05	-9.22149766013858	86	18	0.027906976744186	645	8202	1299,1292,55214,3655,80781,1287,1294,4017,1303,1514,5352,1291,1515,649,140766,1307,10491,7093	COL9A3,COL6A2,P3H2,ITGA6,COL18A1,COL4A5,COL7A1,LOXL2,COL12A1,CTSL,PLOD2,COL6A1,CTSV,BMP1,ADAMTS14,COL16A1,CRTAP,TLL2
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.000154266360540644	-8.77682983570997	198	31	0.048062015503876	645	8202	207,3164,5721,801,5295,5716,2064,9542,808,192670,5720,3709,23239,3710,9965,30011,8660,5154,118788,2263,4792,5336,5290,1027,7220,3084,2065,5293,2549,6850,10125	AKT1,NR4A1,PSME2,CALM1,PIK3R1,PSMD10,ERBB2,NRG2,CALM3,AGO4,PSME1,ITPR2,PHLPP1,ITPR3,FGF19,SH3KBP1,IRS2,PDGFA,PIK3AP1,FGFR2,NFKBIA,PLCG2,PIK3CA,CDKN1B,TRPC1,NRG1,ERBB3,PIK3CD,GAB1,SYK,RASGRP1
R-HSA-1474228	Degradation of the extracellular matrix	0.000157175656235859	-8.75814654851151	89	18	0.027906976744186	645	8202	1299,7077,3339,5045,80781,1303,4324,1514,999,4326,1515,649,8751,5650,1307,823,7093,170690	COL9A3,TIMP2,HSPG2,FURIN,COL18A1,COL12A1,MMP15,CTSL,CDH1,MMP17,CTSV,BMP1,ADAM15,KLK7,COL16A1,CAPN1,TLL2,ADAMTS16
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.000177724594408164	-8.63527542828292	5	4	0.0062015503875969	645	8202	2064,9542,3084,2065	ERBB2,NRG2,NRG1,ERBB3
R-HSA-166520	Signalling by NGF	0.000185847588708927	-8.5905836356989	430	55	0.0852713178294574	645	8202	50650,5721,6195,8826,5922,5716,2064,9542,808,5720,3709,23239,5566,6710,9965,27237,5154,6196,156,53358,5290,11221,1027,5600,5293,2065,221002,7074,10125,10817,207,3164,9693,801,5295,2902,5045,192670,5577,1846,3710,2002,29,5921,9261,8660,2263,27018,4792,3065,3084,2549,50649,6300,5125	ARHGEF3,PSME2,RPS6KA1,IQGAP1,RASA2,PSMD10,ERBB2,NRG2,CALM3,PSME1,ITPR2,PHLPP1,PRKACA,SPTB,FGF19,ARHGEF16,PDGFA,RPS6KA2,ADRBK1,SHC3,PIK3CA,DUSP10,CDKN1B,MAPK11,PIK3CD,ERBB3,RASGEF1A,TIAM1,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,CALM1,PIK3R1,GRIN1,FURIN,AGO4,PRKAR2B,DUSP4,ITPR3,ELK1,ABR,RASA1,MAPKAPK2,IRS2,FGFR2,NGFRAP1,NFKBIA,HDAC1,NRG1,GAB1,ARHGEF4,MAPK12,PCSK5
R-HSA-186797	Signaling by PDGF	0.000244679695325033	-8.31556056878836	345	46	0.0713178294573643	645	8202	1299,5721,8826,5922,5716,2064,9542,808,1287,5720,3709,23239,5566,6710,9965,5154,156,53358,1291,5290,11221,1027,5293,2065,221002,10125,10817,56034,1292,207,3164,9693,5295,801,2902,5045,192670,5577,1846,3710,9564,5921,8660,2263,3084,2549	COL9A3,PSME2,IQGAP1,RASA2,PSMD10,ERBB2,NRG2,CALM3,COL4A5,PSME1,ITPR2,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,ADRBK1,SHC3,COL6A1,PIK3CA,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,PDGFC,COL6A2,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,FURIN,AGO4,PRKAR2B,DUSP4,ITPR3,BCAR1,RASA1,IRS2,FGFR2,NRG1,GAB1
R-HSA-1266738	Developmental Biology	0.000303055884251201	-8.10159333298861	710	81	0.125581395348837	645	8202	10398,2034,5721,6195,8826,2043,2064,9542,5720,5361,6710,5154,6196,9048,53358,1808,11221,7220,59277,2050,6326,1741,221002,7074,10125,6328,10817,1292,207,130399,10589,5588,1846,214,10627,8660,23097,3984,688,1946,3084,219699,103910,6300,1299,6331,5922,808,5716,1287,9965,1947,8828,4756,1291,5600,2065,10499,6837,56896,3280,64283,57167,9693,801,5465,2902,5045,2041,7525,10048,8851,5921,8506,8202,10507,2263,5306,3685,10371,56963	MYL9,EPAS1,PSME2,RPS6KA1,IQGAP1,EPHA4,ERBB2,NRG2,PSME1,PLXNA1,SPTB,PDGFA,RPS6KA2,ARTN,SHC3,DPYSL2,DUSP10,TRPC1,NTN4,EPHB4,SCN2A,DLG3,RASGEF1A,TIAM1,RASGRP1,SCN3A,FRS3,COL6A2,AKT1,ACVR1C,DRAP1,PRKCQ,DUSP4,ALCAM,MYL12A,IRS2,CDK19,LIMK1,KLF5,EFNA5,NRG1,UNC5B,MYL12B,MAPK12,COL9A3,SCN5A,RASA2,CALM3,PSMD10,COL4A5,FGF19,EFNB1,NRP2,NEO1,COL6A1,MAPK11,ERBB3,NCOA2,MED22,DPYSL5,HES1,ARHGEF28,SALL4,RAPGEF2,CALM1,PPARA,GRIN1,FURIN,EPHA1,YES1,RANBP9,CDK5R1,RASA1,CNTNAP1,NCOA3,SEMA4D,FGFR2,PITPNA,ITGAV,SEMA3A,RGMA
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.000357322149514867	-7.93687280349087	64	14	0.0217054263565891	645	8202	1299,1292,5352,55214,1291,649,140766,80781,1287,1294,1307,10491,1303,7093	COL9A3,COL6A2,PLOD2,P3H2,COL6A1,BMP1,ADAMTS14,COL18A1,COL4A5,COL7A1,COL16A1,CRTAP,COL12A1,TLL2
R-HSA-194138	Signaling by VEGF	0.000629727171327737	-7.3702238937614	320	42	0.0651162790697674	645	8202	10810,5721,8826,5922,5716,2064,9542,808,5720,3709,5566,6710,9965,8828,5154,63916,53358,5290,11221,5600,2065,221002,10125,10817,207,9693,5295,801,2902,1846,3710,9564,5921,9261,8660,5228,2263,558,3084,3685,3315,6300	WASF3,PSME2,IQGAP1,RASA2,PSMD10,ERBB2,NRG2,CALM3,PSME1,ITPR2,PRKACA,SPTB,FGF19,NRP2,PDGFA,ELMO2,SHC3,PIK3CA,DUSP10,MAPK11,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,PIK3R1,CALM1,GRIN1,DUSP4,ITPR3,BCAR1,RASA1,MAPKAPK2,IRS2,PGF,FGFR2,AXL,NRG1,ITGAV,HSPB1,MAPK12
R-HSA-2172127	DAP12 interactions	0.000636724596601987	-7.35917334030379	340	44	0.0682170542635659	645	8202	5721,8826,3133,5922,5716,2064,9542,808,5720,3709,23239,5566,9965,6710,5154,156,53358,5336,5290,1027,11221,5293,3107,2065,221002,6850,10125,10817,207,3164,9693,5295,801,2902,5577,192670,1846,3710,5921,8660,3106,2263,3084,2549	PSME2,IQGAP1,HLA-E,RASA2,PSMD10,ERBB2,NRG2,CALM3,PSME1,ITPR2,PHLPP1,PRKACA,FGF19,SPTB,PDGFA,ADRBK1,SHC3,PLCG2,PIK3CA,CDKN1B,DUSP10,PIK3CD,HLA-C,ERBB3,RASGEF1A,SYK,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,PRKAR2B,AGO4,DUSP4,ITPR3,RASA1,IRS2,HLA-B,FGFR2,NRG1,GAB1
R-HSA-114508	Effects of PIP2 hydrolysis	0.000809229231768169	-7.11942832904217	27	8	0.0124031007751938	645	8202	160851,1609,5588,3709,3710,8526,10125,10235	DGKH,DGKQ,PRKCQ,ITPR2,ITPR3,DGKE,RASGRP1,RASGRP2
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.000863677014459803	-7.05431168490723	355	45	0.0697674418604651	645	8202	5721,6195,8826,5922,5716,2064,9542,808,5720,3709,23239,5566,6710,9965,5154,6196,156,53358,5290,11221,1027,5600,5293,2065,221002,10125,10817,207,3164,9693,5295,801,2902,192670,5577,1846,2002,3710,5921,9261,8660,2263,3084,2549,6300	PSME2,RPS6KA1,IQGAP1,RASA2,PSMD10,ERBB2,NRG2,CALM3,PSME1,ITPR2,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,RPS6KA2,ADRBK1,SHC3,PIK3CA,DUSP10,CDKN1B,MAPK11,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,PRKAR2B,DUSP4,ELK1,ITPR3,RASA1,MAPKAPK2,IRS2,FGFR2,NRG1,GAB1,MAPK12
R-HSA-2424491	DAP12 signaling	0.000865434359011581	-7.05227902792075	325	42	0.0651162790697674	645	8202	5721,8826,3133,5922,5716,2064,9542,808,5720,3709,23239,5566,9965,6710,5154,156,53358,5336,5290,1027,11221,5293,2065,221002,6850,10125,10817,207,3164,9693,5295,801,2902,5577,192670,1846,3710,5921,8660,2263,3084,2549	PSME2,IQGAP1,HLA-E,RASA2,PSMD10,ERBB2,NRG2,CALM3,PSME1,ITPR2,PHLPP1,PRKACA,FGF19,SPTB,PDGFA,ADRBK1,SHC3,PLCG2,PIK3CA,CDKN1B,DUSP10,PIK3CD,ERBB3,RASGEF1A,SYK,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,PRKAR2B,AGO4,DUSP4,ITPR3,RASA1,IRS2,FGFR2,NRG1,GAB1
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.00113075253321908	-6.78487190930896	104	18	0.027906976744186	645	8202	207,3164,5295,2064,9542,192670,23239,9965,5154,8660,2263,5290,1027,3084,2065,5293,6850,2549	AKT1,NR4A1,PIK3R1,ERBB2,NRG2,AGO4,PHLPP1,FGF19,PDGFA,IRS2,FGFR2,PIK3CA,CDKN1B,NRG1,ERBB3,PIK3CD,SYK,GAB1
R-HSA-936837	Ion transport by P-type ATPases	0.00120000062068606	-6.72543320494993	49	11	0.0170542635658915	645	8202	476,10079,540,10396,5349,9914,5205,148229,481,57205,490	ATP1A1,ATP9A,ATP7B,ATP8A1,FXYD3,ATP2C2,ATP8B1,ATP8B3,ATP1B1,ATP10D,ATP2B1
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.00131860306055796	-6.63118239022152	342	43	0.0666666666666667	645	8202	5721,8826,5922,5716,2064,9542,808,5720,7006,3709,23239,9965,6710,5154,53358,5336,5290,1027,11221,5293,2065,221002,6850,10125,10817,207,3164,9693,5295,801,2902,5588,192670,1846,3710,2353,5921,10235,8660,2263,4792,3084,2549	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,NRG2,CALM3,PSME1,TEC,ITPR2,PHLPP1,FGF19,SPTB,PDGFA,SHC3,PLCG2,PIK3CA,CDKN1B,DUSP10,PIK3CD,ERBB3,RASGEF1A,SYK,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,PRKCQ,AGO4,DUSP4,ITPR3,FOS,RASA1,RASGRP2,IRS2,FGFR2,NFKBIA,NRG1,GAB1
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.00133060394629313	-6.62212234486115	312	40	0.062015503875969	645	8202	10810,5721,8826,5922,5716,2064,9542,808,5720,3709,5566,6710,9965,5154,63916,53358,5290,11221,5600,2065,221002,10125,10817,207,9693,5295,801,2902,1846,3710,9564,5921,9261,8660,2263,558,3084,3685,3315,6300	WASF3,PSME2,IQGAP1,RASA2,PSMD10,ERBB2,NRG2,CALM3,PSME1,ITPR2,PRKACA,SPTB,FGF19,PDGFA,ELMO2,SHC3,PIK3CA,DUSP10,MAPK11,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,PIK3R1,CALM1,GRIN1,DUSP4,ITPR3,BCAR1,RASA1,MAPKAPK2,IRS2,FGFR2,AXL,NRG1,ITGAV,HSPB1,MAPK12
R-HSA-1630316	Glycosaminoglycan metabolism	0.00137502823645833	-6.5892810124684	123	20	0.0310077519379845	645	8202	3161,337876,126792,93010,11046,9060,3339,2990,6385,3074,29940,6382,79586,26035,2799,9394,9061,9953,411,9348	HMMR,CHSY3,B3GALT6,B3GNT7,SLC35D2,PAPSS2,HSPG2,GUSB,SDC4,HEXB,DSE,SDC1,CHPF,GLCE,GNS,HS6ST1,PAPSS1,HS3ST3B1,ARSB,NDST3
R-HSA-5654741	Signaling by FGFR3	0.00141444461177807	-6.56101832544562	313	40	0.062015503875969	645	8202	5721,8826,5922,5716,2064,808,9542,5720,3709,23239,5566,6710,9965,5154,156,53358,5290,11221,1027,5293,2065,221002,10253,10125,10817,207,3164,9693,5295,801,2902,192670,5577,1846,3710,5921,8660,2263,3084,2549	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,CALM3,NRG2,PSME1,ITPR2,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,ADRBK1,SHC3,PIK3CA,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,SPRY2,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,PRKAR2B,DUSP4,ITPR3,RASA1,IRS2,FGFR2,NRG1,GAB1
R-HSA-5654743	Signaling by FGFR4	0.00141444461177807	-6.56101832544562	313	40	0.062015503875969	645	8202	5721,8826,5922,5716,2064,808,9542,5720,3709,23239,5566,6710,9965,5154,156,53358,5290,11221,1027,5293,2065,221002,10253,10125,10817,207,3164,9693,5295,801,2902,192670,5577,1846,3710,5921,8660,2263,3084,2549	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,CALM3,NRG2,PSME1,ITPR2,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,ADRBK1,SHC3,PIK3CA,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,SPRY2,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,PRKAR2B,DUSP4,ITPR3,RASA1,IRS2,FGFR2,NRG1,GAB1
R-HSA-1250342	PI3K events in ERBB4 signaling	0.00149763011752735	-6.50387134191475	98	17	0.0263565891472868	645	8202	207,3164,5295,9542,2064,192670,23239,9965,5154,8660,2263,5290,1027,3084,2065,5293,2549	AKT1,NR4A1,PIK3R1,NRG2,ERBB2,AGO4,PHLPP1,FGF19,PDGFA,IRS2,FGFR2,PIK3CA,CDKN1B,NRG1,ERBB3,PIK3CD,GAB1
R-HSA-5654720	PI-3K cascade:FGFR4	0.00149763011752735	-6.50387134191475	98	17	0.0263565891472868	645	8202	207,3164,5295,9542,2064,192670,23239,9965,5154,8660,2263,5290,1027,3084,2065,5293,2549	AKT1,NR4A1,PIK3R1,NRG2,ERBB2,AGO4,PHLPP1,FGF19,PDGFA,IRS2,FGFR2,PIK3CA,CDKN1B,NRG1,ERBB3,PIK3CD,GAB1
R-HSA-5654689	PI-3K cascade:FGFR1	0.00149763011752735	-6.50387134191475	98	17	0.0263565891472868	645	8202	207,3164,5295,9542,2064,192670,23239,9965,5154,8660,2263,5290,1027,3084,2065,5293,2549	AKT1,NR4A1,PIK3R1,NRG2,ERBB2,AGO4,PHLPP1,FGF19,PDGFA,IRS2,FGFR2,PIK3CA,CDKN1B,NRG1,ERBB3,PIK3CD,GAB1
R-HSA-5654695	PI-3K cascade:FGFR2	0.00149763011752735	-6.50387134191475	98	17	0.0263565891472868	645	8202	207,3164,5295,9542,2064,192670,23239,9965,5154,8660,2263,5290,1027,3084,2065,5293,2549	AKT1,NR4A1,PIK3R1,NRG2,ERBB2,AGO4,PHLPP1,FGF19,PDGFA,IRS2,FGFR2,PIK3CA,CDKN1B,NRG1,ERBB3,PIK3CD,GAB1
R-HSA-5654710	PI-3K cascade:FGFR3	0.00149763011752735	-6.50387134191475	98	17	0.0263565891472868	645	8202	207,3164,5295,9542,2064,192670,23239,9965,5154,8660,2263,5290,1027,3084,2065,5293,2549	AKT1,NR4A1,PIK3R1,NRG2,ERBB2,AGO4,PHLPP1,FGF19,PDGFA,IRS2,FGFR2,PIK3CA,CDKN1B,NRG1,ERBB3,PIK3CD,GAB1
R-HSA-1257604	PIP3 activates AKT signaling	0.00149763011752735	-6.50387134191475	98	17	0.0263565891472868	645	8202	207,3164,5295,2064,9542,192670,23239,9965,5154,8660,2263,5290,1027,3084,2065,5293,2549	AKT1,NR4A1,PIK3R1,ERBB2,NRG2,AGO4,PHLPP1,FGF19,PDGFA,IRS2,FGFR2,PIK3CA,CDKN1B,NRG1,ERBB3,PIK3CD,GAB1
R-HSA-1963642	PI3K events in ERBB2 signaling	0.00149763011752735	-6.50387134191475	98	17	0.0263565891472868	645	8202	207,3164,5295,9542,2064,192670,23239,9965,5154,8660,2263,5290,1027,3084,2065,5293,2549	AKT1,NR4A1,PIK3R1,NRG2,ERBB2,AGO4,PHLPP1,FGF19,PDGFA,IRS2,FGFR2,PIK3CA,CDKN1B,NRG1,ERBB3,PIK3CD,GAB1
R-HSA-5654736	Signaling by FGFR1	0.00150287396989059	-6.50037602409531	314	40	0.062015503875969	645	8202	5721,8826,5922,5716,2064,808,9542,5720,3709,23239,5566,6710,9965,5154,156,53358,5290,11221,1027,5293,2065,221002,10253,10125,10817,207,3164,9693,5295,801,2902,192670,5577,1846,3710,5921,8660,2263,3084,2549	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,CALM3,NRG2,PSME1,ITPR2,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,ADRBK1,SHC3,PIK3CA,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,SPRY2,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,PRKAR2B,DUSP4,ITPR3,RASA1,IRS2,FGFR2,NRG1,GAB1
R-HSA-177929	Signaling by EGFR	0.00167484817191228	-6.39203276144795	336	42	0.0651162790697674	645	8202	5721,8826,5922,5716,2064,9542,808,5720,3709,23239,5566,6710,9965,30011,5154,156,53358,5290,11221,1027,5293,2065,221002,10253,10125,10817,207,3164,9693,5295,801,2902,192670,5577,1846,3710,5921,8660,2263,26018,3084,2549	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,NRG2,CALM3,PSME1,ITPR2,PHLPP1,PRKACA,SPTB,FGF19,SH3KBP1,PDGFA,ADRBK1,SHC3,PIK3CA,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,SPRY2,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,PRKAR2B,DUSP4,ITPR3,RASA1,IRS2,FGFR2,LRIG1,NRG1,GAB1
R-HSA-5654738	Signaling by FGFR2	0.00169433738707998	-6.38046353665638	316	40	0.062015503875969	645	8202	5721,8826,5922,5716,2064,808,9542,5720,3709,23239,5566,6710,9965,5154,156,53358,5290,11221,1027,5293,2065,221002,10253,10125,10817,207,3164,9693,5295,801,2902,192670,5577,1846,3710,5921,8660,2263,3084,2549	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,CALM3,NRG2,PSME1,ITPR2,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,ADRBK1,SHC3,PIK3CA,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,SPRY2,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,PRKAR2B,DUSP4,ITPR3,RASA1,IRS2,FGFR2,NRG1,GAB1
R-HSA-383280	Nuclear Receptor transcription pathway	0.00169848920425753	-6.37801612642886	51	11	0.0170542635658915	645	8202	7068,2908,3164,7067,5465,8013,4929,4306,5916,29959,7181	THRB,NR3C1,NR4A1,THRA,PPARA,NR4A3,NR4A2,NR3C2,RARG,NRBP1,NR2C1
R-HSA-190236	Signaling by FGFR	0.00179780840277566	-6.32118690991463	317	40	0.062015503875969	645	8202	5721,8826,5922,5716,2064,808,9542,5720,3709,23239,5566,6710,9965,5154,156,53358,5290,11221,1027,5293,2065,221002,10253,10125,10817,207,3164,9693,5295,801,2902,192670,5577,1846,3710,5921,8660,2263,3084,2549	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,CALM3,NRG2,PSME1,ITPR2,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,ADRBK1,SHC3,PIK3CA,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,SPRY2,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,PRKAR2B,DUSP4,ITPR3,RASA1,IRS2,FGFR2,NRG1,GAB1
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.00205205000452937	-6.18891598329149	8	4	0.0062015503875969	645	8202	7855,89780,8322,8323	FZD5,WNT3A,FZD4,FZD6
R-HSA-198203	PI3K/AKT activation	0.00209946591883418	-6.16607229096336	101	17	0.0263565891472868	645	8202	207,3164,5295,9542,2064,192670,23239,9965,5154,8660,2263,5290,1027,3084,2065,5293,2549	AKT1,NR4A1,PIK3R1,NRG2,ERBB2,AGO4,PHLPP1,FGF19,PDGFA,IRS2,FGFR2,PIK3CA,CDKN1B,NRG1,ERBB3,PIK3CD,GAB1
R-HSA-1227986	Signaling by ERBB2	0.00214195246143955	-6.14603750074182	320	40	0.062015503875969	645	8202	5721,8826,5922,5716,2064,808,9542,5720,3709,23239,5566,6710,9965,5154,156,53358,5290,11221,1027,5293,2065,221002,10125,10817,207,3164,9693,5295,801,2902,192670,5577,7525,1846,3710,5921,8660,2263,3084,2549	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,CALM3,NRG2,PSME1,ITPR2,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,ADRBK1,SHC3,PIK3CA,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,PRKAR2B,YES1,DUSP4,ITPR3,RASA1,IRS2,FGFR2,NRG1,GAB1
R-HSA-5654716	Downstream signaling of activated FGFR4	0.00215600421266439	-6.13949867201133	310	39	0.0604651162790698	645	8202	5721,8826,5922,5716,2064,808,9542,5720,3709,23239,5566,6710,9965,5154,156,53358,5290,11221,1027,5293,2065,221002,10125,10817,207,3164,9693,5295,801,2902,192670,5577,1846,3710,5921,8660,2263,3084,2549	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,CALM3,NRG2,PSME1,ITPR2,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,ADRBK1,SHC3,PIK3CA,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,PRKAR2B,DUSP4,ITPR3,RASA1,IRS2,FGFR2,NRG1,GAB1
R-HSA-5654687	Downstream signaling of activated FGFR1	0.00215600421266439	-6.13949867201133	310	39	0.0604651162790698	645	8202	5721,8826,5922,5716,2064,808,9542,5720,3709,23239,5566,6710,9965,5154,156,53358,5290,11221,1027,5293,2065,221002,10125,10817,207,3164,9693,5295,801,2902,192670,5577,1846,3710,5921,8660,2263,3084,2549	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,CALM3,NRG2,PSME1,ITPR2,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,ADRBK1,SHC3,PIK3CA,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,PRKAR2B,DUSP4,ITPR3,RASA1,IRS2,FGFR2,NRG1,GAB1
R-HSA-5654708	Downstream signaling of activated FGFR3	0.00215600421266439	-6.13949867201133	310	39	0.0604651162790698	645	8202	5721,8826,5922,5716,2064,808,9542,5720,3709,23239,5566,6710,9965,5154,156,53358,5290,11221,1027,5293,2065,221002,10125,10817,207,3164,9693,5295,801,2902,192670,5577,1846,3710,5921,8660,2263,3084,2549	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,CALM3,NRG2,PSME1,ITPR2,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,ADRBK1,SHC3,PIK3CA,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,PRKAR2B,DUSP4,ITPR3,RASA1,IRS2,FGFR2,NRG1,GAB1
R-HSA-5654696	Downstream signaling of activated FGFR2	0.00215600421266439	-6.13949867201133	310	39	0.0604651162790698	645	8202	5721,8826,5922,5716,2064,808,9542,5720,3709,23239,5566,6710,9965,5154,156,53358,5290,11221,1027,5293,2065,221002,10125,10817,207,3164,9693,5295,801,2902,192670,5577,1846,3710,5921,8660,2263,3084,2549	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,CALM3,NRG2,PSME1,ITPR2,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,ADRBK1,SHC3,PIK3CA,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,PRKAR2B,DUSP4,ITPR3,RASA1,IRS2,FGFR2,NRG1,GAB1
R-HSA-2022928	HS-GAG biosynthesis	0.00217171202735941	-6.13223946978916	31	8	0.0124031007751938	645	8202	9394,11046,3339,6385,9953,6382,9348,26035	HS6ST1,SLC35D2,HSPG2,SDC4,HS3ST3B1,SDC1,NDST3,GLCE
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.00223591661321656	-6.10310401722164	13	5	0.00775193798449612	645	8202	2064,9542,3084,2065,207	ERBB2,NRG2,NRG1,ERBB3,AKT1
R-HSA-5626467	RHO GTPases activate IQGAPs	0.00223591661321656	-6.10310401722164	13	5	0.00775193798449612	645	8202	808,128239,999,8826,801	CALM3,IQGAP3,CDH1,IQGAP1,CALM1
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.00233864321170333	-6.05818434183391	85	15	0.0232558139534884	645	8202	5154,8660,207,2263,3164,5295,5290,1027,9542,2064,3084,2065,5293,9965,2549	PDGFA,IRS2,AKT1,FGFR2,NR4A1,PIK3R1,PIK3CA,CDKN1B,NRG2,ERBB2,NRG1,ERBB3,PIK3CD,FGF19,GAB1
R-HSA-180292	GAB1 signalosome	0.00234039106078417	-6.05743724358228	102	17	0.0263565891472868	645	8202	207,3164,5295,9542,2064,192670,23239,9965,5154,8660,2263,5290,1027,3084,2065,5293,2549	AKT1,NR4A1,PIK3R1,NRG2,ERBB2,AGO4,PHLPP1,FGF19,PDGFA,IRS2,FGFR2,PIK3CA,CDKN1B,NRG1,ERBB3,PIK3CD,GAB1
R-HSA-186763	Downstream signal transduction	0.00240195115489093	-6.0314738907139	322	40	0.062015503875969	645	8202	5721,8826,5922,5716,2064,808,9542,5720,3709,23239,5566,6710,9965,5154,156,53358,5290,11221,1027,5293,2065,221002,10125,10817,207,3164,9693,5295,801,2902,192670,5577,1846,3710,9564,5921,8660,2263,3084,2549	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,CALM3,NRG2,PSME1,ITPR2,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,ADRBK1,SHC3,PIK3CA,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,PRKAR2B,DUSP4,ITPR3,BCAR1,RASA1,IRS2,FGFR2,NRG1,GAB1
R-HSA-4086398	Ca2+ pathway	0.00244994997677866	-6.01168767227531	61	12	0.0186046511627907	645	8202	10681,8322,801,5592,808,192670,6932,3709,7855,3710,5330,8323	GNB5,FZD4,CALM1,PRKG1,CALM3,AGO4,TCF7,ITPR2,FZD5,ITPR3,PLCB2,FZD6
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.00244994997677866	-6.01168767227531	61	12	0.0186046511627907	645	8202	5154,8660,2263,5295,5290,9542,2064,3084,2065,5293,9965,2549	PDGFA,IRS2,FGFR2,PIK3R1,PIK3CA,NRG2,ERBB2,NRG1,ERBB3,PIK3CD,FGF19,GAB1
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.00275173878617578	-5.89552228123005	54	11	0.0170542635658915	645	8202	1514,1292,3655,1515,1291,649,80781,1287,1294,4017,7093	CTSL,COL6A2,ITGA6,CTSV,COL6A1,BMP1,COL18A1,COL4A5,COL7A1,LOXL2,TLL2
R-HSA-168256	Immune System	0.00289275618589108	-5.84554553379819	1371	134	0.207751937984496	645	8202	59307,23321,6890,26232,9542,3606,5720,3709,55128,6710,30011,10053,6196,63916,53358,3572,5290,11221,7220,3660,5293,10125,64167,147945,81603,1604,11274,83737,192670,5577,127544,3984,64127,2549,23586,9902,3133,3134,5922,140462,9493,808,7006,23239,92912,118788,5592,970,3107,79902,10112,801,3437,2002,5921,10235,9261,5819,57161,4792,84166,5476,5337,126433,64135,340061,5721,6195,8826,2064,221687,598,29126,5566,5154,533,999,5336,1027,4940,3434,221002,10817,4599,10484,207,5588,1846,79754,3710,958,837,9021,8660,6892,5795,3084,6300,10810,90293,51191,5716,9965,3105,151636,156,1075,51465,147700,6737,5600,11059,2065,6850,55223,4644,3164,9693,5295,7319,2902,7525,2353,3832,1514,3106,2263,1515,23220,51752,3685,1062,11065,945	SIGIRR,TRIM2,TAP1,FBXO2,NRG2,IL18,PSME1,ITPR2,TRIM68,SPTB,SH3KBP1,AP1M2,RPS6KA2,ELMO2,SHC3,IL6ST,PIK3CA,DUSP10,TRPC1,IRF2,PIK3CD,RASGRP1,ERAP2,NLRP4,TRIM8,CD55,USP18,ITCH,AGO4,PRKAR2B,RNF19B,LIMK1,NOD2,GAB1,DDX58,MRC2,HLA-E,HLA-F,RASA2,ASB9,KIF23,CALM3,TEC,PHLPP1,UBE2Q2,PIK3AP1,PRKG1,CD70,HLA-C,NUP85,KIF20A,CALM1,IFIT3,ELK1,RASA1,RASGRP2,MAPKAPK2,PVRL2,PELI2,NFKBIA,NLRC5,CTSA,PLD1,FBXO27,IFIH1,TMEM173,PSME2,RPS6KA1,IQGAP1,ERBB2,RNF182,BCL2L1,CD274,PRKACA,PDGFA,ATP6V0B,CDH1,PLCG2,CDKN1B,OAS3,IFIT1,RASGEF1A,FRS3,MX1,SEC23A,AKT1,PRKCQ,DUSP4,ASB13,ITPR3,CD40,CASP4,SOCS3,IRS2,TAPBP,PTPRJ,NRG1,MAPK12,WASF3,KLHL13,HERC5,PSMD10,FGF19,HLA-A,DTX3L,ADRBK1,CTSC,UBE2J1,KLC3,TRIM21,MAPK11,WWP1,ERBB3,SYK,TRIM62,MYO5A,NR4A1,RAPGEF2,PIK3R1,UBE2A,GRIN1,YES1,FOS,KIF11,CTSL,HLA-B,FGFR2,CTSV,DTX4,ERAP1,ITGAV,CENPE,UBE2C,CD33
R-HSA-2029485	Role of phospholipids in phagocytosis	0.00315160192617416	-5.7598444074195	26	7	0.0108527131782946	645	8202	5337,3709,3710,6850,5336,5295,5290	PLD1,ITPR2,ITPR3,SYK,PLCG2,PIK3R1,PIK3CA
R-HSA-5663202	Diseases of signal transduction	0.00353733985513452	-5.64438028767088	268	34	0.0527131782945736	645	8202	5721,79885,5716,2064,9542,7046,5720,83999,9965,9372,8323,9734,5154,11064,5290,1027,2065,5293,89780,3280,27248,207,8322,3164,5295,139285,84441,54492,8660,2263,3065,3084,7855,2549	PSME2,HDAC11,PSMD10,ERBB2,NRG2,TGFBR1,PSME1,KREMEN1,FGF19,ZFYVE9,FZD6,HDAC9,PDGFA,CNTRL,PIK3CA,CDKN1B,ERBB3,PIK3CD,WNT3A,HES1,ERLEC1,AKT1,FZD4,NR4A1,PIK3R1,AMER1,MAML2,NEURL1B,IRS2,FGFR2,HDAC1,NRG1,FZD5,GAB1
R-HSA-168249	Innate Immune System	0.00391542582643955	-5.54283118752581	752	79	0.122480620155039	645	8202	59307,5721,6195,8826,2064,9542,5720,598,3709,5566,6710,5154,6196,63916,53358,5336,5290,1027,11221,3660,5293,221002,10125,10817,147945,1604,207,83737,5588,192670,5577,1846,3710,837,8660,3984,64127,3084,2549,6300,23586,10810,5922,3133,51191,808,5716,7006,23239,9965,156,6737,5600,2065,3107,6850,4644,3164,9693,801,5295,2902,7525,2002,2353,5921,10235,1514,9261,3106,2263,57161,4792,1515,84166,23220,5337,64135,340061	SIGIRR,PSME2,RPS6KA1,IQGAP1,ERBB2,NRG2,PSME1,BCL2L1,ITPR2,PRKACA,SPTB,PDGFA,RPS6KA2,ELMO2,SHC3,PLCG2,PIK3CA,CDKN1B,DUSP10,IRF2,PIK3CD,RASGEF1A,RASGRP1,FRS3,NLRP4,CD55,AKT1,ITCH,PRKCQ,AGO4,PRKAR2B,DUSP4,ITPR3,CASP4,IRS2,LIMK1,NOD2,NRG1,GAB1,MAPK12,DDX58,WASF3,RASA2,HLA-E,HERC5,CALM3,PSMD10,TEC,PHLPP1,FGF19,ADRBK1,TRIM21,MAPK11,ERBB3,HLA-C,SYK,MYO5A,NR4A1,RAPGEF2,CALM1,PIK3R1,GRIN1,YES1,ELK1,FOS,RASA1,RASGRP2,CTSL,MAPKAPK2,HLA-B,FGFR2,PELI2,NFKBIA,CTSV,NLRC5,DTX4,PLD1,IFIH1,TMEM173
R-HSA-1236975	Antigen processing-Cross presentation	0.00392921821157233	-5.53931480124293	81	14	0.0217054263565891	645	8202	1514,3106,6892,9902,5721,3133,3134,1515,6890,5716,5720,3685,3107,3105	CTSL,HLA-B,TAPBP,MRC2,PSME2,HLA-E,HLA-F,CTSV,TAP1,PSMD10,PSME1,ITGAV,HLA-C,HLA-A
R-HSA-2428924	IGF1R signaling cascade	0.00419634478590819	-5.47354142168369	281	35	0.0542635658914729	645	8202	5563,5721,8826,5922,5716,2064,9542,808,5720,6710,9965,5154,3480,53358,5290,11221,2065,221002,10125,10817,207,9693,5295,801,2902,55437,1846,6009,5921,8660,51422,2263,51719,3084,2549	PRKAA2,PSME2,IQGAP1,RASA2,PSMD10,ERBB2,NRG2,CALM3,PSME1,SPTB,FGF19,PDGFA,IGF1R,SHC3,PIK3CA,DUSP10,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,PIK3R1,CALM1,GRIN1,STRADB,DUSP4,RHEB,RASA1,IRS2,PRKAG2,FGFR2,CAB39,NRG1,GAB1
R-HSA-2428928	IRS-related events triggered by IGF1R	0.00419634478590819	-5.47354142168369	281	35	0.0542635658914729	645	8202	5563,5721,8826,5922,5716,2064,9542,808,5720,6710,9965,5154,3480,53358,5290,11221,2065,221002,10125,10817,207,9693,5295,801,2902,55437,1846,6009,5921,8660,51422,2263,51719,3084,2549	PRKAA2,PSME2,IQGAP1,RASA2,PSMD10,ERBB2,NRG2,CALM3,PSME1,SPTB,FGF19,PDGFA,IGF1R,SHC3,PIK3CA,DUSP10,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,PIK3R1,CALM1,GRIN1,STRADB,DUSP4,RHEB,RASA1,IRS2,PRKAG2,FGFR2,CAB39,NRG1,GAB1
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.00419634478590819	-5.47354142168369	281	35	0.0542635658914729	645	8202	5563,5721,8826,5922,5716,2064,9542,808,5720,6710,9965,5154,3480,53358,5290,11221,2065,221002,10125,10817,207,9693,5295,801,2902,55437,1846,6009,5921,8660,51422,2263,51719,3084,2549	PRKAA2,PSME2,IQGAP1,RASA2,PSMD10,ERBB2,NRG2,CALM3,PSME1,SPTB,FGF19,PDGFA,IGF1R,SHC3,PIK3CA,DUSP10,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,PIK3R1,CALM1,GRIN1,STRADB,DUSP4,RHEB,RASA1,IRS2,PRKAG2,FGFR2,CAB39,NRG1,GAB1
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.00429138746446359	-5.45114518004075	5	3	0.00465116279069767	645	8202	3159,11168,60489	HMGA1,PSIP1,APOBEC3G
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.00429138746446359	-5.45114518004075	5	3	0.00465116279069767	645	8202	6102,27031,192668	RP2,NPHP3,CYS1
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.00459697048021876	-5.38235778371037	42	9	0.013953488372093	645	8202	5154,3339,3655,6385,59277,3685,6382,780,1605	PDGFA,HSPG2,ITGA6,SDC4,NTN4,ITGAV,SDC1,DDR1,DAG1
R-HSA-1566948	Elastic fibre formation	0.00459697048021876	-5.38235778371037	42	9	0.013953488372093	645	8202	4052,10516,3696,655,5045,3685,4017,4053,2192	LTBP1,FBLN5,ITGB8,BMP7,FURIN,ITGAV,LOXL2,LTBP2,FBLN1
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.00509604223875523	-5.27929107213689	254	32	0.0496124031007752	645	8202	5721,8826,5922,5716,2064,9542,808,5720,7006,5566,9965,6710,5154,53358,5290,11221,5293,2065,221002,6850,10125,10817,9693,5295,801,2902,7525,1846,5921,8660,2263,3084	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,NRG2,CALM3,PSME1,TEC,PRKACA,FGF19,SPTB,PDGFA,SHC3,PIK3CA,DUSP10,PIK3CD,ERBB3,RASGEF1A,SYK,RASGRP1,FRS3,RAPGEF2,PIK3R1,CALM1,GRIN1,YES1,DUSP4,RASA1,IRS2,FGFR2,NRG1
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.00541902576601183	-5.21783922765548	10	4	0.0062015503875969	645	8202	5563,5600,51422,6300	PRKAA2,MAPK11,PRKAG2,MAPK12
R-HSA-1433557	Signaling by SCF-KIT	0.00569141208522176	-5.16879689199813	307	37	0.0573643410852713	645	8202	5721,8826,5922,5716,2064,808,9542,5720,7006,23239,6710,9965,5154,53358,5290,11221,1027,5293,2065,221002,10125,10817,207,10076,3164,9693,5295,801,2902,192670,7525,1846,5921,8660,2263,3084,2549	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,CALM3,NRG2,PSME1,TEC,PHLPP1,SPTB,FGF19,PDGFA,SHC3,PIK3CA,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,PTPRU,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,YES1,DUSP4,RASA1,IRS2,FGFR2,NRG1,GAB1
R-HSA-112399	IRS-mediated signalling	0.00594925303639572	-5.12448960740698	277	34	0.0527131782945736	645	8202	5563,5721,8826,5922,5716,2064,9542,808,5720,6710,9965,5154,53358,5290,11221,2065,221002,10125,10817,207,9693,5295,801,2902,55437,1846,6009,5921,8660,51422,2263,51719,3084,2549	PRKAA2,PSME2,IQGAP1,RASA2,PSMD10,ERBB2,NRG2,CALM3,PSME1,SPTB,FGF19,PDGFA,SHC3,PIK3CA,DUSP10,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,PIK3R1,CALM1,GRIN1,STRADB,DUSP4,RHEB,RASA1,IRS2,PRKAG2,FGFR2,CAB39,NRG1,GAB1
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.00601662523577287	-5.1132287689162	267	33	0.0511627906976744	645	8202	9902,90293,5721,3133,3134,6890,26232,140462,5716,221687,5720,3105,151636,92912,51465,6737,11059,3107,64167,10484,83737,7319,79754,127544,9021,1514,3106,6892,1515,51752,3685,126433,11065	MRC2,KLHL13,PSME2,HLA-E,HLA-F,TAP1,FBXO2,ASB9,PSMD10,RNF182,PSME1,HLA-A,DTX3L,UBE2Q2,UBE2J1,TRIM21,WWP1,HLA-C,ERAP2,SEC23A,ITCH,UBE2A,ASB13,RNF19B,SOCS3,CTSL,HLA-B,TAPBP,CTSV,ERAP1,ITGAV,FBXO27,UBE2C
R-HSA-445355	Smooth Muscle Contraction	0.00608354225912782	-5.10216814424527	29	7	0.0108527131782946	645	8202	10398,808,10580,10627,800,103910,801	MYL9,CALM3,SORBS1,MYL12A,CALD1,MYL12B,CALM1
R-HSA-909733	Interferon alpha/beta signaling	0.00618370943933576	-5.08583695467803	68	12	0.0186046511627907	645	8202	4599,3106,3133,3134,11274,3660,3434,4940,3107,3437,3105,9021	MX1,HLA-B,HLA-E,HLA-F,USP18,IRF2,IFIT1,OAS3,HLA-C,IFIT3,HLA-A,SOCS3
R-HSA-399956	CRMPs in Sema3A signaling	0.00622497471434286	-5.07918589859257	16	5	0.00775193798449612	645	8202	56896,5361,10371,1808,8851	DPYSL5,PLXNA1,SEMA3A,DPYSL2,CDK5R1
R-HSA-5625900	RHO GTPases activate CIT	0.00622497471434286	-5.07918589859257	16	5	0.00775193798449612	645	8202	10398,1027,11113,103910,9928	MYL9,CDKN1B,CIT,MYL12B,KIF14
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.00699340696623559	-4.96278743572386	37	8	0.0124031007751938	645	8202	156,801,808,2064,5577,3709,3710,5566	ADRBK1,CALM1,CALM3,ERBB2,PRKAR2B,ITPR2,ITPR3,PRKACA
R-HSA-449147	Signaling by Interleukins	0.00700679133279252	-4.96087540985842	311	37	0.0573643410852713	645	8202	5721,8826,5922,5716,2064,9542,808,3606,5720,7006,5566,9965,6710,5154,53358,3572,5290,11221,5293,2065,221002,6850,10125,10817,9693,5295,801,2902,7525,1846,5921,9021,8660,2263,57161,64127,3084	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,NRG2,CALM3,IL18,PSME1,TEC,PRKACA,FGF19,SPTB,PDGFA,SHC3,IL6ST,PIK3CA,DUSP10,PIK3CD,ERBB3,RASGEF1A,SYK,RASGRP1,FRS3,RAPGEF2,PIK3R1,CALM1,GRIN1,YES1,DUSP4,RASA1,SOCS3,IRS2,FGFR2,PELI2,NOD2,NRG1
R-HSA-74751	Insulin receptor signalling cascade	0.0070114787394948	-4.96020665303567	280	34	0.0527131782945736	645	8202	5563,5721,8826,5922,5716,2064,9542,808,5720,6710,9965,5154,53358,5290,11221,2065,221002,10125,10817,207,9693,5295,801,2902,55437,1846,6009,5921,8660,51422,2263,51719,3084,2549	PRKAA2,PSME2,IQGAP1,RASA2,PSMD10,ERBB2,NRG2,CALM3,PSME1,SPTB,FGF19,PDGFA,SHC3,PIK3CA,DUSP10,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,PIK3R1,CALM1,GRIN1,STRADB,DUSP4,RHEB,RASA1,IRS2,PRKAG2,FGFR2,CAB39,NRG1,GAB1
R-HSA-5627123	RHO GTPases activate PAKs	0.00731585506700391	-4.91771135906474	23	6	0.00930232558139535	645	8202	10398,808,2017,3984,103910,801	MYL9,CALM3,CTTN,LIMK1,MYL12B,CALM1
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.00740908211653478	-4.90504871825976	30	7	0.0108527131782946	645	8202	9261,5600,6196,1846,2002,2353,6195	MAPKAPK2,MAPK11,RPS6KA2,DUSP4,ELK1,FOS,RPS6KA1
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.00740908211653478	-4.90504871825976	30	7	0.0108527131782946	645	8202	808,7006,3709,3710,6850,5336,801	CALM3,TEC,ITPR2,ITPR3,SYK,PLCG2,CALM1
R-HSA-1280215	Cytokine Signaling in Immune system	0.00795656486930816	-4.83375792135184	539	58	0.089922480620155	645	8202	23586,23321,5721,8826,3133,3134,5922,5716,2064,9542,808,51191,3606,5720,7006,5566,55128,9965,6710,3105,5154,53358,3572,5290,11221,6737,3660,970,3434,5293,3107,2065,4940,221002,55223,79902,6850,10125,10817,4599,81603,9693,11274,5295,801,2902,7525,1846,3437,958,5921,9021,8660,3106,2263,57161,64127,3084	DDX58,TRIM2,PSME2,IQGAP1,HLA-E,HLA-F,RASA2,PSMD10,ERBB2,NRG2,CALM3,HERC5,IL18,PSME1,TEC,PRKACA,TRIM68,FGF19,SPTB,HLA-A,PDGFA,SHC3,IL6ST,PIK3CA,DUSP10,TRIM21,IRF2,CD70,IFIT1,PIK3CD,HLA-C,ERBB3,OAS3,RASGEF1A,TRIM62,NUP85,SYK,RASGRP1,FRS3,MX1,TRIM8,RAPGEF2,USP18,PIK3R1,CALM1,GRIN1,YES1,DUSP4,IFIT3,CD40,RASA1,SOCS3,IRS2,HLA-B,FGFR2,PELI2,NOD2,NRG1
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.00808286275824699	-4.81800916743594	6	3	0.00465116279069767	645	8202	147945,340061,23220	NLRP4,TMEM173,DTX4
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.00808286275824699	-4.81800916743594	6	3	0.00465116279069767	645	8202	808,84254,801	CALM3,CAMKK1,CALM1
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.00825774911476699	-4.79660323285078	17	5	0.00775193798449612	645	8202	808,2548,5236,5256,801	CALM3,GAA,PGM1,PHKA2,CALM1
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.00852307832828056	-4.76497769726004	54	10	0.0155038759689922	645	8202	126792,9394,11046,3339,2990,6385,9953,6382,9348,26035	B3GALT6,HS6ST1,SLC35D2,HSPG2,GUSB,SDC4,HS3ST3B1,SDC1,NDST3,GLCE
R-HSA-112043	PLC beta mediated events	0.00857396074204284	-4.75902548953822	46	9	0.013953488372093	645	8202	5321,156,801,808,5577,3709,3710,5566,5330	PLA2G4A,ADRBK1,CALM1,CALM3,PRKAR2B,ITPR2,ITPR3,PRKACA,PLCB2
R-HSA-2129379	Molecules associated with elastic fibres	0.00893664839243378	-4.71759466026455	31	7	0.0108527131782946	645	8202	4052,4053,3685,10516,3696,2192,655	LTBP1,LTBP2,ITGAV,FBLN5,ITGB8,FBLN1,BMP7
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.00911989248822172	-4.69729726353756	24	6	0.00930232558139535	645	8202	9261,5600,6196,1846,2002,6195	MAPKAPK2,MAPK11,RPS6KA2,DUSP4,ELK1,RPS6KA1
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.00929985668883037	-4.67775628874485	63	11	0.0170542635658915	645	8202	5347,80321,11064,4751,10733,7283,5577,54820,95681,5566,983	PLK1,CEP70,CNTRL,NEK2,PLK4,TUBG1,PRKAR2B,NDE1,CEP41,PRKACA,CDK1
R-HSA-380284	Loss of proteins required for interphase microtubule organizationfrom the centrosome	0.00929985668883037	-4.67775628874485	63	11	0.0170542635658915	645	8202	5347,80321,11064,4751,10733,7283,5577,54820,95681,5566,983	PLK1,CEP70,CNTRL,NEK2,PLK4,TUBG1,PRKAR2B,NDE1,CEP41,PRKACA,CDK1
R-HSA-112040	G-protein mediated events	0.00988660719745233	-4.61657424605103	47	9	0.013953488372093	645	8202	5321,156,801,808,5577,3709,3710,5566,5330	PLA2G4A,ADRBK1,CALM1,CALM3,PRKAR2B,ITPR2,ITPR3,PRKACA,PLCB2
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.0100522119402976	-4.59996257513214	81	13	0.0201550387596899	645	8202	5347,80321,11064,4751,10733,7283,6790,5577,54820,95681,5566,9133,983	PLK1,CEP70,CNTRL,NEK2,PLK4,TUBG1,AURKA,PRKAR2B,NDE1,CEP41,PRKACA,CCNB2,CDK1
R-HSA-912631	Regulation of signaling by CBL	0.0107081396832494	-4.53675110865291	18	5	0.00775193798449612	645	8202	5293,7525,6850,5295,5290	PIK3CD,YES1,SYK,PIK3R1,PIK3CA
R-HSA-203615	eNOS activation	0.0112526070094999	-4.48715544300016	12	4	0.0062015503875969	645	8202	808,207,801,340481	CALM3,AKT1,CALM1,ZDHHC21
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	0.0112526070094999	-4.48715544300016	12	4	0.0062015503875969	645	8202	808,207,6697,801	CALM3,AKT1,SPR,CALM1
R-HSA-1660662	Glycosphingolipid metabolism	0.0113132194779012	-4.48178337172205	40	8	0.0124031007751938	645	8202	22901,3074,427,5476,2717,411,80772,2760	ARSG,HEXB,ASAH1,CTSA,GLA,ARSB,CPTP,GM2A
R-HSA-157118	Signaling by NOTCH	0.0117696072759393	-4.44223472479685	110	16	0.0248062015503876	645	8202	3280,83737,79885,7157,5045,192670,84441,5870,54492,92737,9734,595,4192,23220,3065,7088	HES1,ITCH,HDAC11,TP53,FURIN,AGO4,MAML2,RAB6A,NEURL1B,DNER,HDAC9,CCND1,MDK,DTX4,HDAC1,TLE1
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.0120286974137257	-4.42046003301884	168	22	0.0341085271317829	645	8202	207,3164,5721,5295,5716,2064,9542,192670,5720,23239,9965,5154,8660,2263,4792,5290,1027,3084,2065,5293,2549,10125	AKT1,NR4A1,PSME2,PIK3R1,PSMD10,ERBB2,NRG2,AGO4,PSME1,PHLPP1,FGF19,PDGFA,IRS2,FGFR2,NFKBIA,PIK3CA,CDKN1B,NRG1,ERBB3,PIK3CD,GAB1,RASGRP1
R-HSA-1236394	Signaling by ERBB4	0.0123197288010086	-4.3965533340242	312	36	0.0558139534883721	645	8202	5721,8826,5922,5716,2064,9542,808,5720,23239,6710,9965,5154,53358,5290,11221,1027,11059,5293,2065,221002,10125,10817,207,3164,83737,9693,5295,801,2902,192670,1846,5921,8660,2263,3084,2549	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,NRG2,CALM3,PSME1,PHLPP1,SPTB,FGF19,PDGFA,SHC3,PIK3CA,DUSP10,CDKN1B,WWP1,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,NR4A1,ITCH,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,DUSP4,RASA1,IRS2,FGFR2,NRG1,GAB1
R-HSA-5694530	Cargo concentration in the ER	0.0126643638894148	-4.36896322265525	33	7	0.0108527131782946	645	8202	10484,1294,1522,90411,5265,3998,1075	SEC23A,COL7A1,CTSZ,MCFD2,SERPINA1,LMAN1,CTSC
R-HSA-199920	CREB phosphorylation	0.013324591230039	-4.31814398632092	7	3	0.00465116279069767	645	8202	9261,6196,6195	MAPKAPK2,RPS6KA2,RPS6KA1
R-HSA-2214320	Anchoring fibril formation	0.013324591230039	-4.31814398632092	7	3	0.00465116279069767	645	8202	1294,649,7093	COL7A1,BMP1,TLL2
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	0.013324591230039	-4.31814398632092	7	3	0.00465116279069767	645	8202	5347,9133,983	PLK1,CCNB2,CDK1
R-HSA-74752	Signaling by Insulin receptor	0.0139038173902671	-4.27559184415674	304	35	0.0542635658914729	645	8202	5563,5721,8826,5922,5716,2064,9542,808,5720,6710,9965,5154,533,53358,5290,11221,2065,221002,10125,10817,207,9693,5295,801,2902,55437,1846,6009,5921,8660,51422,2263,51719,3084,2549	PRKAA2,PSME2,IQGAP1,RASA2,PSMD10,ERBB2,NRG2,CALM3,PSME1,SPTB,FGF19,PDGFA,ATP6V0B,SHC3,PIK3CA,DUSP10,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,PIK3R1,CALM1,GRIN1,STRADB,DUSP4,RHEB,RASA1,IRS2,PRKAG2,FGFR2,CAB39,NRG1,GAB1
R-HSA-5683057	MAPK family signaling cascades	0.0142892323066122	-4.24824901090388	273	32	0.0496124031007752	645	8202	5721,8826,5922,5716,2064,808,9542,5720,5566,6710,9965,5154,53358,3572,11221,2065,221002,2118,10125,10817,9693,801,2902,192670,1846,983,5921,8660,8202,2263,3084,3315	PSME2,IQGAP1,RASA2,PSMD10,ERBB2,CALM3,NRG2,PSME1,PRKACA,SPTB,FGF19,PDGFA,SHC3,IL6ST,DUSP10,ERBB3,RASGEF1A,ETV4,RASGRP1,FRS3,RAPGEF2,CALM1,GRIN1,AGO4,DUSP4,CDK1,RASA1,IRS2,NCOA3,FGFR2,NRG1,HSPB1
R-HSA-428157	Sphingolipid metabolism	0.0148479459061829	-4.20989374611688	76	12	0.0186046511627907	645	8202	221,22901,8613,3074,427,5476,2717,411,80772,224,2760,8879	ALDH3B1,ARSG,PLPP3,HEXB,ASAH1,CTSA,GLA,ARSB,CPTP,ALDH3A2,GM2A,SGPL1
R-HSA-1489509	DAG and IP3 signaling	0.0148969762069304	-4.20659702575784	34	7	0.0108527131782946	645	8202	808,5577,3709,156,3710,5566,801	CALM3,PRKAR2B,ITPR2,ADRBK1,ITPR3,PRKACA,CALM1
R-HSA-3928662	EPHB-mediated forward signaling	0.015120789678061	-4.19168468220957	42	8	0.0124031007751938	645	8202	64283,3984,2902,2050,7525,7074,1947,5921	ARHGEF28,LIMK1,GRIN1,EPHB4,YES1,TIAM1,EFNB1,RASA1
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.015120789678061	-4.19168468220957	42	8	0.0124031007751938	645	8202	2778,10681,8826,3790,5577,3709,3710,5566	GNAS,GNB5,IQGAP1,KCNS3,PRKAR2B,ITPR2,ITPR3,PRKACA
R-HSA-5210891	Uptake and function of anthrax toxins	0.0152600249635884	-4.18251861724326	13	4	0.0062015503875969	645	8202	808,84168,801,5045	CALM3,ANTXR1,CALM1,FURIN
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	0.0152600249635884	-4.18251861724326	13	4	0.0062015503875969	645	8202	808,3709,3710,801	CALM3,ITPR2,ITPR3,CALM1
R-HSA-2682334	EPH-Ephrin signaling	0.0159721619367897	-4.13690795104032	95	14	0.0217054263565891	645	8202	10398,64283,3984,2043,2902,1946,7525,2050,2041,7074,10627,1947,103910,5921	MYL9,ARHGEF28,LIMK1,EPHA4,GRIN1,EFNA5,YES1,EPHB4,EPHA1,TIAM1,MYL12A,EFNB1,MYL12B,RASA1
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.0164041527900703	-4.11022075729976	27	6	0.00930232558139535	645	8202	808,23007,3706,5330,5336,801	CALM3,PLCH1,ITPKA,PLCB2,PLCG2,CALM1
R-HSA-109582	Hemostasis	0.0166065751155106	-4.09795657074727	515	54	0.0837209302325581	645	8202	5321,5270,3655,1609,22927,7157,9493,808,3709,5566,5154,10681,2624,5336,928,5592,5290,147700,3660,5293,2149,6850,10125,490,3920,10112,207,5329,5295,801,10362,8654,5588,5577,2161,481,7525,3710,80005,9564,3832,8526,10235,2778,160851,27345,5265,5547,3065,5269,1062,3685,23348,10938	PLA2G4A,SERPINE2,ITGA6,DGKQ,HABP4,TP53,KIF23,CALM3,ITPR2,PRKACA,PDGFA,GNB5,GATA2,PLCG2,CD9,PRKG1,PIK3CA,KLC3,IRF2,PIK3CD,F2R,SYK,RASGRP1,ATP2B1,LAMP2,KIF20A,AKT1,PLAUR,PIK3R1,CALM1,HMG20B,PDE5A,PRKCQ,PRKAR2B,F12,ATP1B1,YES1,ITPR3,DOCK5,BCAR1,KIF11,DGKE,RASGRP2,GNAS,DGKH,KCNMB4,SERPINA1,PRCP,HDAC1,SERPINB6,CENPE,ITGAV,DOCK9,EHD1
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.0166887218871696	-4.0930221237992	51	9	0.013953488372093	645	8202	337876,126792,3339,6385,3074,29940,6382,411,79586	CHSY3,B3GALT6,HSPG2,SDC4,HEXB,DSE,SDC1,ARSB,CHPF
R-HSA-451927	Interleukin-2 signaling	0.0168949467341066	-4.08074071158164	245	29	0.0449612403100775	645	8202	5721,8826,9693,5922,801,5295,2902,5716,2064,9542,808,5720,1846,9965,6710,5921,5154,8660,53358,2263,5290,11221,3084,2065,5293,221002,6850,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,PIK3R1,GRIN1,PSMD10,ERBB2,NRG2,CALM3,PSME1,DUSP4,FGF19,SPTB,RASA1,PDGFA,IRS2,SHC3,FGFR2,PIK3CA,DUSP10,NRG1,ERBB3,PIK3CD,RASGEF1A,SYK,RASGRP1,FRS3
R-HSA-177539	Autointegration results in viral DNA circles	0.0175574703991053	-4.0422757558727	3	2	0.00310077519379845	645	8202	3159,11168	HMGA1,PSIP1
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.0175574703991053	-4.0422757558727	3	2	0.00310077519379845	645	8202	3159,11168	HMGA1,PSIP1
R-HSA-109704	PI3K Cascade	0.0197871784545856	-3.92272110383322	79	12	0.0186046511627907	645	8202	8660,5563,51422,207,2263,5295,5290,51719,55437,2549,9965,6009	IRS2,PRKAA2,PRKAG2,AKT1,FGFR2,PIK3R1,PIK3CA,CAB39,STRADB,GAB1,FGF19,RHEB
R-HSA-912526	Interleukin receptor SHC signaling	0.0201106336907064	-3.90650656447045	238	28	0.0434108527131783	645	8202	5721,8826,9693,5922,801,5295,2902,5716,2064,9542,808,5720,1846,9965,6710,5921,5154,8660,53358,2263,5290,11221,3084,2065,5293,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,PIK3R1,GRIN1,PSMD10,ERBB2,NRG2,CALM3,PSME1,DUSP4,FGF19,SPTB,RASA1,PDGFA,IRS2,SHC3,FGFR2,PIK3CA,DUSP10,NRG1,ERBB3,PIK3CD,RASGEF1A,RASGRP1,FRS3
R-HSA-167021	PLC-gamma1 signalling	0.0201769740322238	-3.9032132241493	36	7	0.0108527131782946	645	8202	808,5577,3709,156,3710,5566,801	CALM3,PRKAR2B,ITPR2,ADRBK1,ITPR3,PRKACA,CALM1
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.0201769740322238	-3.9032132241493	36	7	0.0108527131782946	645	8202	808,5577,3709,156,3710,5566,801	CALM3,PRKAR2B,ITPR2,ADRBK1,ITPR3,PRKACA,CALM1
R-HSA-4641263	Regulation of FZD by ubiquitination	0.0209101578567054	-3.8675202162298	21	5	0.00775193798449612	645	8202	7855,89780,55366,8322,8323	FZD5,WNT3A,LGR4,FZD4,FZD6
R-HSA-198753	ERK/MAPK targets	0.0209101578567054	-3.8675202162298	21	5	0.00775193798449612	645	8202	5600,6196,1846,2002,6195	MAPK11,RPS6KA2,DUSP4,ELK1,RPS6KA1
R-HSA-167044	Signalling to RAS	0.0211453350155621	-3.85633596445834	239	28	0.0434108527131783	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,5921,9261,8660,5154,2263,53358,11221,5600,3084,2065,221002,10125,10817,6300	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,RASA1,MAPKAPK2,IRS2,PDGFA,FGFR2,SHC3,DUSP10,MAPK11,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3,MAPK12
R-HSA-438064	Post NMDA receptor activation events	0.023253139681285	-3.76131511601059	37	7	0.0108527131782946	645	8202	808,6196,5566,84254,6195,801,2902	CALM3,RPS6KA2,PRKACA,CAMKK1,RPS6KA1,CALM1,GRIN1
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.0240886533256915	-3.7260143657157	100	14	0.0217054263565891	645	8202	5347,11130,1058,57405,2491,113130,83540,699,1062,54820,9133,55839,983,79902	PLK1,ZWINT,CENPA,SPC25,CENPI,CDCA5,NUF2,BUB1,CENPE,NDE1,CCNB2,CENPN,CDK1,NUP85
R-HSA-71387	Metabolism of carbohydrates	0.0247157138985996	-3.70031604740471	274	31	0.048062015503876	645	8202	3161,337876,126792,2548,93010,5236,11046,9060,2026,3339,2990,10165,801,6385,3074,808,29940,6382,5566,79586,26035,2799,9394,5634,9061,2805,9953,5256,411,9348,79902	HMMR,CHSY3,B3GALT6,GAA,B3GNT7,PGM1,SLC35D2,PAPSS2,ENO2,HSPG2,GUSB,SLC25A13,CALM1,SDC4,HEXB,CALM3,DSE,SDC1,PRKACA,CHPF,GLCE,GNS,HS6ST1,PRPS2,PAPSS1,GOT1,HS3ST3B1,PHKA2,ARSB,NDST3,NUP85
R-HSA-203765	eNOS activation and regulation	0.0253589255312831	-3.67462451895094	22	5	0.00775193798449612	645	8202	808,207,6697,801,340481	CALM3,AKT1,SPR,CALM1,ZDHHC21
R-HSA-202131	Metabolism of nitric oxide	0.0253589255312831	-3.67462451895094	22	5	0.00775193798449612	645	8202	808,207,6697,801,340481	CALM3,AKT1,SPR,CALM1,ZDHHC21
R-HSA-1483249	Inositol phosphate metabolism	0.0253807809774027	-3.67376304579806	46	8	0.0124031007751938	645	8202	23007,5336,801,8821,808,51477,3706,5330	PLCH1,PLCG2,CALM1,INPP4B,CALM3,ISYNA1,ITPKA,PLCB2
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.0256948942624116	-3.66146297365007	15	4	0.0062015503875969	645	8202	147945,6737,340061,23220	NLRP4,TRIM21,TMEM173,DTX4
R-HSA-2142753	Arachidonic acid metabolism	0.0264061599167481	-3.63415796586727	55	9	0.013953488372093	645	8202	9261,5321,127281,1543,57834,113612,4048,4051,1545	MAPKAPK2,PLA2G4A,FAM213B,CYP1A1,CYP4F11,CYP2U1,LTA4H,CYP4F3,CYP1B1
R-HSA-380287	Centrosome maturation	0.0264406885180912	-3.6328512235627	73	11	0.0170542635658915	645	8202	5347,80321,11064,4751,10733,7283,5577,54820,95681,5566,983	PLK1,CEP70,CNTRL,NEK2,PLK4,TUBG1,PRKAR2B,NDE1,CEP41,PRKACA,CDK1
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.0264406885180912	-3.6328512235627	73	11	0.0170542635658915	645	8202	5347,80321,11064,4751,10733,7283,5577,54820,95681,5566,983	PLK1,CEP70,CNTRL,NEK2,PLK4,TUBG1,PRKAR2B,NDE1,CEP41,PRKACA,CDK1
R-HSA-1442490	Collagen degradation	0.0266378030043123	-3.62542390651887	38	7	0.0108527131782946	645	8202	1514,80781,4324,1299,1307,1303,5045	CTSL,COL18A1,MMP15,COL9A3,COL16A1,COL12A1,FURIN
R-HSA-1236974	ER-Phagosome pathway	0.0266790266483382	-3.62387754104631	64	10	0.0155038759689922	645	8202	3106,6892,5721,3133,3134,6890,5716,5720,3107,3105	HLA-B,TAPBP,PSME2,HLA-E,HLA-F,TAP1,PSMD10,PSME1,HLA-C,HLA-A
R-HSA-111996	Ca-dependent events	0.0269447184348294	-3.6139679772772	30	6	0.00930232558139535	645	8202	5321,808,5577,156,5566,801	PLA2G4A,CALM3,PRKAR2B,ADRBK1,PRKACA,CALM1
R-HSA-2559585	Oncogene Induced Senescence	0.0269447184348294	-3.6139679772772	30	6	0.00930232558139535	645	8202	1031,192670,2114,2113,1032,7157	CDKN2C,AGO4,ETS2,ETS1,CDKN2D,TP53
R-HSA-877300	Interferon gamma signaling	0.0271562049186884	-3.60614971658916	92	13	0.0201550387596899	645	8202	3106,81603,23321,3133,3134,6737,3660,4940,3107,55223,55128,3105,9021	HLA-B,TRIM8,TRIM2,HLA-E,HLA-F,TRIM21,IRF2,OAS3,HLA-C,TRIM62,TRIM68,HLA-A,SOCS3
R-HSA-5684996	MAPK1/MAPK3 signaling	0.0277055212208769	-3.58612356359753	234	27	0.0418604651162791	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,983,6710,9965,5921,8660,5154,2263,53358,3572,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,CDK1,SPTB,FGF19,RASA1,IRS2,PDGFA,FGFR2,SHC3,IL6ST,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-375165	NCAM signaling for neurite out-growth	0.0278822214553099	-3.57976601709223	266	30	0.0465116279069767	645	8202	1299,1292,5721,8826,9693,5922,801,2902,5716,2064,808,9542,1287,5720,1846,6710,9965,5921,8660,5154,9048,2263,53358,1291,11221,3084,2065,221002,10125,10817	COL9A3,COL6A2,PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,COL4A5,PSME1,DUSP4,SPTB,FGF19,RASA1,IRS2,PDGFA,ARTN,FGFR2,SHC3,COL6A1,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.0283995859511497	-3.56138071310612	9	3	0.00465116279069767	645	8202	113612,1543,1545	CYP2U1,CYP1A1,CYP1B1
R-HSA-2243919	Crosslinking of collagen fibrils	0.0283995859511497	-3.56138071310612	9	3	0.00465116279069767	645	8202	4017,649,7093	LOXL2,BMP1,TLL2
R-HSA-425986	Sodium/Proton exchangers	0.0283995859511497	-3.56138071310612	9	3	0.00465116279069767	645	8202	10479,6549,84679	SLC9A6,SLC9A2,SLC9A7
R-HSA-73614	Pyrimidine salvage reactions	0.0283995859511497	-3.56138071310612	9	3	0.00465116279069767	645	8202	1890,1633,978	TYMP,DCK,CDA
R-HSA-187687	Signalling to ERKs	0.0296060893791697	-3.5197752165408	246	28	0.0434108527131783	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,5921,9261,8660,5154,2263,53358,11221,5600,3084,2065,221002,10125,10817,6300	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,RASA1,MAPKAPK2,IRS2,PDGFA,FGFR2,SHC3,DUSP10,MAPK11,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3,MAPK12
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.0303429915396332	-3.4951897094072	39	7	0.0108527131782946	645	8202	5625,501,10157,1428,144193,3034,2184	PRODH,ALDH7A1,AASS,CRYM,AMDHD1,HAL,FAH
R-HSA-2586552	Signaling by Leptin	0.0304718750414279	-3.49095115058124	236	27	0.0418604651162791	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,3953,5921,9021,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,LEPR,RASA1,SOCS3,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.0312666552445316	-3.46520307695162	31	6	0.00930232558139535	645	8202	80781,4324,7077,4326,1515,5045	COL18A1,MMP15,TIMP2,MMP17,CTSV,FURIN
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.0320018590102545	-3.44196128379935	48	8	0.0124031007751938	645	8202	156,801,808,5577,3709,3710,5566,9965	ADRBK1,CALM1,CALM3,PRKAR2B,ITPR2,ITPR3,PRKACA,FGF19
R-HSA-156711	Polo-like kinase mediated events	0.0321848674450189	-3.43625889201893	16	4	0.0062015503875969	645	8202	5347,2305,9133,4605	PLK1,FOXM1,CCNB2,MYBL2
R-HSA-392517	Rap1 signalling	0.0321848674450189	-3.43625889201893	16	4	0.0062015503875969	645	8202	5566,10125,5592,10235	PRKACA,RASGRP1,PRKG1,RASGRP2
R-HSA-1834941	STING mediated induction of host immune responses	0.0321848674450189	-3.43625889201893	16	4	0.0062015503875969	645	8202	147945,6737,340061,23220	NLRP4,TRIM21,TMEM173,DTX4
R-HSA-2871796	FCERI mediated MAPK activation	0.0324462301652617	-3.42817101622442	248	28	0.0434108527131783	645	8202	5721,8826,9693,5922,801,2902,5716,2064,9542,808,5720,1846,2353,6710,9965,5921,5154,8660,53358,2263,5336,11221,3084,2065,221002,6850,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,NRG2,CALM3,PSME1,DUSP4,FOS,SPTB,FGF19,RASA1,PDGFA,IRS2,SHC3,FGFR2,PLCG2,DUSP10,NRG1,ERBB3,RASGEF1A,SYK,RASGRP1,FRS3
R-HSA-3858494	Beta-catenin independent WNT signaling	0.0329761552260389	-3.4119705476023	144	18	0.027906976744186	645	8202	8322,5721,801,144165,808,5716,192670,6932,5720,3709,4919,3710,8323,8324,10681,5592,7855,5330	FZD4,PSME2,CALM1,PRICKLE1,CALM3,PSMD10,AGO4,TCF7,PSME1,ITPR2,ROR1,ITPR3,FZD6,FZD7,GNB5,PRKG1,FZD5,PLCB2
R-HSA-442745	Activation of CaMK IV	0.0332917510568543	-3.4024456286928	4	2	0.00310077519379845	645	8202	808,801	CALM3,CALM1
R-HSA-167060	NGF processing	0.0332917510568543	-3.4024456286928	4	2	0.00310077519379845	645	8202	5045,5125	FURIN,PCSK5
R-HSA-69275	G2/M Transition	0.035293245528923	-3.34406367814135	115	15	0.0232558139534884	645	8202	5347,80321,2305,11064,4605,4751,10733,7283,6790,5577,95681,54820,5566,9133,983	PLK1,CEP70,FOXM1,CNTRL,MYBL2,NEK2,PLK4,TUBG1,AURKA,PRKAR2B,CEP41,NDE1,PRKACA,CCNB2,CDK1
R-HSA-373755	Semaphorin interactions	0.0354143482087886	-3.34063822432856	67	10	0.0155038759689922	645	8202	10398,56896,10507,1808,3984,2064,5361,10371,103910,8851	MYL9,DPYSL5,SEMA4D,DPYSL2,LIMK1,ERBB2,PLXNA1,SEMA3A,MYL12B,CDK5R1
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.0359314561170861	-3.32614215217952	86	12	0.0186046511627907	645	8202	10810,63916,3984,5336,5295,5290,3709,5337,7525,3710,6850,4644	WASF3,ELMO2,LIMK1,PLCG2,PIK3R1,PIK3CA,ITPR2,PLD1,YES1,ITPR3,SYK,MYO5A
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.0359632571965012	-3.32525749515752	24	5	0.00775193798449612	645	8202	10398,2064,10507,3984,103910	MYL9,ERBB2,SEMA4D,LIMK1,MYL12B
R-HSA-1614635	Sulfur amino acid metabolism	0.0359632571965012	-3.32525749515752	24	5	0.00775193798449612	645	8202	2805,2730,191,2729,1491	GOT1,GCLM,AHCY,GCLC,CTH
R-HSA-382551	Transmembrane transport of small molecules	0.0376000418680969	-3.28075011507369	586	58	0.089922480620155	645	8202	11046,10079,1831,10396,5349,9914,9429,2495,6542,6507,338440,5566,80024,6574,55107,6549,84679,533,120,6337,28965,10681,23446,23678,261729,20,6446,5205,7220,215,11059,57181,6558,53373,79902,490,4645,64116,196527,55343,4891,5577,148229,481,57205,2778,28231,476,8671,22841,540,10479,5243,6508,376497,123606,79901,9619	SLC35D2,ATP9A,TSC22D3,ATP8A1,FXYD3,ATP2C2,ABCG2,FTH1,SLC7A2,SLC1A3,ANO9,PRKACA,SLC8B1,SLC20A1,ANO1,SLC9A2,SLC9A7,ATP6V0B,ADD3,SCNN1A,SLC27A6,GNB5,SLC44A1,SGK3,STEAP2,ABCA2,SGK1,ATP8B1,TRPC1,ABCD1,WWP1,SLC39A10,SLC12A2,TPCN1,NUP85,ATP2B1,MYO5B,SLC39A8,ANO6,SLC35C1,SLC11A2,PRKAR2B,ATP8B3,ATP1B1,ATP10D,GNAS,SLCO4A1,ATP1A1,SLC4A4,RAB11FIP2,ATP7B,SLC9A6,ABCB1,SLC4A3,SLC27A1,NIPA1,CYBRD1,ABCG1
R-HSA-418889	Ligand-independent caspase activation via DCC	0.038248397459634	-3.26365361606743	10	3	0.00465116279069767	645	8202	23604,219699,1612	DAPK2,UNC5B,DAPK1
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.0383092220869159	-3.26206462622057	241	27	0.0418604651162791	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,3709,1846,3710,6710,9965,5921,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,ITPR2,DUSP4,ITPR3,SPTB,FGF19,RASA1,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.0387573598599654	-3.25043460934748	41	7	0.0108527131782946	645	8202	808,6196,5566,84254,6195,801,2902	CALM3,RPS6KA2,PRKACA,CAMKK1,RPS6KA1,CALM1,GRIN1
R-HSA-373760	L1CAM interactions	0.0396900258592079	-3.22665536065782	97	13	0.0201550387596899	645	8202	8506,6331,6196,1808,6195,3685,6326,1741,214,6710,10048,8828,6328	CNTNAP1,SCN5A,RPS6KA2,DPYSL2,RPS6KA1,ITGAV,SCN2A,DLG3,ALCAM,SPTB,RANBP9,NRP2,SCN3A
R-HSA-163685	Integration of energy metabolism	0.0401403367095083	-3.21537354727074	107	14	0.0217054263565891	645	8202	2778,5563,32,51422,10681,8826,9254,3790,5577,3709,3710,292,5566,5330	GNAS,PRKAA2,ACACB,PRKAG2,GNB5,IQGAP1,CACNA2D2,KCNS3,PRKAR2B,ITPR2,ITPR3,SLC25A5,PRKACA,PLCB2
R-HSA-453274	Mitotic G2-G2/M phases	0.0402702044428504	-3.21214342732882	117	15	0.0232558139534884	645	8202	5347,80321,2305,11064,4605,4751,10733,7283,6790,5577,95681,54820,5566,9133,983	PLK1,CEP70,FOXM1,CNTRL,MYBL2,NEK2,PLK4,TUBG1,AURKA,PRKAR2B,CEP41,NDE1,PRKACA,CCNB2,CDK1
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.041206163608513	-3.18916743166757	33	6	0.00930232558139535	645	8202	4534,5287,5293,5295,8821,5290	MTM1,PIK3C2B,PIK3CD,PIK3R1,INPP4B,PIK3CA
R-HSA-68877	Mitotic Prometaphase	0.0429374527146978	-3.14801081025903	108	14	0.0217054263565891	645	8202	5347,11130,1058,57405,2491,113130,83540,699,1062,54820,9133,55839,983,79902	PLK1,ZWINT,CENPA,SPC25,CENPI,CDCA5,NUF2,BUB1,CENPE,NDE1,CCNB2,CENPN,CDK1,NUP85
R-HSA-373752	Netrin-1 signaling	0.0434846738969152	-3.1353467271771	42	7	0.0108527131782946	645	8202	7220,5306,5588,59277,219699,4756,56963	TRPC1,PITPNA,PRKCQ,NTN4,UNC5B,NEO1,RGMA
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.0439976037996792	-3.12362010564503	51	8	0.0124031007751938	645	8202	156,2263,801,808,5577,3709,3710,5566	ADRBK1,FGFR2,CALM1,CALM3,PRKAR2B,ITPR2,ITPR3,PRKACA
R-HSA-556833	Metabolism of lipids and lipoproteins	0.0461927212061173	-3.07493304295783	628	61	0.0945736434108527	645	8202	5321,5563,127281,4534,32,3339,3074,427,64900,6382,5566,7005,8879,1040,1543,1490,29841,57834,22901,622,23446,2172,5290,215,5293,8309,2182,9524,200576,224,10499,2760,6837,1545,10484,9415,9926,5295,5465,3417,80772,4051,9261,8202,221,51422,10555,23097,8613,8821,649,376497,5476,5287,113612,2717,5337,411,4048,19,9619	PLA2G4A,PRKAA2,FAM213B,MTM1,ACACB,HSPG2,HEXB,ASAH1,LPIN3,SDC1,PRKACA,TEAD3,SGPL1,CDS1,CYP1A1,CTGF,GRHL1,CYP4F11,ARSG,BDH1,SLC44A1,FABP6,PIK3CA,ABCD1,PIK3CD,ACOX2,ACSL4,TECR,PIKFYVE,ALDH3A2,NCOA2,GM2A,MED22,CYP1B1,SEC23A,FADS2,LPGAT1,PIK3R1,PPARA,IDH1,CPTP,CYP4F3,MAPKAPK2,NCOA3,ALDH3B1,PRKAG2,AGPAT2,CDK19,PLPP3,INPP4B,BMP1,SLC27A1,CTSA,PIK3C2B,CYP2U1,GLA,PLD1,ARSB,LTA4H,ABCA1,ABCG1
R-HSA-4791275	Signaling by WNT in cancer	0.0468438466238893	-3.06093562099663	34	6	0.00930232558139535	645	8202	7855,89780,8322,83999,139285,8323	FZD5,WNT3A,FZD4,KREMEN1,AMER1,FZD6
R-HSA-3928663	EPHA-mediated growth cone collapse	0.0468438466238893	-3.06093562099663	34	6	0.00930232558139535	645	8202	10398,1946,7525,2041,103910,2043	MYL9,EFNA5,YES1,EPHA1,MYL12B,EPHA4
R-HSA-422356	Regulation of insulin secretion	0.0475814176656068	-3.04531297914122	80	11	0.0170542635658915	645	8202	2778,10681,8826,9254,3790,5577,3709,3710,292,5566,5330	GNAS,GNB5,IQGAP1,CACNA2D2,KCNS3,PRKAR2B,ITPR2,ITPR3,SLC25A5,PRKACA,PLCB2
R-HSA-1430728	Metabolism	0.0483466592599393	-3.02935815440404	1691	150	0.232558139534884	645	8202	2548,32,11046,3339,10157,122481,1428,10165,3074,9254,5720,3709,4942,6382,79586,1890,1543,1490,29841,9061,23446,5290,316,3790,5293,8309,9524,1545,978,5577,292,3417,4051,23007,9394,5167,10555,649,5287,2717,3706,5563,127281,9429,808,427,4697,51477,1345,2799,760,10476,622,191,200576,55967,5330,79902,224,64087,56603,337876,9415,5625,93010,9926,801,4682,144193,1528,26035,9261,2778,2235,131870,8202,51422,1633,8613,5634,5476,5337,7498,5321,4534,1728,9060,5721,8826,64900,5566,1040,57834,2172,5336,2805,2182,5256,6820,2760,1491,10484,207,53354,6303,3710,116228,53905,221,23097,8821,376497,113612,9953,4048,19,9348,2730,2026,6385,3034,645,5716,29940,6697,2950,7005,340481,8879,10681,22901,501,215,10499,6837,2184,126792,3161,5236,26873,217,2990,2729,5295,5465,80772,36,5243,411,9619	GAA,ACACB,SLC35D2,HSPG2,AASS,AK7,CRYM,SLC25A13,HEXB,CACNA2D2,PSME1,ITPR2,OAT,SDC1,CHPF,TYMP,CYP1A1,CTGF,GRHL1,PAPSS1,SLC44A1,PIK3CA,AOX1,KCNS3,PIK3CD,ACOX2,TECR,CYP1B1,CDA,PRKAR2B,SLC25A5,IDH1,CYP4F3,PLCH1,HS6ST1,ENPP1,AGPAT2,BMP1,PIK3C2B,GLA,ITPKA,PRKAA2,FAM213B,ABCG2,CALM3,ASAH1,NDUFA4,ISYNA1,COX6C,GNS,CA2,ATP5H,BDH1,AHCY,PIKFYVE,NDUFA12,PLCB2,NUP85,ALDH3A2,MCCC2,CYP26B1,CHSY3,FADS2,PRODH,B3GNT7,LPGAT1,CALM1,NUBP1,AMDHD1,CYB5A,GLCE,MAPKAPK2,GNAS,FECH,NUDT16,NCOA3,PRKAG2,DCK,PLPP3,PRPS2,CTSA,PLD1,XDH,PLA2G4A,MTM1,NQO1,PAPSS2,PSME2,IQGAP1,LPIN3,PRKACA,CDS1,CYP4F11,FABP6,PLCG2,GOT1,ACSL4,PHKA2,SULT2B1,GM2A,CTH,SEC23A,AKT1,PANK1,SAT1,ITPR3,COX20,DUOX1,ALDH3B1,CDK19,INPP4B,SLC27A1,CYP2U1,HS3ST3B1,LTA4H,ABCA1,NDST3,GCLM,ENO2,SDC4,HAL,BLVRB,PSMD10,DSE,SPR,GSTP1,TEAD3,ZDHHC21,SGPL1,GNB5,ARSG,ALDH7A1,ABCD1,NCOA2,MED22,FAH,B3GALT6,HMMR,PGM1,OPLAH,ALDH2,GUSB,GCLC,PIK3R1,PPARA,CPTP,ACADSB,ABCB1,ARSB,ABCG1
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.0485135837870692	-3.02591144216934	90	12	0.0186046511627907	645	8202	5347,79867,80321,11064,10733,4751,7283,5577,95681,54820,5566,983	PLK1,TCTN2,CEP70,CNTRL,PLK4,NEK2,TUBG1,PRKAR2B,CEP41,NDE1,PRKACA,CDK1
R-HSA-983189	Kinesins	0.0489364378916411	-3.01723300883029	26	5	0.00775193798449612	645	8202	9493,1062,10112,3832,147700	KIF23,CENPE,KIF20A,KIF11,KLC3
R-HSA-71064	Lysine catabolism	0.0495946082264459	-3.00387315627206	11	3	0.00465116279069767	645	8202	501,10157,1428	ALDH7A1,AASS,CRYM
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.0495946082264459	-3.00387315627206	11	3	0.00465116279069767	645	8202	5563,32,51422	PRKAA2,ACACB,PRKAG2
R-HSA-5655291	Signaling by FGFR4 in disease	0.0495946082264459	-3.00387315627206	11	3	0.00465116279069767	645	8202	2549,5295,5290	GAB1,PIK3R1,PIK3CA
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	0.052625326785333	-2.94455777730133	5	2	0.00310077519379845	645	8202	808,801	CALM3,CALM1
R-HSA-2161517	Abacavir transmembrane transport	0.052625326785333	-2.94455777730133	5	2	0.00310077519379845	645	8202	5243,9429	ABCB1,ABCG2
R-HSA-157881	Cyclin B2 mediated events	0.052625326785333	-2.94455777730133	5	2	0.00310077519379845	645	8202	9133,983	CCNB2,CDK1
R-HSA-69478	G2/M DNA replication checkpoint	0.052625326785333	-2.94455777730133	5	2	0.00310077519379845	645	8202	9133,983	CCNB2,CDK1
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.052625326785333	-2.94455777730133	5	2	0.00310077519379845	645	8202	5563,51422	PRKAA2,PRKAG2
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.052625326785333	-2.94455777730133	5	2	0.00310077519379845	645	8202	2673,6675	GFPT1,UAP1
R-HSA-1980143	Signaling by NOTCH1	0.0540700526192066	-2.91747480242046	72	10	0.0155038759689922	645	8202	3280,83737,79885,23220,7088,3065,84441,54492,92737,9734	HES1,ITCH,HDAC11,DTX4,TLE1,HDAC1,MAML2,NEURL1B,DNER,HDAC9
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.055551364441384	-2.890447200797	228	25	0.0387596899224806	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,5921,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,RASA1,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.055551364441384	-2.890447200797	228	25	0.0387596899224806	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,5921,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,RASA1,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-180336	SHC1 events in EGFR signaling	0.055551364441384	-2.890447200797	228	25	0.0387596899224806	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,5921,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,RASA1,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-5673001	RAF/MAP kinase cascade	0.055551364441384	-2.890447200797	228	25	0.0387596899224806	645	8202	5721,8826,9693,5922,801,2902,5716,2064,9542,808,5720,1846,6710,9965,5921,5154,8660,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,NRG2,CALM3,PSME1,DUSP4,SPTB,FGF19,RASA1,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-179812	GRB2 events in EGFR signaling	0.055551364441384	-2.890447200797	228	25	0.0387596899224806	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,5921,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,RASA1,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-112412	SOS-mediated signalling	0.055551364441384	-2.890447200797	228	25	0.0387596899224806	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,5921,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,RASA1,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.055551364441384	-2.890447200797	228	25	0.0387596899224806	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,5921,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,RASA1,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.0563301390509749	-2.87652555757199	27	5	0.00775193798449612	645	8202	207,9564,6850,10125,10235	AKT1,BCAR1,SYK,RASGRP1,RASGRP2
R-HSA-180024	DARPP-32 events	0.0563301390509749	-2.87652555757199	27	5	0.00775193798449612	645	8202	808,5577,5144,5566,801	CALM3,PRKAR2B,PDE4D,PRKACA,CALM1
R-HSA-400685	Sema4D in semaphorin signaling	0.0563301390509749	-2.87652555757199	27	5	0.00775193798449612	645	8202	10398,2064,10507,3984,103910	MYL9,ERBB2,SEMA4D,LIMK1,MYL12B
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.0579366375234263	-2.84840532209392	229	25	0.0387596899224806	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,5921,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,RASA1,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.0579366375234263	-2.84840532209392	229	25	0.0387596899224806	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,5921,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,RASA1,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.0579366375234263	-2.84840532209392	229	25	0.0387596899224806	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,5921,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,RASA1,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.0579366375234263	-2.84840532209392	229	25	0.0387596899224806	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,5921,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,RASA1,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-76002	Platelet activation, signaling and aggregation	0.060393962134258	-2.80686614370277	230	25	0.0387596899224806	645	8202	5321,3920,207,1609,801,5295,22927,808,5588,3709,3710,9564,8526,10235,160851,5154,5265,10681,5336,5290,928,5293,2149,6850,10125	PLA2G4A,LAMP2,AKT1,DGKQ,CALM1,PIK3R1,HABP4,CALM3,PRKCQ,ITPR2,ITPR3,BCAR1,DGKE,RASGRP2,DGKH,PDGFA,SERPINA1,GNB5,PLCG2,PIK3CA,CD9,PIK3CD,F2R,SYK,RASGRP1
R-HSA-983712	Ion channel transport	0.0617009238986291	-2.78545637413705	198	22	0.0341085271317829	645	8202	10079,1831,10396,5349,196527,9914,148229,481,338440,57205,55107,533,6337,476,540,23678,6446,7220,5205,11059,53373,490	ATP9A,TSC22D3,ATP8A1,FXYD3,ANO6,ATP2C2,ATP8B3,ATP1B1,ANO9,ATP10D,ANO1,ATP6V0B,SCNN1A,ATP1A1,ATP7B,SGK3,SGK1,TRPC1,ATP8B1,WWP1,TPCN1,ATP2B1
R-HSA-2160916	Hyaluronan uptake and degradation	0.0623752753005655	-2.77458631128387	12	3	0.00465116279069767	645	8202	3161,2990,3074	HMMR,GUSB,HEXB
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.0623752753005655	-2.77458631128387	12	3	0.00465116279069767	645	8202	808,1741,801	CALM3,DLG3,CALM1
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.0623752753005655	-2.77458631128387	12	3	0.00465116279069767	645	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.0623752753005655	-2.77458631128387	12	3	0.00465116279069767	645	8202	808,1741,801	CALM3,DLG3,CALM1
R-HSA-211958	Miscellaneous substrates	0.0623752753005655	-2.77458631128387	12	3	0.00465116279069767	645	8202	113612,57834,4051	CYP2U1,CYP4F11,CYP4F3
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.0623752753005655	-2.77458631128387	12	3	0.00465116279069767	645	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-111885	Opioid Signalling	0.0637694183326535	-2.75248154002863	84	11	0.0170542635658915	645	8202	5321,156,10681,801,808,5577,5144,3709,3710,5566,5330	PLA2G4A,ADRBK1,GNB5,CALM1,CALM3,PRKAR2B,PDE4D,ITPR2,ITPR3,PRKACA,PLCB2
R-HSA-194315	Signaling by Rho GTPases	0.0643046568631799	-2.74412322636137	399	40	0.062015503875969	645	8202	10398,9824,10810,50650,64411,57405,9322,11113,2491,8826,808,83540,5585,55839,27237,999,9928,147700,1027,699,2017,128239,7074,79902,10499,5347,116984,1058,11130,801,1730,397,29,83478,3984,23221,1062,54820,103910,50649	MYL9,ARHGAP11A,WASF3,ARHGEF3,ARAP3,SPC25,TRIP10,CIT,CENPI,IQGAP1,CALM3,NUF2,PKN1,CENPN,ARHGEF16,CDH1,KIF14,KLC3,CDKN1B,BUB1,CTTN,IQGAP3,TIAM1,NUP85,NCOA2,PLK1,ARAP2,CENPA,ZWINT,CALM1,DIAPH2,ARHGDIB,ABR,ARHGAP24,LIMK1,RHOBTB2,CENPE,NDE1,MYL12B,ARHGEF4
R-HSA-111933	Calmodulin induced events	0.0643302003861044	-2.74372607859277	28	5	0.00775193798449612	645	8202	808,5577,156,5566,801	CALM3,PRKAR2B,ADRBK1,PRKACA,CALM1
R-HSA-111997	CaM pathway	0.0643302003861044	-2.74372607859277	28	5	0.00775193798449612	645	8202	808,5577,156,5566,801	CALM3,PRKAR2B,ADRBK1,PRKACA,CALM1
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.0643302003861044	-2.74372607859277	28	5	0.00775193798449612	645	8202	51719,5563,55437,51422,6009	CAB39,PRKAA2,STRADB,PRKAG2,RHEB
R-HSA-170984	ARMS-mediated activation	0.0655281737711377	-2.7252750949115	232	25	0.0387596899224806	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,5921,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,RASA1,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-187706	Signalling to p38 via RIT and RIN	0.0655281737711377	-2.7252750949115	232	25	0.0387596899224806	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,5921,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,RASA1,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.066011110162493	-2.71793221532724	46	7	0.0108527131782946	645	8202	808,5577,3709,156,3710,5566,801	CALM3,PRKAR2B,ITPR2,ADRBK1,ITPR3,PRKACA,CALM1
R-HSA-3000170	Syndecan interactions	0.0668741473065948	-2.70494282440285	20	4	0.0062015503875969	645	8202	3685,6382,3655,6385	ITGAV,SDC1,ITGA6,SDC4
R-HSA-170968	Frs2-mediated activation	0.0682066652562566	-2.68521298787793	233	25	0.0387596899224806	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,5921,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,RASA1,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.0687436163611782	-2.67737139967487	424	42	0.0651162790697674	645	8202	5721,6195,8826,5922,1609,5716,2064,9542,808,5720,3709,6710,9965,2915,5154,6196,156,10681,53358,5290,11221,2065,221002,2149,5330,10125,10817,9693,5295,801,2902,5588,1846,3710,5921,8526,1909,10235,160851,8660,2263,3084	PSME2,RPS6KA1,IQGAP1,RASA2,DGKQ,PSMD10,ERBB2,NRG2,CALM3,PSME1,ITPR2,SPTB,FGF19,GRM5,PDGFA,RPS6KA2,ADRBK1,GNB5,SHC3,PIK3CA,DUSP10,ERBB3,RASGEF1A,F2R,PLCB2,RASGRP1,FRS3,RAPGEF2,PIK3R1,CALM1,GRIN1,PRKCQ,DUSP4,ITPR3,RASA1,DGKE,EDNRA,RASGRP2,DGKH,IRS2,FGFR2,NRG1
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.0729328273059974	-2.61821643534408	29	5	0.00775193798449612	645	8202	860,1490,10499,7005,5465	RUNX2,CTGF,NCOA2,TEAD3,PPARA
R-HSA-5339562	Uptake and actions of bacterial toxins	0.0729328273059974	-2.61821643534408	29	5	0.00775193798449612	645	8202	808,84168,801,5045,928	CALM3,ANTXR1,CALM1,FURIN,CD9
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.0729328273059974	-2.61821643534408	29	5	0.00775193798449612	645	8202	808,6196,6195,801,2902	CALM3,RPS6KA2,RPS6KA1,CALM1,GRIN1
R-HSA-169893	Prolonged ERK activation events	0.0737901161392281	-2.60653048399756	235	25	0.0387596899224806	645	8202	5721,8826,9693,5922,801,2902,5716,2064,808,9542,5720,1846,6710,9965,5921,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,IQGAP1,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,ERBB2,CALM3,NRG2,PSME1,DUSP4,SPTB,FGF19,RASA1,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-70921	Histidine catabolism	0.0748965587981375	-2.59164733346452	6	2	0.00310077519379845	645	8202	144193,3034	AMDHD1,HAL
R-HSA-176417	Phosphorylation of Emi1	0.0748965587981375	-2.59164733346452	6	2	0.00310077519379845	645	8202	5347,983	PLK1,CDK1
R-HSA-174362	Transport and synthesis of PAPS	0.0748965587981375	-2.59164733346452	6	2	0.00310077519379845	645	8202	9060,9061	PAPSS2,PAPSS1
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.0748965587981375	-2.59164733346452	6	2	0.00310077519379845	645	8202	2517,2530	FUCA1,FUT8
R-HSA-111957	Cam-PDE 1 activation	0.0748965587981375	-2.59164733346452	6	2	0.00310077519379845	645	8202	808,801	CALM3,CALM1
R-HSA-444257	RSK activation	0.0748965587981375	-2.59164733346452	6	2	0.00310077519379845	645	8202	6196,6195	RPS6KA2,RPS6KA1
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.0748965587981375	-2.59164733346452	6	2	0.00310077519379845	645	8202	7046,9372	TGFBR1,ZFYVE9
R-HSA-75205	Dissolution of Fibrin Clot	0.0765098504013119	-2.5703357830231	13	3	0.00465116279069767	645	8202	5269,5270,5329	SERPINB6,SERPINE2,PLAUR
R-HSA-3270619	IRF3-mediated induction of type I IFN	0.0765098504013119	-2.5703357830231	13	3	0.00465116279069767	645	8202	147945,340061,23220	NLRP4,TMEM173,DTX4
R-HSA-174403	Glutathione synthesis and recycling	0.0765098504013119	-2.5703357830231	13	3	0.00465116279069767	645	8202	26873,2730,2729	OPLAH,GCLM,GCLC
R-HSA-171007	p38MAPK events	0.0765098504013119	-2.5703357830231	13	3	0.00465116279069767	645	8202	9261,5600,6300	MAPKAPK2,MAPK11,MAPK12
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.0765098504013119	-2.5703357830231	13	3	0.00465116279069767	645	8202	4534,200576,8821	MTM1,PIKFYVE,INPP4B
R-HSA-4641265	Repression of WNT target genes	0.0765098504013119	-2.5703357830231	13	3	0.00465116279069767	645	8202	3065,7088,6932	HDAC1,TLE1,TCF7
R-HSA-2024096	HS-GAG degradation	0.0776892036489627	-2.55503898043967	21	4	0.0062015503875969	645	8202	3339,6382,2990,6385	HSPG2,SDC1,GUSB,SDC4
R-HSA-216083	Integrin cell surface interactions	0.0777297560059749	-2.55451713473921	67	9	0.013953488372093	645	8202	1299,3696,999,3339,3655,80781,3685,1307,1605	COL9A3,ITGB8,CDH1,HSPG2,ITGA6,COL18A1,ITGAV,COL16A1,DAG1
R-HSA-389542	NADPH regeneration	0.0786393562535042	-2.54288298916981	1	1	0.00155038759689922	645	8202	3417	IDH1
R-HSA-171286	Synthesis and processing of ENV and VPU	0.0786393562535042	-2.54288298916981	1	1	0.00155038759689922	645	8202	5045	FURIN
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.0786393562535042	-2.54288298916981	1	1	0.00155038759689922	645	8202	2263	FGFR2
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.0786393562535042	-2.54288298916981	1	1	0.00155038759689922	645	8202	3417	IDH1
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.0794906679649381	-2.53211564830073	48	7	0.0108527131782946	645	8202	1946,7525,2050,2041,7074,1947,2043	EFNA5,YES1,EPHB4,EPHA1,TIAM1,EFNB1,EPHA4
R-HSA-2467813	Separation of Sister Chromatids	0.081088018591934	-2.51222006500254	161	18	0.027906976744186	645	8202	5347,11130,1058,57405,5721,2491,9232,5716,5720,83540,55839,113130,699,1062,54820,11065,9700,79902	PLK1,ZWINT,CENPA,SPC25,PSME2,CENPI,PTTG1,PSMD10,PSME1,NUF2,CENPN,CDCA5,BUB1,CENPE,NDE1,UBE2C,ESPL1,NUP85
R-HSA-165159	mTOR signalling	0.0819093691833197	-2.50214189682332	39	6	0.00930232558139535	645	8202	51719,5563,55437,51422,207,6009	CAB39,PRKAA2,STRADB,PRKAG2,AKT1,RHEB
R-HSA-174824	Lipoprotein metabolism	0.0821304490787832	-2.49944645334308	30	5	0.00775193798449612	645	8202	3339,6382,19,9619,649	HSPG2,SDC1,ABCA1,ABCG1,BMP1
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.0867861852593787	-2.44430782598043	49	7	0.0108527131782946	645	8202	808,5577,3709,156,3710,5566,801	CALM3,PRKAR2B,ITPR2,ADRBK1,ITPR3,PRKACA,CALM1
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.089318154339497	-2.41555051568654	22	4	0.0062015503875969	645	8202	5347,2305,9133,983	PLK1,FOXM1,CCNB2,CDK1
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.089318154339497	-2.41555051568654	22	4	0.0062015503875969	645	8202	2517,11320,2530,11282	FUCA1,MGAT4A,FUT8,MGAT4B
R-HSA-109703	PKB-mediated events	0.0902969737690974	-2.40465133219832	40	6	0.00930232558139535	645	8202	51719,5563,55437,51422,207,6009	CAB39,PRKAA2,STRADB,PRKAG2,AKT1,RHEB
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.0919047515163839	-2.3870025478408	14	3	0.00465116279069767	645	8202	5347,9133,983	PLK1,CCNB2,CDK1
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.0919047515163839	-2.3870025478408	14	3	0.00465116279069767	645	8202	5347,9493,10112	PLK1,KIF23,KIF20A
R-HSA-168638	NOD1/2 Signaling Pathway	0.0919119478927077	-2.38692424835712	31	5	0.00775193798449612	645	8202	5600,837,83737,6300,64127	MAPK11,CASP4,ITCH,MAPK12,NOD2
R-HSA-450294	MAP kinase activation in TLR cascade	0.0961787269197389	-2.34154707965463	60	8	0.0124031007751938	645	8202	9261,6196,6195,64127,5600,2002,1846,2353	MAPKAPK2,RPS6KA2,RPS6KA1,NOD2,MAPK11,ELK1,DUSP4,FOS
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.099525345826598	-2.30734293533065	7	2	0.00310077519379845	645	8202	7046,9372	TGFBR1,ZFYVE9
R-HSA-3323169	Defects in biotin (Btn) metabolism	0.099525345826598	-2.30734293533065	7	2	0.00310077519379845	645	8202	32,64087	ACACB,MCCC2
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.099525345826598	-2.30734293533065	7	2	0.00310077519379845	645	8202	7046,9372	TGFBR1,ZFYVE9
R-HSA-447038	NrCAM interactions	0.099525345826598	-2.30734293533065	7	2	0.00310077519379845	645	8202	1741,8828	DLG3,NRP2
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	0.099525345826598	-2.30734293533065	7	2	0.00310077519379845	645	8202	7046,9372	TGFBR1,ZFYVE9
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	0.099525345826598	-2.30734293533065	7	2	0.00310077519379845	645	8202	32,64087	ACACB,MCCC2
R-HSA-420597	Nectin/Necl  trans heterodimerization	0.099525345826598	-2.30734293533065	7	2	0.00310077519379845	645	8202	81607,5819	PVRL4,PVRL2
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.099525345826598	-2.30734293533065	7	2	0.00310077519379845	645	8202	7046,9372	TGFBR1,ZFYVE9
R-HSA-164843	2-LTR circle formation	0.099525345826598	-2.30734293533065	7	2	0.00310077519379845	645	8202	3159,11168	HMGA1,PSIP1
R-HSA-112409	RAF-independent MAPK1/3 activation	0.101728104821801	-2.28545166384179	23	4	0.0062015503875969	645	8202	11221,1846,983,3572	DUSP10,DUSP4,CDK1,IL6ST
R-HSA-3000157	Laminin interactions	0.101728104821801	-2.28545166384179	23	4	0.0062015503875969	645	8202	80781,3685,3339,3655	COL18A1,ITGAV,HSPG2,ITGA6
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.101728104821801	-2.28545166384179	23	4	0.0062015503875969	645	8202	9261,4048,57834,4051	MAPKAPK2,LTA4H,CYP4F11,CYP4F3
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.102262911303122	-2.28020822011768	32	5	0.00775193798449612	645	8202	808,10681,1741,5330,801	CALM3,GNB5,DLG3,PLCB2,CALM1
R-HSA-1483255	PI Metabolism	0.102475500263621	-2.27813153079227	51	7	0.0108527131782946	645	8202	4534,5287,5293,200576,5295,8821,5290	MTM1,PIK3C2B,PIK3CD,PIKFYVE,PIK3R1,INPP4B,PIK3CA
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.105890776236054	-2.24534712897779	92	11	0.0170542635658915	645	8202	9261,59307,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,SIGIRR,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.105890776236054	-2.24534712897779	92	11	0.0170542635658915	645	8202	9261,59307,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,SIGIRR,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.105890776236054	-2.24534712897779	92	11	0.0170542635658915	645	8202	9261,59307,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,SIGIRR,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.105890776236054	-2.24534712897779	92	11	0.0170542635658915	645	8202	9261,59307,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,SIGIRR,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.108275334975672	-2.22307789813724	82	10	0.0155038759689922	645	8202	9261,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.108275334975672	-2.22307789813724	82	10	0.0155038759689922	645	8202	9261,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.108275334975672	-2.22307789813724	82	10	0.0155038759689922	645	8202	9261,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.108406946530403	-2.22186310964599	42	6	0.00930232558139535	645	8202	3065,7088,6932,26108,207,6662	HDAC1,TLE1,TCF7,PYGO1,AKT1,SOX9
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.108457215830283	-2.22139950791269	15	3	0.00465116279069767	645	8202	2549,5295,5290	GAB1,PIK3R1,PIK3CA
R-HSA-194223	HDL-mediated lipid transport	0.108457215830283	-2.22139950791269	15	3	0.00465116279069767	645	8202	19,9619,649	ABCA1,ABCG1,BMP1
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.108457215830283	-2.22139950791269	15	3	0.00465116279069767	645	8202	2549,5295,5290	GAB1,PIK3R1,PIK3CA
R-HSA-75153	Apoptotic execution  phase	0.110860050360615	-2.19948668071839	52	7	0.0108527131782946	645	8202	5588,999,51765,3005,10059,10134,100506658	PRKCQ,CDH1,STK26,H1F0,DNM1L,BCAP31,OCLN
R-HSA-5617833	Assembly of the primary cilium	0.114505418911739	-2.16713313036764	180	19	0.0294573643410853	645	8202	5347,54585,83658,79867,80321,192668,5577,27031,5566,983,79809,11064,26146,4751,10733,7283,6102,95681,54820	PLK1,LZTFL1,DYNLRB1,TCTN2,CEP70,CYS1,PRKAR2B,NPHP3,PRKACA,CDK1,TTC21B,CNTRL,TRAF3IP1,NEK2,PLK4,TUBG1,RP2,CEP41,NDE1
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.114967105018721	-2.16310923485255	83	10	0.0155038759689922	645	8202	9261,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.117398335243851	-2.14218255189438	73	9	0.013953488372093	645	8202	5563,51422,143686,207,7157,1345,27244,6009,116228	PRKAA2,PRKAG2,SESN3,AKT1,TP53,COX6C,SESN1,RHEB,COX20
R-HSA-3700989	Transcriptional Regulation by TP53	0.117398335243851	-2.14218255189438	73	9	0.013953488372093	645	8202	5563,51422,143686,207,7157,1345,27244,6009,116228	PRKAA2,PRKAG2,SESN3,AKT1,TP53,COX6C,SESN1,RHEB,COX20
R-HSA-917937	Iron uptake and transport	0.118110452343475	-2.13613505551663	43	6	0.00930232558139535	645	8202	4891,2495,533,79901,261729,9429	SLC11A2,FTH1,ATP6V0B,CYBRD1,STEAP2,ABCG2
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.118110452343475	-2.13613505551663	43	6	0.00930232558139535	645	8202	4645,2778,5577,10681,5566,22841	MYO5B,GNAS,PRKAR2B,GNB5,PRKACA,RAB11FIP2
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.119046187505956	-2.12824373087153	137	15	0.0232558139534884	645	8202	10112,2624,7157,147700,10362,9493,3065,3660,5577,1062,80005,5566,3832,23348,10938	KIF20A,GATA2,TP53,KLC3,HMG20B,KIF23,HDAC1,IRF2,PRKAR2B,CENPE,DOCK5,PRKACA,KIF11,DOCK9,EHD1
R-HSA-381038	XBP1(S) activates chaperone genes	0.119596264011667	-2.12363367531414	53	7	0.0108527131782946	645	8202	2673,51726,56005,10130,55062,10106,5611	GFPT1,DNAJB11,MYDGF,PDIA6,WIPI1,CTDSP2,DNAJC3
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.12460073909216	-2.0826407409276	34	5	0.00775193798449612	645	8202	808,5588,10681,801,10988	CALM3,PRKCQ,GNB5,CALM1,METAP2
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.12460073909216	-2.0826407409276	34	5	0.00775193798449612	645	8202	23586,51191,64135,83737,84166	DDX58,HERC5,IFIH1,ITCH,NLRC5
R-HSA-109581	Apoptosis	0.124621502801801	-2.08247411286478	160	17	0.0263565891472868	645	8202	90427,207,5721,7157,5716,5720,5588,598,10134,23604,999,10059,3005,51765,1612,219699,100506658	BMF,AKT1,PSME2,TP53,PSMD10,PSME1,PRKCQ,BCL2L1,BCAP31,DAPK2,CDH1,DNM1L,H1F0,STK26,DAPK1,UNC5B,OCLN
R-HSA-948021	Transport to the Golgi and subsequent modification	0.12507616523264	-2.07883240537991	95	11	0.0170542635658915	645	8202	2517,10484,5265,1075,11320,2530,11282,1522,1294,90411,3998	FUCA1,SEC23A,SERPINA1,CTSC,MGAT4A,FUT8,MGAT4B,CTSZ,COL7A1,MCFD2,LMAN1
R-HSA-1253288	Downregulation of ERBB4 signaling	0.126004422445198	-2.07143827387519	8	2	0.00310077519379845	645	8202	11059,83737	WWP1,ITCH
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.126004422445198	-2.07143827387519	8	2	0.00310077519379845	645	8202	90427,598	BMF,BCL2L1
R-HSA-804914	Transport of fatty acids	0.126004422445198	-2.07143827387519	8	2	0.00310077519379845	645	8202	376497,28965	SLC27A1,SLC27A6
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.126004422445198	-2.07143827387519	8	2	0.00310077519379845	645	8202	23239,207	PHLPP1,AKT1
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.126004422445198	-2.07143827387519	8	2	0.00310077519379845	645	8202	7046,9372	TGFBR1,ZFYVE9
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.126004422445198	-2.07143827387519	8	2	0.00310077519379845	645	8202	1543,1545	CYP1A1,CYP1B1
R-HSA-2046105	Linoleic acid (LA) metabolism	0.126004422445198	-2.07143827387519	8	2	0.00310077519379845	645	8202	9415,215	FADS2,ABCD1
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.126058526996002	-2.0710089799091	16	3	0.00465116279069767	645	8202	3159,3005,7157	HMGA1,H1F0,TP53
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.126058526996002	-2.0710089799091	16	3	0.00465116279069767	645	8202	5361,10371,3984	PLXNA1,SEMA3A,LIMK1
R-HSA-1369062	ABC transporters in lipid homeostasis	0.126058526996002	-2.0710089799091	16	3	0.00465116279069767	645	8202	215,9619,20	ABCD1,ABCG1,ABCA2
R-HSA-913531	Interferon Signaling	0.127645205666487	-2.05850069442938	194	20	0.0310077519379845	645	8202	23586,4599,81603,23321,3133,3134,11274,51191,3437,55128,3105,9021,3106,3660,6737,3434,4940,3107,55223,79902	DDX58,MX1,TRIM8,TRIM2,HLA-E,HLA-F,USP18,HERC5,IFIT3,TRIM68,HLA-A,SOCS3,HLA-B,IRF2,TRIM21,IFIT1,OAS3,HLA-C,TRIM62,NUP85
R-HSA-195258	RHO GTPase Effectors	0.128605028598689	-2.05100936530944	285	28	0.0434108527131783	645	8202	10398,5347,10810,11130,1058,57405,11113,2491,8826,801,1730,808,83540,5585,55839,999,3984,9928,147700,1027,699,1062,2017,128239,54820,79902,103910,10499	MYL9,PLK1,WASF3,ZWINT,CENPA,SPC25,CIT,CENPI,IQGAP1,CALM1,DIAPH2,CALM3,NUF2,PKN1,CENPN,CDH1,LIMK1,KIF14,KLC3,CDKN1B,BUB1,CENPE,CTTN,IQGAP3,NDE1,NUP85,MYL12B,NCOA2
R-HSA-1538133	G0 and Early G1	0.128734818723643	-2.05000065921663	25	4	0.0062015503875969	645	8202	9134,3065,983,4605	CCNE2,HDAC1,CDK1,MYBL2
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.129028426617786	-2.04772253751828	85	10	0.0155038759689922	645	8202	9261,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.129028426617786	-2.04772253751828	85	10	0.0155038759689922	645	8202	9261,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-68882	Mitotic Anaphase	0.129242737108567	-2.04606295975608	172	18	0.027906976744186	645	8202	5347,11130,1058,57405,5721,2491,9232,5716,5720,83540,55839,113130,699,1062,54820,11065,9700,79902	PLK1,ZWINT,CENPA,SPC25,PSME2,CENPI,PTTG1,PSMD10,PSME1,NUF2,CENPN,CDCA5,BUB1,CENPE,NDE1,UBE2C,ESPL1,NUP85
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.134311301411425	-2.0075950284988	173	18	0.027906976744186	645	8202	5347,11130,1058,57405,5721,2491,9232,5716,5720,83540,55839,113130,699,1062,54820,11065,9700,79902	PLK1,ZWINT,CENPA,SPC25,PSME2,CENPI,PTTG1,PSMD10,PSME1,NUF2,CENPN,CDCA5,BUB1,CENPE,NDE1,UBE2C,ESPL1,NUP85
R-HSA-397014	Muscle contraction	0.135845761896152	-1.99623514053309	65	8	0.0124031007751938	645	8202	10398,10580,800,801,808,29767,103910,10627	MYL9,SORBS1,CALD1,CALM1,CALM3,TMOD2,MYL12B,MYL12A
R-HSA-2514856	The phototransduction cascade	0.136544786727093	-1.99110261028196	35	5	0.00775193798449612	645	8202	808,5588,10681,801,10988	CALM3,PRKCQ,GNB5,CALM1,METAP2
R-HSA-381070	IRE1alpha activates chaperones	0.138091792024566	-1.97983665534722	55	7	0.0108527131782946	645	8202	2673,51726,56005,10130,55062,10106,5611	GFPT1,DNAJB11,MYDGF,PDIA6,WIPI1,CTDSP2,DNAJC3
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.138754244941351	-1.97505093265169	45	6	0.00930232558139535	645	8202	595,192670,84441,5870,7157,5045	CCND1,AGO4,MAML2,RAB6A,TP53,FURIN
R-HSA-5357801	Programmed Cell Death	0.140403045136988	-1.96323809861574	163	17	0.0263565891472868	645	8202	90427,207,5721,7157,5716,5720,5588,598,10134,23604,999,10059,3005,51765,1612,219699,100506658	BMF,AKT1,PSME2,TP53,PSMD10,PSME1,PRKCQ,BCL2L1,BCAP31,DAPK2,CDH1,DNM1L,H1F0,STK26,DAPK1,UNC5B,OCLN
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.143243615239182	-1.94320849513674	26	4	0.0062015503875969	645	8202	147945,4792,340061,23220	NLRP4,NFKBIA,TMEM173,DTX4
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.143243615239182	-1.94320849513674	26	4	0.0062015503875969	645	8202	126792,3339,6382,6385	B3GALT6,HSPG2,SDC1,SDC4
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.144596698990868	-1.93380679807359	17	3	0.00465116279069767	645	8202	808,801,2902	CALM3,CALM1,GRIN1
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.144596698990868	-1.93380679807359	17	3	0.00465116279069767	645	8202	9261,5600,64127	MAPKAPK2,MAPK11,NOD2
R-HSA-176412	Phosphorylation of the APC/C	0.144596698990868	-1.93380679807359	17	3	0.00465116279069767	645	8202	5347,11065,983	PLK1,UBE2C,CDK1
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.144596698990868	-1.93380679807359	17	3	0.00465116279069767	645	8202	9261,207,167227	MAPKAPK2,AKT1,DCP2
R-HSA-5627117	RHO GTPases Activate ROCKs	0.144596698990868	-1.93380679807359	17	3	0.00465116279069767	645	8202	10398,3984,103910	MYL9,LIMK1,MYL12B
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.144596698990868	-1.93380679807359	17	3	0.00465116279069767	645	8202	5600,207,167227	MAPK11,AKT1,DCP2
R-HSA-2142845	Hyaluronan metabolism	0.144596698990868	-1.93380679807359	17	3	0.00465116279069767	645	8202	3161,2990,3074	HMMR,GUSB,HEXB
R-HSA-164378	PKA activation in glucagon signalling	0.144596698990868	-1.93380679807359	17	3	0.00465116279069767	645	8202	2778,5577,5566	GNAS,PRKAR2B,PRKACA
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	0.144596698990868	-1.93380679807359	17	3	0.00465116279069767	645	8202	9261,7538,167227	MAPKAPK2,ZFP36,DCP2
R-HSA-70326	Glucose metabolism	0.148981492908285	-1.90393318942044	77	9	0.013953488372093	645	8202	2548,5236,2026,10165,801,808,2805,5256,5566	GAA,PGM1,ENO2,SLC25A13,CALM1,CALM3,GOT1,PHKA2,PRKACA
R-HSA-1643685	Disease	0.151014702879789	-1.89037807684254	657	59	0.0914728682170543	645	8202	32,3339,5721,5611,79885,6385,808,5716,2064,9542,7046,5720,6382,83999,9965,11168,3105,9372,8323,9734,5154,10053,11064,6170,5902,928,5290,2963,1027,2065,5293,89780,60489,79902,64087,3280,27248,207,8322,3164,801,139285,5295,5045,84441,2958,54492,84168,292,3417,8660,6136,2263,4792,3065,3084,3159,7855,2549	ACACB,HSPG2,PSME2,DNAJC3,HDAC11,SDC4,CALM3,PSMD10,ERBB2,NRG2,TGFBR1,PSME1,SDC1,KREMEN1,FGF19,PSIP1,HLA-A,ZFYVE9,FZD6,HDAC9,PDGFA,AP1M2,CNTRL,RPL39,RANBP1,CD9,PIK3CA,GTF2F2,CDKN1B,ERBB3,PIK3CD,WNT3A,APOBEC3G,NUP85,MCCC2,HES1,ERLEC1,AKT1,FZD4,NR4A1,CALM1,AMER1,PIK3R1,FURIN,MAML2,GTF2A2,NEURL1B,ANTXR1,SLC25A5,IDH1,IRS2,RPL12,FGFR2,NFKBIA,HDAC1,NRG1,HMGA1,FZD5,GAB1
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.151103399076645	-1.88979091441281	2	1	0.00155038759689922	645	8202	5347	PLK1
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.151103399076645	-1.88979091441281	2	1	0.00155038759689922	645	8202	7157	TP53
R-HSA-1614603	Cysteine formation from homocysteine	0.151103399076645	-1.88979091441281	2	1	0.00155038759689922	645	8202	1491	CTH
R-HSA-380612	Metabolism of serotonin	0.151103399076645	-1.88979091441281	2	1	0.00155038759689922	645	8202	217	ALDH2
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.151103399076645	-1.88979091441281	2	1	0.00155038759689922	645	8202	7157	TP53
R-HSA-888568	GABA synthesis	0.151103399076645	-1.88979091441281	2	1	0.00155038759689922	645	8202	2571	GAD1
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.151103399076645	-1.88979091441281	2	1	0.00155038759689922	645	8202	217	ALDH2
R-HSA-70688	Proline catabolism	0.151103399076645	-1.88979091441281	2	1	0.00155038759689922	645	8202	5625	PRODH
R-HSA-111995	phospho-PLA2 pathway	0.151103399076645	-1.88979091441281	2	1	0.00155038759689922	645	8202	5321	PLA2G4A
R-HSA-1483226	Synthesis of PI	0.151103399076645	-1.88979091441281	2	1	0.00155038759689922	645	8202	1040	CDS1
R-HSA-1632852	Macroautophagy	0.153719144495952	-1.87262807864087	67	8	0.0124031007751938	645	8202	5563,51422,55062,56270,6009,115201,84971,23710	PRKAA2,PRKAG2,WIPI1,WDR45B,RHEB,ATG4A,ATG4D,GABARAPL1
R-HSA-162592	Integration of provirus	0.153891518588339	-1.87150734954324	9	2	0.00310077519379845	645	8202	3159,11168	HMGA1,PSIP1
R-HSA-425381	Bicarbonate transporters	0.153891518588339	-1.87150734954324	9	2	0.00310077519379845	645	8202	8671,6508	SLC4A4,SLC4A3
R-HSA-727802	Transport of nucleotide sugars	0.153891518588339	-1.87150734954324	9	2	0.00310077519379845	645	8202	55343,11046	SLC35C1,SLC35D2
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.153891518588339	-1.87150734954324	9	2	0.00310077519379845	645	8202	3709,3710	ITPR2,ITPR3
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.153891518588339	-1.87150734954324	9	2	0.00310077519379845	645	8202	207,3164	AKT1,NR4A1
R-HSA-1296052	Ca2+ activated K+ channels	0.153891518588339	-1.87150734954324	9	2	0.00310077519379845	645	8202	27345,3783	KCNMB4,KCNN4
R-HSA-418346	Platelet homeostasis	0.1574816546959	-1.84844630562182	78	9	0.013953488372093	645	8202	2778,5321,27345,10681,5592,8654,3709,3710,490	GNAS,PLA2G4A,KCNMB4,GNB5,PRKG1,PDE5A,ITPR2,ITPR3,ATP2B1
R-HSA-5655253	Signaling by FGFR2 in disease	0.158359002401352	-1.84289065632611	27	4	0.0062015503875969	645	8202	2263,2549,5295,5290	FGFR2,GAB1,PIK3R1,PIK3CA
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.159769099139702	-1.83402563644073	89	10	0.0155038759689922	645	8202	9261,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-71291	Metabolism of amino acids and derivatives	0.160580639427104	-1.82895903624882	212	21	0.0325581395348837	645	8202	2730,5625,1728,10157,1428,2729,5721,3034,6303,5716,5720,4942,144193,53905,36,501,191,2805,64087,2184,1491	GCLM,PRODH,NQO1,AASS,CRYM,GCLC,PSME2,HAL,SAT1,PSMD10,PSME1,OAT,AMDHD1,DUOX1,ACADSB,ALDH7A1,AHCY,GOT1,MCCC2,FAH,CTH
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.160948714937713	-1.82666950550211	47	6	0.00930232558139535	645	8202	5600,598,837,83737,6300,64127	MAPK11,BCL2L1,CASP4,ITCH,MAPK12,NOD2
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.160948714937713	-1.82666950550211	47	6	0.00930232558139535	645	8202	3065,7088,84441,3280,79885,9734	HDAC1,TLE1,MAML2,HES1,HDAC11,HDAC9
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.161859436422468	-1.82102699680333	37	5	0.00775193798449612	645	8202	207,9564,6850,10125,10235	AKT1,BCAR1,SYK,RASGRP1,RASGRP2
R-HSA-419037	NCAM1 interactions	0.161859436422468	-1.82102699680333	37	5	0.00775193798449612	645	8202	1287,1299,1292,9048,1291	COL4A5,COL9A3,COL6A2,ARTN,COL6A1
R-HSA-1839117	Signaling by FGFR1 fusion mutants	0.163958689073586	-1.80814077878181	18	3	0.00465116279069767	645	8202	11064,5295,5290	CNTRL,PIK3R1,PIK3CA
R-HSA-156584	Cytosolic sulfonation of small molecules	0.163958689073586	-1.80814077878181	18	3	0.00465116279069767	645	8202	9060,6820,9061	PAPSS2,SULT2B1,PAPSS1
R-HSA-418457	cGMP effects	0.163958689073586	-1.80814077878181	18	3	0.00465116279069767	645	8202	8654,27345,5592	PDE5A,KCNMB4,PRKG1
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.175175096439753	-1.74196925419192	38	5	0.00775193798449612	645	8202	55343,376497,28231,11046,28965	SLC35C1,SLC27A1,SLCO4A1,SLC35D2,SLC27A6
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.175175096439753	-1.74196925419192	38	5	0.00775193798449612	645	8202	5588,999,51765,10134,100506658	PRKCQ,CDH1,STK26,BCAP31,OCLN
R-HSA-2132295	MHC class II antigen presentation	0.176673324710578	-1.73345287477321	102	11	0.0170542635658915	645	8202	1514,10484,10053,10112,1075,1515,147700,9493,5476,1062,3832	CTSL,SEC23A,AP1M2,KIF20A,CTSC,CTSV,KLC3,KIF23,CTSA,CENPE,KIF11
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.182802298867792	-1.69935004417797	10	2	0.00310077519379845	645	8202	4534,200576	MTM1,PIKFYVE
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.182802298867792	-1.69935004417797	10	2	0.00310077519379845	645	8202	57181,64116	SLC39A10,SLC39A8
R-HSA-110056	MAPK3 (ERK1) activation	0.182802298867792	-1.69935004417797	10	2	0.00310077519379845	645	8202	983,3572	CDK1,IL6ST
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.182802298867792	-1.69935004417797	10	2	0.00310077519379845	645	8202	5600,2353	MAPK11,FOS
R-HSA-5621480	Dectin-2 family	0.182802298867792	-1.69935004417797	10	2	0.00310077519379845	645	8202	6850,5336	SYK,PLCG2
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.182802298867792	-1.69935004417797	10	2	0.00310077519379845	645	8202	983,55844	CDK1,PPP2R2D
R-HSA-2161522	Abacavir transport and metabolism	0.182802298867792	-1.69935004417797	10	2	0.00310077519379845	645	8202	5243,9429	ABCB1,ABCG2
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.182802298867792	-1.69935004417797	10	2	0.00310077519379845	645	8202	10053,3105	AP1M2,HLA-A
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.182802298867792	-1.69935004417797	10	2	0.00310077519379845	645	8202	7220,5306	TRPC1,PITPNA
R-HSA-5663220	RHO GTPases Activate Formins	0.183966374498027	-1.6930022853668	114	12	0.0186046511627907	645	8202	5347,11130,1058,57405,2491,1730,83540,699,1062,54820,55839,79902	PLK1,ZWINT,CENPA,SPC25,CENPI,DIAPH2,NUF2,BUB1,CENPE,NDE1,CENPN,NUP85
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.184032203904836	-1.69264451546564	19	3	0.00465116279069767	645	8202	2549,5295,5290	GAB1,PIK3R1,PIK3CA
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.184032203904836	-1.69264451546564	19	3	0.00465116279069767	645	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.184032203904836	-1.69264451546564	19	3	0.00465116279069767	645	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.184032203904836	-1.69264451546564	19	3	0.00465116279069767	645	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-1181150	Signaling by NODAL	0.184032203904836	-1.69264451546564	19	3	0.00465116279069767	645	8202	130399,10589,5045	ACVR1C,DRAP1,FURIN
R-HSA-418360	Platelet calcium homeostasis	0.184032203904836	-1.69264451546564	19	3	0.00465116279069767	645	8202	3709,3710,490	ITPR2,ITPR3,ATP2B1
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.184032203904836	-1.69264451546564	19	3	0.00465116279069767	645	8202	808,801,2902	CALM3,CALM1,GRIN1
R-HSA-3928664	Ephrin signaling	0.184032203904836	-1.69264451546564	19	3	0.00465116279069767	645	8202	2050,10627,1947	EPHB4,MYL12A,EFNB1
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.184032203904836	-1.69264451546564	19	3	0.00465116279069767	645	8202	2549,5295,5290	GAB1,PIK3R1,PIK3CA
R-HSA-1643713	Signaling by EGFR in Cancer	0.184032203904836	-1.69264451546564	19	3	0.00465116279069767	645	8202	2549,5295,5290	GAB1,PIK3R1,PIK3CA
R-HSA-73923	Lipid digestion, mobilization, and transport	0.189817580016423	-1.66169177319457	60	7	0.0108527131782946	645	8202	3339,6382,5566,19,2172,9619,649	HSPG2,SDC1,PRKACA,ABCA1,FABP6,ABCG1,BMP1
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.190206092140986	-1.65964709919986	29	4	0.0062015503875969	645	8202	595,192670,84441,7157	CCND1,AGO4,MAML2,TP53
R-HSA-445095	Interaction between L1 and Ankyrins	0.190206092140986	-1.65964709919986	29	4	0.0062015503875969	645	8202	6331,6326,6710,6328	SCN5A,SCN2A,SPTB,SCN3A
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.201004797815306	-1.60442650148005	61	7	0.0108527131782946	645	8202	56603,113612,1543,57834,4051,10499,1545	CYP26B1,CYP2U1,CYP1A1,CYP4F11,CYP4F3,NCOA2,CYP1B1
R-HSA-453276	Regulation of mitotic cell cycle	0.20328811857573	-1.59313100287059	83	9	0.013953488372093	645	8202	5347,5721,9232,4751,6790,5716,5720,11065,983	PLK1,PSME2,PTTG1,NEK2,AURKA,PSMD10,PSME1,UBE2C,CDK1
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.20328811857573	-1.59313100287059	83	9	0.013953488372093	645	8202	5347,5721,9232,4751,6790,5716,5720,11065,983	PLK1,PSME2,PTTG1,NEK2,AURKA,PSMD10,PSME1,UBE2C,CDK1
R-HSA-195721	Signaling by Wnt	0.205853048905759	-1.58059271957759	326	30	0.0465116279069767	645	8202	55366,207,8322,5721,801,139285,6662,144165,5716,808,192670,6932,5720,3709,4919,26108,3710,83999,8323,9559,8324,10681,51339,5592,3065,7088,7855,89780,5330,81847	LGR4,AKT1,FZD4,PSME2,CALM1,AMER1,SOX9,PRICKLE1,PSMD10,CALM3,AGO4,TCF7,PSME1,ITPR2,ROR1,PYGO1,ITPR3,KREMEN1,FZD6,VPS26A,FZD7,GNB5,DACT1,PRKG1,HDAC1,TLE1,FZD5,WNT3A,PLCB2,RNF146
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.206833114149021	-1.57584302272079	30	4	0.0062015503875969	645	8202	54492,92737,83737,23220	NEURL1B,DNER,ITCH,DTX4
R-HSA-445717	Aquaporin-mediated transport	0.20942771911054	-1.56337661533053	51	6	0.00930232558139535	645	8202	4645,2778,5577,10681,5566,22841	MYO5B,GNAS,PRKAR2B,GNB5,PRKACA,RAB11FIP2
R-HSA-397795	G-protein beta:gamma signalling	0.20942771911054	-1.56337661533053	51	6	0.00930232558139535	645	8202	5293,10681,207,5330,5295,5290	PIK3CD,GNB5,AKT1,PLCB2,PIK3R1,PIK3CA
R-HSA-1592230	Mitochondrial biogenesis	0.20942771911054	-1.56337661533053	51	6	0.00930232558139535	645	8202	5563,5600,51422,10499,5465,6300	PRKAA2,MAPK11,PRKAG2,NCOA2,PPARA,MAPK12
R-HSA-168898	Toll-Like Receptors Cascades	0.210171918840079	-1.55982942204169	140	14	0.0217054263565891	645	8202	9261,1514,59307,6196,6195,57161,4792,5336,1515,64127,5600,1846,2002,2353	MAPKAPK2,CTSL,SIGIRR,RPS6KA2,RPS6KA1,PELI2,NFKBIA,PLCG2,CTSV,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.212404007901299	-1.54926512020058	11	2	0.00310077519379845	645	8202	7283,983	TUBG1,CDK1
R-HSA-196780	Biotin transport and metabolism	0.212404007901299	-1.54926512020058	11	2	0.00310077519379845	645	8202	32,64087	ACACB,MCCC2
R-HSA-376172	DSCAM interactions	0.212404007901299	-1.54926512020058	11	2	0.00310077519379845	645	8202	5600,6300	MAPK11,MAPK12
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.212404007901299	-1.54926512020058	11	2	0.00310077519379845	645	8202	999,100506658	CDH1,OCLN
R-HSA-1059683	Interleukin-6 signaling	0.212404007901299	-1.54926512020058	11	2	0.00310077519379845	645	8202	3572,9021	IL6ST,SOCS3
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.212404007901299	-1.54926512020058	11	2	0.00310077519379845	645	8202	51477,8821	ISYNA1,INPP4B
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.212404007901299	-1.54926512020058	11	2	0.00310077519379845	645	8202	9133,983	CCNB2,CDK1
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.212440068005152	-1.54909536331336	62	7	0.0108527131782946	645	8202	5563,808,51422,207,9882,801,4644	PRKAA2,CALM3,PRKAG2,AKT1,TBC1D4,CALM1,MYO5A
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.213399223734079	-1.54459057773085	73	8	0.0124031007751938	645	8202	5347,5721,9232,4751,5716,5720,11065,983	PLK1,PSME2,PTTG1,NEK2,PSMD10,PSME1,UBE2C,CDK1
R-HSA-2559583	Cellular Senescence	0.21663532999771	-1.5295398460004	187	18	0.027906976744186	645	8202	9134,6195,7157,23466,192670,2353,2113,1031,9261,6196,2114,3005,1027,5600,3159,4217,11065,1032	CCNE2,RPS6KA1,TP53,CBX6,AGO4,FOS,ETS1,CDKN2C,MAPKAPK2,RPS6KA2,ETS2,H1F0,CDKN1B,MAPK11,HMGA1,MAP3K5,UBE2C,CDKN2D
R-HSA-77108	Utilization of Ketone Bodies	0.217876363419837	-1.5238275173539	3	1	0.00155038759689922	645	8202	622	BDH1
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.217876363419837	-1.5238275173539	3	1	0.00155038759689922	645	8202	5634	PRPS2
R-HSA-844455	The NLRP1 inflammasome	0.217876363419837	-1.5238275173539	3	1	0.00155038759689922	645	8202	598	BCL2L1
R-HSA-5357572	Lysosomal glycogen catabolism	0.217876363419837	-1.5238275173539	3	1	0.00155038759689922	645	8202	2548	GAA
R-HSA-3249367	STAT6-mediated induction of chemokines	0.217876363419837	-1.5238275173539	3	1	0.00155038759689922	645	8202	340061	TMEM173
R-HSA-351200	Interconversion of polyamines	0.217876363419837	-1.5238275173539	3	1	0.00155038759689922	645	8202	6303	SAT1
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.217876363419837	-1.5238275173539	3	1	0.00155038759689922	645	8202	292	SLC25A5
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.217876363419837	-1.5238275173539	3	1	0.00155038759689922	645	8202	316	AOX1
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.217876363419837	-1.5238275173539	3	1	0.00155038759689922	645	8202	90427	BMF
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.217876363419837	-1.5238275173539	3	1	0.00155038759689922	645	8202	983	CDK1
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.217876363419837	-1.5238275173539	3	1	0.00155038759689922	645	8202	2034	EPAS1
R-HSA-1307965	betaKlotho-mediated ligand binding	0.217876363419837	-1.5238275173539	3	1	0.00155038759689922	645	8202	9965	FGF19
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.221153174499147	-1.50889972026417	96	10	0.0155038759689922	645	8202	8671,10479,6508,6542,6507,6558,6574,80024,84679,6549	SLC4A4,SLC9A6,SLC4A3,SLC7A2,SLC1A3,SLC12A2,SLC20A1,SLC8B1,SLC9A7,SLC9A2
R-HSA-70263	Gluconeogenesis	0.223858472111432	-1.49674124774116	31	4	0.0062015503875969	645	8202	2805,2026,5566,10165	GOT1,ENO2,PRKACA,SLC25A13
R-HSA-418990	Adherens junctions interactions	0.223858472111432	-1.49674124774116	31	4	0.0062015503875969	645	8202	1001,81607,999,5819	CDH3,PVRL4,CDH1,PVRL2
R-HSA-4608870	Asymmetric localization of PCP proteins	0.224108238003762	-1.49562613845928	63	7	0.0108527131782946	645	8202	144165,5716,5720,7855,8322,5721,8324	PRICKLE1,PSMD10,PSME1,FZD5,FZD4,PSME2,FZD7
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.225876813643651	-1.48776550068902	21	3	0.00465116279069767	645	8202	207,5295,5290	AKT1,PIK3R1,PIK3CA
R-HSA-390918	Peroxisomal lipid metabolism	0.225876813643651	-1.48776550068902	21	3	0.00465116279069767	645	8202	215,8309,3417	ABCD1,ACOX2,IDH1
R-HSA-1500931	Cell-Cell communication	0.22926064910167	-1.47289571700874	131	13	0.0201550387596899	645	8202	81607,54751,999,5819,8826,3655,5295,5290,1001,1364,5600,64398,6300	PVRL4,FBLIM1,CDH1,PVRL2,IQGAP1,ITGA6,PIK3R1,PIK3CA,CDH3,CLDN4,MAPK11,MPP5,MAPK12
R-HSA-416482	G alpha (12/13) signalling events	0.235040634931397	-1.4479968651843	75	8	0.0124031007751938	645	8202	50650,10681,5295,5290,7074,29,27237,50649	ARHGEF3,GNB5,PIK3R1,PIK3CA,TIAM1,ABR,ARHGEF16,ARHGEF4
R-HSA-913709	O-linked glycosylation of mucins	0.235993713437015	-1.44395011229008	64	7	0.0108527131782946	645	8202	29071,2591,93010,51809,94025,79695,2650	C1GALT1C1,GALNT3,B3GNT7,GALNT7,MUC16,GALNT12,GCNT1
R-HSA-69278	Cell Cycle, Mitotic	0.238748260675287	-1.43234558477752	477	42	0.0651162790697674	645	8202	9134,80321,57405,2305,5721,2491,9232,9493,5716,83540,5720,64900,5566,55839,1031,595,11064,10733,4751,7283,1027,699,1032,79902,5347,1058,11130,10112,4605,5577,983,5557,113130,6790,3065,1062,54820,95681,9133,11065,9700,55844	CCNE2,CEP70,SPC25,FOXM1,PSME2,CENPI,PTTG1,KIF23,PSMD10,NUF2,PSME1,LPIN3,PRKACA,CENPN,CDKN2C,CCND1,CNTRL,PLK4,NEK2,TUBG1,CDKN1B,BUB1,CDKN2D,NUP85,PLK1,CENPA,ZWINT,KIF20A,MYBL2,PRKAR2B,CDK1,PRIM1,CDCA5,AURKA,HDAC1,CENPE,NDE1,CEP41,CCNB2,UBE2C,ESPL1,PPP2R2D
R-HSA-1852241	Organelle biogenesis and maintenance	0.240906161025781	-1.42334779465397	321	29	0.0449612403100775	645	8202	5563,5347,54585,83658,65080,51650,79867,80321,64960,192668,5465,5577,27031,5566,983,79809,51422,11064,26146,10733,4751,7283,28957,5600,6102,95681,54820,10499,6300	PRKAA2,PLK1,LZTFL1,DYNLRB1,MRPL44,MRPS33,TCTN2,CEP70,MRPS15,CYS1,PPARA,PRKAR2B,NPHP3,PRKACA,CDK1,TTC21B,PRKAG2,CNTRL,TRAF3IP1,PLK4,NEK2,TUBG1,MRPS28,MAPK11,RP2,CEP41,NDE1,NCOA2,MAPK12
R-HSA-1980145	Signaling by NOTCH2	0.241229266514274	-1.42200748436601	32	4	0.0062015503875969	645	8202	4192,84441,3280,54492	MDK,MAML2,HES1,NEURL1B
R-HSA-389356	CD28 co-stimulation	0.241229266514274	-1.42200748436601	32	4	0.0062015503875969	645	8202	7525,207,5295,5290	YES1,AKT1,PIK3R1,PIK3CA
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.241693511969858	-1.42008483495174	121	12	0.0186046511627907	645	8202	9261,59307,6196,6195,57161,4792,5336,64127,5600,1846,2002,2353	MAPKAPK2,SIGIRR,RPS6KA2,RPS6KA1,PELI2,NFKBIA,PLCG2,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-2022857	Keratan sulfate degradation	0.242409754424847	-1.41712578457003	12	2	0.00310077519379845	645	8202	2799,3074	GNS,HEXB
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.242409754424847	-1.41712578457003	12	2	0.00310077519379845	645	8202	23586,64135	DDX58,IFIH1
R-HSA-210990	PECAM1 interactions	0.242409754424847	-1.41712578457003	12	2	0.00310077519379845	645	8202	7525,3685	YES1,ITGAV
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.242409754424847	-1.41712578457003	12	2	0.00310077519379845	645	8202	84441,3280	MAML2,HES1
R-HSA-211979	Eicosanoids	0.242409754424847	-1.41712578457003	12	2	0.00310077519379845	645	8202	57834,4051	CYP4F11,CYP4F3
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.243418396155889	-1.41297352135092	87	9	0.013953488372093	645	8202	9261,207,5721,7538,5716,5720,5600,3315,167227	MAPKAPK2,AKT1,PSME2,ZFP36,PSMD10,PSME1,MAPK11,HSPB1,DCP2
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.247438707210565	-1.39659237527721	22	3	0.00465116279069767	645	8202	2161,5270,5547	F12,SERPINE2,PRCP
R-HSA-5655332	Signaling by FGFR3 in disease	0.247438707210565	-1.39659237527721	22	3	0.00465116279069767	645	8202	2549,5295,5290	GAB1,PIK3R1,PIK3CA
R-HSA-373753	Nephrin interactions	0.247438707210565	-1.39659237527721	22	3	0.00465116279069767	645	8202	8826,5295,5290	IQGAP1,PIK3R1,PIK3CA
R-HSA-114604	GPVI-mediated activation cascade	0.248733121987282	-1.39137475655285	54	6	0.00930232558139535	645	8202	5293,207,6850,5336,5295,5290	PIK3CD,AKT1,SYK,PLCG2,PIK3R1,PIK3CA
R-HSA-2672351	Stimuli-sensing channels	0.249971327595634	-1.38640905731471	99	10	0.0155038759689922	645	8202	6337,1831,196527,23678,7220,6446,11059,338440,53373,55107	SCNN1A,TSC22D3,ANO6,SGK3,TRPC1,SGK1,WWP1,ANO9,TPCN1,ANO1
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.249971327595634	-1.38640905731471	99	10	0.0155038759689922	645	8202	5721,4792,5336,801,808,5716,5720,3709,3710,6850	PSME2,NFKBIA,PLCG2,CALM1,CALM3,PSMD10,PSME1,ITPR2,ITPR3,SYK
R-HSA-5687128	MAPK6/MAPK4 signaling	0.253859724008274	-1.37097343220353	88	9	0.013953488372093	645	8202	8202,5721,5716,5720,192670,3315,2118,5566,983	NCOA3,PSME2,PSMD10,PSME1,AGO4,HSPB1,ETV4,PRKACA,CDK1
R-HSA-1483257	Phospholipid metabolism	0.257235247815255	-1.3577642516256	146	14	0.0217054263565891	645	8202	5321,4534,10555,9926,23446,5295,8821,5290,5287,5293,5337,64900,200576,1040	PLA2G4A,MTM1,AGPAT2,LPGAT1,SLC44A1,PIK3R1,INPP4B,PIK3CA,PIK3C2B,PIK3CD,PLD1,LPIN3,PIKFYVE,CDS1
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.258893178866013	-1.35133973916881	33	4	0.0062015503875969	645	8202	2799,93010,11046,3074	GNS,B3GNT7,SLC35D2,HEXB
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.260352454724155	-1.34571897086321	66	7	0.0108527131782946	645	8202	10484,1294,1522,90411,5265,3998,1075	SEC23A,COL7A1,CTSZ,MCFD2,SERPINA1,LMAN1,CTSC
R-HSA-5358351	Signaling by Hedgehog	0.262710529513634	-1.3367025011996	135	13	0.0201550387596899	645	8202	79809,2778,27248,156,5721,23288,83737,5716,5720,5577,147111,5566,23432	TTC21B,GNAS,ERLEC1,ADRBK1,PSME2,IQCE,ITCH,PSMD10,PSME1,PRKAR2B,NOTUM,PRKACA,GPR161
R-HSA-166054	Activated TLR4 signalling	0.264580168129412	-1.32961098049035	112	11	0.0170542635658915	645	8202	9261,59307,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,SIGIRR,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-1989781	PPARA activates gene expression	0.264580168129412	-1.32961098049035	112	11	0.0170542635658915	645	8202	8202,1543,1490,29841,23097,5465,376497,19,10499,6837,7005	NCOA3,CYP1A1,CTGF,GRHL1,CDK19,PPARA,SLC27A1,ABCA1,NCOA2,MED22,TEAD3
R-HSA-194840	Rho GTPase cycle	0.268333700635918	-1.31552392140311	124	12	0.0186046511627907	645	8202	9824,83478,116984,50650,64411,9322,23221,397,7074,29,27237,50649	ARHGAP11A,ARHGAP24,ARAP2,ARHGEF3,ARAP3,TRIP10,RHOBTB2,ARHGDIB,TIAM1,ABR,ARHGEF16,ARHGEF4
R-HSA-1502540	Signaling by Activin	0.272573373336585	-1.29984744117202	13	2	0.00310077519379845	645	8202	130399,10589	ACVR1C,DRAP1
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.272573373336585	-1.29984744117202	13	2	0.00310077519379845	645	8202	9415,215	FADS2,ABCD1
R-HSA-1679131	Trafficking and processing of endosomal TLR	0.272573373336585	-1.29984744117202	13	2	0.00310077519379845	645	8202	1514,1515	CTSL,CTSV
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.272573373336585	-1.29984744117202	13	2	0.00310077519379845	645	8202	9415,215	FADS2,ABCD1
R-HSA-2029481	FCGR activation	0.272573373336585	-1.29984744117202	13	2	0.00310077519379845	645	8202	7525,6850	YES1,SYK
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.272573373336585	-1.29984744117202	13	2	0.00310077519379845	645	8202	1027,207	CDKN1B,AKT1
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.272573373336585	-1.29984744117202	13	2	0.00310077519379845	645	8202	4919,7855	ROR1,FZD5
R-HSA-1663150	The activation of arylsulfatases	0.272573373336585	-1.29984744117202	13	2	0.00310077519379845	645	8202	411,22901	ARSB,ARSG
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.27679883750472	-1.28446425501363	34	4	0.0062015503875969	645	8202	3159,292,11168,79902	HMGA1,SLC25A5,PSIP1,NUP85
R-HSA-193648	NRAGE signals death through JNK	0.277824342688382	-1.28076622583284	45	5	0.00775193798449612	645	8202	50650,7074,27237,29,50649	ARHGEF3,TIAM1,ARHGEF16,ABR,ARHGEF4
R-HSA-1226099	Signaling by FGFR in disease	0.277824342688382	-1.28076622583284	45	5	0.00775193798449612	645	8202	2263,11064,2549,5295,5290	FGFR2,CNTRL,GAB1,PIK3R1,PIK3CA
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	0.279404567545012	-1.27509448460137	4	1	0.00155038759689922	645	8202	7046	TGFBR1
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	0.279404567545012	-1.27509448460137	4	1	0.00155038759689922	645	8202	7046	TGFBR1
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.279404567545012	-1.27509448460137	4	1	0.00155038759689922	645	8202	56648	EIF5A2
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.279404567545012	-1.27509448460137	4	1	0.00155038759689922	645	8202	6507	SLC1A3
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.279404567545012	-1.27509448460137	4	1	0.00155038759689922	645	8202	7157	TP53
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	0.279404567545012	-1.27509448460137	4	1	0.00155038759689922	645	8202	7046	TGFBR1
R-HSA-1296053	Classical Kir channels	0.279404567545012	-1.27509448460137	4	1	0.00155038759689922	645	8202	3768	KCNJ12
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.279404567545012	-1.27509448460137	4	1	0.00155038759689922	645	8202	9134	CCNE2
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.279404567545012	-1.27509448460137	4	1	0.00155038759689922	645	8202	8828	NRP2
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.279404567545012	-1.27509448460137	4	1	0.00155038759689922	645	8202	207	AKT1
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.279404567545012	-1.27509448460137	4	1	0.00155038759689922	645	8202	7157	TP53
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.279404567545012	-1.27509448460137	4	1	0.00155038759689922	645	8202	6507	SLC1A3
R-HSA-199977	ER to Golgi Anterograde Transport	0.285385584208996	-1.25391408604554	68	7	0.0108527131782946	645	8202	10484,1294,1522,90411,5265,3998,1075	SEC23A,COL7A1,CTSZ,MCFD2,SERPINA1,LMAN1,CTSC
R-HSA-4086400	PCP/CE pathway	0.286006067107875	-1.25174225472339	91	9	0.013953488372093	645	8202	8322,5721,5716,144165,5720,4919,7855,8324,8323	FZD4,PSME2,PSMD10,PRICKLE1,PSME1,ROR1,FZD5,FZD7,FZD6
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.289912212849923	-1.23817711613945	57	6	0.00930232558139535	645	8202	3065,84441,3280,54492,79885,9734	HDAC1,MAML2,HES1,NEURL1B,HDAC11,HDAC9
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.289912212849923	-1.23817711613945	57	6	0.00930232558139535	645	8202	9134,1027,5716,5720,5721,7157	CCNE2,CDKN1B,PSMD10,PSME1,PSME2,TP53
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.289912212849923	-1.23817711613945	57	6	0.00930232558139535	645	8202	3065,84441,3280,54492,79885,9734	HDAC1,MAML2,HES1,NEURL1B,HDAC11,HDAC9
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.289912212849923	-1.23817711613945	57	6	0.00930232558139535	645	8202	3065,84441,3280,54492,79885,9734	HDAC1,MAML2,HES1,NEURL1B,HDAC11,HDAC9
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.289912212849923	-1.23817711613945	57	6	0.00930232558139535	645	8202	3065,84441,3280,54492,79885,9734	HDAC1,MAML2,HES1,NEURL1B,HDAC11,HDAC9
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.289912212849923	-1.23817711613945	57	6	0.00930232558139535	645	8202	9134,1027,5716,5720,5721,7157	CCNE2,CDKN1B,PSMD10,PSME1,PSME2,TP53
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.289912212849923	-1.23817711613945	57	6	0.00930232558139535	645	8202	3065,84441,3280,54492,79885,9734	HDAC1,MAML2,HES1,NEURL1B,HDAC11,HDAC9
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.291354472315685	-1.23321463519103	24	3	0.00465116279069767	645	8202	1027,207,3164	CDKN1B,AKT1,NR4A1
R-HSA-73848	Pyrimidine metabolism	0.291354472315685	-1.23321463519103	24	3	0.00465116279069767	645	8202	1890,1633,978	TYMP,DCK,CDA
R-HSA-933542	TRAF6 mediated NF-kB activation	0.291354472315685	-1.23321463519103	24	3	0.00465116279069767	645	8202	23586,64135,4792	DDX58,IFIH1,NFKBIA
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.291354472315685	-1.23321463519103	24	3	0.00465116279069767	645	8202	8654,27345,5592	PDE5A,KCNMB4,PRKG1
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.293450869628379	-1.22604504851863	115	11	0.0170542635658915	645	8202	8202,1543,1490,29841,23097,5465,376497,19,10499,6837,7005	NCOA3,CYP1A1,CTGF,GRHL1,CDK19,PPARA,SLC27A1,ABCA1,NCOA2,MED22,TEAD3
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.298113498296318	-1.2102809982219	69	7	0.0108527131782946	645	8202	5347,5716,6790,5720,11065,5721,9232	PLK1,PSMD10,AURKA,PSME1,UBE2C,PSME2,PTTG1
R-HSA-162594	Early Phase of HIV Life Cycle	0.302684810301306	-1.19506324491621	14	2	0.00310077519379845	645	8202	3159,11168	HMGA1,PSIP1
R-HSA-2024101	CS/DS degradation	0.302684810301306	-1.19506324491621	14	2	0.00310077519379845	645	8202	411,3074	ARSB,HEXB
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.302684810301306	-1.19506324491621	14	2	0.00310077519379845	645	8202	5361,10371	PLXNA1,SEMA3A
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.302684810301306	-1.19506324491621	14	2	0.00310077519379845	645	8202	23586,64135	DDX58,IFIH1
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.308804136997781	-1.17504806390771	212	19	0.0294573643410853	645	8202	5563,32,5465,64900,7005,8202,51422,1543,1490,10555,29841,23097,622,376497,2182,9524,19,10499,6837	PRKAA2,ACACB,PPARA,LPIN3,TEAD3,NCOA3,PRKAG2,CYP1A1,CTGF,AGPAT2,GRHL1,CDK19,BDH1,SLC27A1,ACSL4,TECR,ABCA1,NCOA2,MED22
R-HSA-421837	Clathrin derived vesicle budding	0.310960052138835	-1.16809082476763	70	7	0.0108527131782946	645	8202	1362,2799,2495,1522,6272,10053,54885	CPD,GNS,FTH1,CTSZ,SORT1,AP1M2,TBC1D8B
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.310960052138835	-1.16809082476763	70	7	0.0108527131782946	645	8202	1362,2799,2495,1522,6272,10053,54885	CPD,GNS,FTH1,CTSZ,SORT1,AP1M2,TBC1D8B
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.31313649561912	-1.16111609526083	36	4	0.0062015503875969	645	8202	411,22901,56648,5045	ARSB,ARSG,EIF5A2,FURIN
R-HSA-5655302	Signaling by FGFR1 in disease	0.31313649561912	-1.16111609526083	36	4	0.0062015503875969	645	8202	11064,2549,5295,5290	CNTRL,GAB1,PIK3R1,PIK3CA
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.31313649561912	-1.16111609526083	36	4	0.0062015503875969	645	8202	221,8613,224,8879	ALDH3B1,PLPP3,ALDH3A2,SGPL1
R-HSA-114452	Activation of BH3-only proteins	0.313529879631919	-1.15986061362017	25	3	0.00465116279069767	645	8202	90427,207,7157	BMF,AKT1,TP53
R-HSA-425410	Metal ion SLC transporters	0.313529879631919	-1.15986061362017	25	3	0.00465116279069767	645	8202	4891,57181,64116	SLC11A2,SLC39A10,SLC39A8
R-HSA-193704	p75 NTR receptor-mediated signalling	0.315791292342862	-1.15267375086924	82	8	0.0124031007751938	645	8202	50650,27018,4792,3065,7074,29,27237,50649	ARHGEF3,NGFRAP1,NFKBIA,HDAC1,TIAM1,ABR,ARHGEF16,ARHGEF4
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.325116448307332	-1.12357185834331	48	5	0.00775193798449612	645	8202	5293,10681,207,5295,5290	PIK3CD,GNB5,AKT1,PIK3R1,PIK3CA
R-HSA-156590	Glutathione conjugation	0.331473108862	-1.10420859221823	37	4	0.0062015503875969	645	8202	26873,2730,2950,2729	OPLAH,GCLM,GSTP1,GCLC
R-HSA-69615	G1/S DNA Damage Checkpoints	0.332362693198569	-1.10152845696097	60	6	0.00930232558139535	645	8202	9134,1027,5716,5720,5721,7157	CCNE2,CDKN1B,PSMD10,PSME1,PSME2,TP53
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.332565978683306	-1.10091700644104	15	2	0.00310077519379845	645	8202	64900,983	LPIN3,CDK1
R-HSA-211935	Fatty acids	0.332565978683306	-1.10091700644104	15	2	0.00310077519379845	645	8202	57834,4051	CYP4F11,CYP4F3
R-HSA-159418	Recycling of bile acids and salts	0.332565978683306	-1.10091700644104	15	2	0.00310077519379845	645	8202	10499,2172	NCOA2,FABP6
R-HSA-975577	N-Glycan antennae elongation	0.332565978683306	-1.10091700644104	15	2	0.00310077519379845	645	8202	11320,11282	MGAT4A,MGAT4B
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.332565978683306	-1.10091700644104	15	2	0.00310077519379845	645	8202	89780,83999	WNT3A,KREMEN1
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.335741131509444	-1.09141485789803	26	3	0.00465116279069767	645	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-3781865	Diseases of glycosylation	0.335741131509444	-1.09141485789803	26	3	0.00465116279069767	645	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-74713	IRS activation	0.336099377733995	-1.09034839568393	5	1	0.00155038759689922	645	8202	8660	IRS2
R-HSA-1300652	Sperm:Oocyte Membrane Binding	0.336099377733995	-1.09034839568393	5	1	0.00155038759689922	645	8202	928	CD9
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	0.336099377733995	-1.09034839568393	5	1	0.00155038759689922	645	8202	5566	PRKACA
R-HSA-70370	Galactose catabolism	0.336099377733995	-1.09034839568393	5	1	0.00155038759689922	645	8202	5236	PGM1
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.336099377733995	-1.09034839568393	5	1	0.00155038759689922	645	8202	6574	SLC20A1
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.336099377733995	-1.09034839568393	5	1	0.00155038759689922	645	8202	5167	ENPP1
R-HSA-112303	Electric Transmission Across Gap Junctions	0.336099377733995	-1.09034839568393	5	1	0.00155038759689922	645	8202	56666	PANX2
R-HSA-1169092	Activation of RAS in B cells	0.336099377733995	-1.09034839568393	5	1	0.00155038759689922	645	8202	10125	RASGRP1
R-HSA-112307	Transmission across Electrical Synapses	0.336099377733995	-1.09034839568393	5	1	0.00155038759689922	645	8202	56666	PANX2
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.336942600991028	-1.08784268660522	72	7	0.0108527131782946	645	8202	5716,5720,11065,5721,983,9232,4751	PSMD10,PSME1,UBE2C,PSME2,CDK1,PTTG1,NEK2
R-HSA-421270	Cell-cell junction organization	0.3466926454235	-1.05931663960096	61	6	0.00930232558139535	645	8202	1364,1001,81607,64398,999,5819	CLDN4,CDH3,PVRL4,MPP5,CDH1,PVRL2
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.3466926454235	-1.05931663960096	61	6	0.00930232558139535	645	8202	50650,7074,27018,27237,29,50649	ARHGEF3,TIAM1,NGFRAP1,ARHGEF16,ABR,ARHGEF4
R-HSA-446203	Asparagine N-linked glycosylation	0.349674756011661	-1.05075182507447	181	16	0.0248062015503876	645	8202	2673,10484,11282,1522,1294,90411,2517,5265,6675,1075,79868,11320,2530,5476,6185,3998	GFPT1,SEC23A,MGAT4B,CTSZ,COL7A1,MCFD2,FUCA1,SERPINA1,UAP1,CTSC,ALG13,MGAT4A,FUT8,CTSA,RPN2,LMAN1
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.349861110324015	-1.05021903090128	38	4	0.0062015503875969	645	8202	90427,598,207,7157	BMF,BCL2L1,AKT1,TP53
R-HSA-69236	G1 Phase	0.349861110324015	-1.05021903090128	38	4	0.0062015503875969	645	8202	1031,1027,595,1032	CDKN2C,CDKN1B,CCND1,CDKN2D
R-HSA-69231	Cyclin D associated events in G1	0.349861110324015	-1.05021903090128	38	4	0.0062015503875969	645	8202	1031,1027,595,1032	CDKN2C,CDKN1B,CCND1,CDKN2D
R-HSA-162582	Signal Transduction	0.351777911035648	-1.04475523706483	2357	190	0.294573643410853	645	8202	10398,3339,55366,9542,5720,3709,92737,6382,55839,6710,83999,30011,2915,3352,6196,63916,53358,23288,3572,220,5290,11221,5293,2017,7074,10125,10988,5347,1604,1058,130399,83737,192670,397,5577,4919,60485,983,6009,29,1909,5228,4192,3984,8567,26018,51719,3065,3315,2549,103910,5125,5563,64411,5922,6662,1609,808,7006,5870,23239,3480,1291,23596,5592,89780,5330,79902,23432,56603,801,139285,55437,6932,2002,5921,10235,160851,9261,2778,8202,51422,4792,23221,54820,5916,81847,9824,5321,57405,9322,5721,8826,6195,79885,8601,7157,2064,83540,5566,27237,9372,595,5154,79809,533,999,51339,9928,1027,5144,221002,2149,2118,10817,1292,27248,207,10076,8322,10589,5734,5588,26108,1846,3710,8324,9021,8660,27018,558,7088,3084,6300,10810,1299,50650,11113,2491,6385,5716,1287,7046,147111,1382,5585,9965,8323,8828,9559,9734,58191,156,10681,147700,11059,5600,699,2065,128239,10253,6850,10499,51421,7050,56034,3280,116984,11130,3164,9693,5295,2902,5045,1730,144165,84441,7525,54492,9564,3953,8526,83478,2263,23220,2852,1062,3685,7855,50649	MYL9,HSPG2,LGR4,NRG2,PSME1,ITPR2,DNER,SDC1,CENPN,SPTB,KREMEN1,SH3KBP1,GRM5,HTR1D,RPS6KA2,ELMO2,SHC3,IQCE,IL6ST,ALDH1A3,PIK3CA,DUSP10,PIK3CD,CTTN,TIAM1,RASGRP1,METAP2,PLK1,CD55,CENPA,ACVR1C,ITCH,AGO4,ARHGDIB,PRKAR2B,ROR1,SAV1,CDK1,RHEB,ABR,EDNRA,PGF,MDK,LIMK1,MADD,LRIG1,CAB39,HDAC1,HSPB1,GAB1,MYL12B,PCSK5,PRKAA2,ARAP3,RASA2,SOX9,DGKQ,CALM3,TEC,RAB6A,PHLPP1,IGF1R,COL6A1,OPN3,PRKG1,WNT3A,PLCB2,NUP85,GPR161,CYP26B1,CALM1,AMER1,STRADB,TCF7,ELK1,RASA1,RASGRP2,DGKH,MAPKAPK2,GNAS,NCOA3,PRKAG2,NFKBIA,RHOBTB2,NDE1,RARG,RNF146,ARHGAP11A,PLA2G4A,SPC25,TRIP10,PSME2,IQGAP1,RPS6KA1,HDAC11,RGS20,TP53,ERBB2,NUF2,PRKACA,ARHGEF16,ZFYVE9,CCND1,PDGFA,TTC21B,ATP6V0B,CDH1,DACT1,KIF14,CDKN1B,PDE4D,RASGEF1A,F2R,ETV4,FRS3,COL6A2,ERLEC1,AKT1,PTPRU,FZD4,DRAP1,PTGER4,PRKCQ,PYGO1,DUSP4,ITPR3,FZD7,SOCS3,IRS2,NGFRAP1,AXL,TLE1,NRG1,MAPK12,WASF3,COL9A3,ARHGEF3,CIT,CENPI,SDC4,PSMD10,COL4A5,TGFBR1,NOTUM,CRABP2,PKN1,FGF19,FZD6,NRP2,VPS26A,HDAC9,CXCL16,ADRBK1,GNB5,KLC3,WWP1,MAPK11,BUB1,ERBB3,IQGAP3,SPRY2,SYK,NCOA2,AMOTL2,TGIF1,PDGFC,HES1,ARAP2,ZWINT,NR4A1,RAPGEF2,PIK3R1,GRIN1,FURIN,DIAPH2,PRICKLE1,MAML2,YES1,NEURL1B,BCAR1,LEPR,DGKE,ARHGAP24,FGFR2,DTX4,GPER1,CENPE,ITGAV,FZD5,ARHGEF4
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.353061567373445	-1.04111282543402	97	9	0.013953488372093	645	8202	9261,6196,6195,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.353061567373445	-1.04111282543402	97	9	0.013953488372093	645	8202	9261,6196,6195,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.353061567373445	-1.04111282543402	97	9	0.013953488372093	645	8202	9261,6196,6195,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-2980766	Nuclear Envelope Breakdown	0.35711615072871	-1.02969419793678	50	5	0.00775193798449612	645	8202	5347,64900,9133,983,79902	PLK1,LPIN3,CCNB2,CDK1,NUP85
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalig pathway	0.357913897643525	-1.02746283088408	27	3	0.00465116279069767	645	8202	23604,219699,1612	DAPK2,UNC5B,DAPK1
R-HSA-437239	Recycling pathway of L1	0.357913897643525	-1.02746283088408	27	3	0.00465116279069767	645	8202	6196,1808,6195	RPS6KA2,DPYSL2,RPS6KA1
R-HSA-1368082	RORA activates gene expression	0.357913897643525	-1.02746283088408	27	3	0.00465116279069767	645	8202	23411,10499,5465	SIRT1,NCOA2,PPARA
R-HSA-2262752	Cellular responses to stress	0.361903792839085	-1.0163768681162	379	32	0.0496124031007752	645	8202	9134,5563,2034,6195,7157,2950,2113,115201,1031,6196,1027,5600,1032,79902,84971,23411,259217,23466,192670,2353,6009,23710,9261,51422,2114,3005,55062,3159,4217,11065,56270,54583	CCNE2,PRKAA2,EPAS1,RPS6KA1,TP53,GSTP1,ETS1,ATG4A,CDKN2C,RPS6KA2,CDKN1B,MAPK11,CDKN2D,NUP85,ATG4D,SIRT1,HSPA12A,CBX6,AGO4,FOS,RHEB,GABARAPL1,MAPKAPK2,PRKAG2,ETS2,H1F0,WIPI1,HMGA1,MAP3K5,UBE2C,WDR45B,EGLN1
R-HSA-163615	PKA activation	0.362067043208868	-1.01592588206974	16	2	0.00310077519379845	645	8202	5577,5566	PRKAR2B,PRKACA
R-HSA-446728	Cell junction organization	0.364203301440653	-1.01004304681853	86	8	0.0124031007751938	645	8202	81607,54751,999,5819,3655,1001,1364,64398	PVRL4,FBLIM1,CDH1,PVRL2,ITGA6,CDH3,CLDN4,MPP5
R-HSA-381119	Unfolded Protein Response (UPR)	0.364203301440653	-1.01004304681853	86	8	0.0124031007751938	645	8202	2673,55062,5611,51726,56005,10130,10106,167227	GFPT1,WIPI1,DNAJC3,DNAJB11,MYDGF,PDIA6,CTDSP2,DCP2
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.368257734984573	-0.998972219149678	39	4	0.0062015503875969	645	8202	2161,5270,2149,5547	F12,SERPINE2,F2R,PRCP
R-HSA-453279	Mitotic G1-G1/S phases	0.372585672397098	-0.987288274594518	135	12	0.0186046511627907	645	8202	9134,1031,595,5721,4605,5716,1027,3065,5720,1032,983,5557	CCNE2,CDKN2C,CCND1,PSME2,MYBL2,PSMD10,CDKN1B,HDAC1,PSME1,CDKN2D,CDK1,PRIM1
R-HSA-5621481	C-type lectin receptors (CLRs)	0.373903446616922	-0.983757679023577	123	11	0.0170542635658915	645	8202	5721,4792,5336,801,5716,808,5720,3709,3710,5566,6850	PSME2,NFKBIA,PLCG2,CALM1,PSMD10,CALM3,PSME1,ITPR2,ITPR3,PRKACA,SYK
R-HSA-5610787	Hedgehog 'off' state	0.375922628448679	-0.978371932169355	99	9	0.013953488372093	645	8202	79809,2778,5721,83737,5716,5720,5577,5566,23432	TTC21B,GNAS,PSME2,ITCH,PSMD10,PSME1,PRKAR2B,PRKACA,GPR161
R-HSA-373080	Class B/2 (Secretin family receptors)	0.37643468425836	-0.977010728177324	87	8	0.0124031007751938	645	8202	2778,1604,10681,8322,89780,7855,8324,8323	GNAS,CD55,GNB5,FZD4,WNT3A,FZD5,FZD7,FZD6
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.379979909033831	-0.967636898623027	28	3	0.00465116279069767	645	8202	808,207,801	CALM3,AKT1,CALM1
R-HSA-1483166	Synthesis of PA	0.379979909033831	-0.967636898623027	28	3	0.00465116279069767	645	8202	5321,5337,10555	PLA2G4A,PLD1,AGPAT2
R-HSA-5336415	Uptake and function of diphtheria toxin	0.388339941518979	-0.945874185008159	6	1	0.00155038759689922	645	8202	928	CD9
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.388339941518979	-0.945874185008159	6	1	0.00155038759689922	645	8202	3065	HDAC1
R-HSA-68952	DNA replication initiation	0.388339941518979	-0.945874185008159	6	1	0.00155038759689922	645	8202	5557	PRIM1
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.388339941518979	-0.945874185008159	6	1	0.00155038759689922	645	8202	215	ABCD1
R-HSA-1482798	Acyl chain remodeling of CL	0.388339941518979	-0.945874185008159	6	1	0.00155038759689922	645	8202	5321	PLA2G4A
R-HSA-1237112	Methionine salvage pathway	0.388339941518979	-0.945874185008159	6	1	0.00155038759689922	645	8202	2805	GOT1
R-HSA-77111	Synthesis of Ketone Bodies	0.388339941518979	-0.945874185008159	6	1	0.00155038759689922	645	8202	622	BDH1
R-HSA-205025	NADE modulates death signalling	0.388339941518979	-0.945874185008159	6	1	0.00155038759689922	645	8202	27018	NGFRAP1
R-HSA-174430	Telomere C-strand synthesis initiation	0.388339941518979	-0.945874185008159	6	1	0.00155038759689922	645	8202	5557	PRIM1
R-HSA-211916	Vitamins	0.388339941518979	-0.945874185008159	6	1	0.00155038759689922	645	8202	56603	CYP26B1
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.388339941518979	-0.945874185008159	6	1	0.00155038759689922	645	8202	83999	KREMEN1
R-HSA-189483	Heme degradation	0.388339941518979	-0.945874185008159	6	1	0.00155038759689922	645	8202	645	BLVRB
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.391063089112537	-0.938886378783808	17	2	0.00310077519379845	645	8202	5577,5566	PRKAR2B,PRKACA
R-HSA-435354	Zinc transporters	0.391063089112537	-0.938886378783808	17	2	0.00310077519379845	645	8202	57181,64116	SLC39A10,SLC39A8
R-HSA-1482925	Acyl chain remodelling of PG	0.391063089112537	-0.938886378783808	17	2	0.00310077519379845	645	8202	5321,9926	PLA2G4A,LPGAT1
R-HSA-174800	Chylomicron-mediated lipid transport	0.391063089112537	-0.938886378783808	17	2	0.00310077519379845	645	8202	3339,6382	HSPG2,SDC1
R-HSA-189445	Metabolism of porphyrins	0.391063089112537	-0.938886378783808	17	2	0.00310077519379845	645	8202	2235,645	FECH,BLVRB
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.391878452182232	-0.936803558237309	223	19	0.0294573643410853	645	8202	90293,5721,83737,26232,140462,7319,5716,221687,5720,79754,127544,9021,151636,92912,51465,6737,11059,126433,11065	KLHL13,PSME2,ITCH,FBXO2,ASB9,UBE2A,PSMD10,RNF182,PSME1,ASB13,RNF19B,SOCS3,DTX3L,UBE2Q2,UBE2J1,TRIM21,WWP1,FBXO27,UBE2C
R-HSA-1640170	Cell Cycle	0.396371537082192	-0.925403282630558	572	47	0.0728682170542636	645	8202	9134,80321,55355,57405,2305,5721,2491,9232,7157,9493,5716,83540,5720,64900,5566,580,55839,1031,595,11064,10733,4751,7283,1027,699,1032,79902,5347,25777,11130,1058,10112,23224,4605,5577,983,5557,113130,6790,3065,1062,95681,54820,9133,11065,9700,55844	CCNE2,CEP70,HJURP,SPC25,FOXM1,PSME2,CENPI,PTTG1,TP53,KIF23,PSMD10,NUF2,PSME1,LPIN3,PRKACA,BARD1,CENPN,CDKN2C,CCND1,CNTRL,PLK4,NEK2,TUBG1,CDKN1B,BUB1,CDKN2D,NUP85,PLK1,SUN2,ZWINT,CENPA,KIF20A,SYNE2,MYBL2,PRKAR2B,CDK1,PRIM1,CDCA5,AURKA,HDAC1,CENPE,CEP41,NDE1,CCNB2,UBE2C,ESPL1,PPP2R2D
R-HSA-211945	Phase 1 - Functionalization of compounds	0.400963514702481	-0.913884841594375	89	8	0.0124031007751938	645	8202	56603,1543,217,57834,113612,4051,10499,1545	CYP26B1,CYP1A1,ALDH2,CYP4F11,CYP2U1,CYP4F3,NCOA2,CYP1B1
R-HSA-375170	CDO in myogenesis	0.401876887909366	-0.911609486248588	29	3	0.00465116279069767	645	8202	5600,4756,6300	MAPK11,NEO1,MAPK12
R-HSA-525793	Myogenesis	0.401876887909366	-0.911609486248588	29	3	0.00465116279069767	645	8202	5600,4756,6300	MAPK11,NEO1,MAPK12
R-HSA-1839124	FGFR1 mutant receptor activation	0.401876887909366	-0.911609486248588	29	3	0.00465116279069767	645	8202	11064,5295,5290	CNTRL,PIK3R1,PIK3CA
R-HSA-2871837	FCERI mediated NF-kB activation	0.402829991376006	-0.909240663670194	77	7	0.0108527131782946	645	8202	5716,5588,5720,5721,4792,10125,10235	PSMD10,PRKCQ,PSME1,PSME2,NFKBIA,RASGRP1,RASGRP2
R-HSA-162909	Host Interactions of HIV factors	0.415126058888986	-0.879173048517059	127	11	0.0170542635658915	645	8202	10053,5721,5902,5716,5720,3159,292,11168,60489,79902,3105	AP1M2,PSME2,RANBP1,PSMD10,PSME1,HMGA1,SLC25A5,PSIP1,APOBEC3G,NUP85,HLA-A
R-HSA-5635838	Activation of SMO	0.419451139113708	-0.86880823396171	18	2	0.00310077519379845	645	8202	156,23288	ADRBK1,IQCE
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.419451139113708	-0.86880823396171	18	2	0.00310077519379845	645	8202	5870,5045	RAB6A,FURIN
R-HSA-5223345	Miscellaneous transport and binding events	0.419451139113708	-0.86880823396171	18	2	0.00310077519379845	645	8202	120,123606	ADD3,NIPA1
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.419451139113708	-0.86880823396171	18	2	0.00310077519379845	645	8202	2034,54583	EPAS1,EGLN1
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.419451139113708	-0.86880823396171	18	2	0.00310077519379845	645	8202	32,64087	ACACB,MCCC2
R-HSA-210993	Tie2 Signaling	0.419451139113708	-0.86880823396171	18	2	0.00310077519379845	645	8202	5295,5290	PIK3R1,PIK3CA
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.421215052445429	-0.864611762310944	54	5	0.00775193798449612	645	8202	1362,2495,6272,10053,54885	CPD,FTH1,SORT1,AP1M2,TBC1D8B
R-HSA-5173105	O-linked glycosylation	0.421911182154271	-0.862960455926538	103	9	0.013953488372093	645	8202	2591,93010,94025,79695,29071,140766,51809,170690,2650	GALNT3,B3GNT7,MUC16,GALNT12,C1GALT1C1,ADAMTS14,GALNT7,ADAMTS16,GCNT1
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.423105407702362	-0.860133940193001	42	4	0.0062015503875969	645	8202	2908,79365,10499,5465	NR3C1,BHLHE41,NCOA2,PPARA
R-HSA-416476	G alpha (q) signalling events	0.425431188084268	-0.854652064177798	190	16	0.0248062015503876	645	8202	1609,5295,5588,3709,3710,8526,2915,10235,1909,160851,10681,156,5290,2149,5330,10125	DGKQ,PIK3R1,PRKCQ,ITPR2,ITPR3,DGKE,GRM5,RASGRP2,EDNRA,DGKH,GNB5,ADRBK1,PIK3CA,F2R,PLCB2,RASGRP1
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	0.436475707471864	-0.829022558236586	7	1	0.00155038759689922	645	8202	5566	PRKACA
R-HSA-447043	Neurofascin interactions	0.436475707471864	-0.829022558236586	7	1	0.00155038759689922	645	8202	8506	CNTNAP1
R-HSA-162791	Attachment of GPI anchor to uPAR	0.436475707471864	-0.829022558236586	7	1	0.00155038759689922	645	8202	5329	PLAUR
R-HSA-426117	Cation-coupled Chloride cotransporters	0.436475707471864	-0.829022558236586	7	1	0.00155038759689922	645	8202	6558	SLC12A2
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	0.436475707471864	-0.829022558236586	7	1	0.00155038759689922	645	8202	3280	HES1
R-HSA-74182	Ketone body metabolism	0.436475707471864	-0.829022558236586	7	1	0.00155038759689922	645	8202	622	BDH1
R-HSA-5603029	IkBA variant leads to EDA-ID	0.436475707471864	-0.829022558236586	7	1	0.00155038759689922	645	8202	4792	NFKBIA
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	0.436475707471864	-0.829022558236586	7	1	0.00155038759689922	645	8202	79661	NEIL1
R-HSA-448706	Interleukin-1 processing	0.436475707471864	-0.829022558236586	7	1	0.00155038759689922	645	8202	3606	IL18
R-HSA-426496	Post-transcriptional silencing by small RNAs	0.436475707471864	-0.829022558236586	7	1	0.00155038759689922	645	8202	192670	AGO4
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	0.436475707471864	-0.829022558236586	7	1	0.00155038759689922	645	8202	131870	NUDT16
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	0.436475707471864	-0.829022558236586	7	1	0.00155038759689922	645	8202	6932	TCF7
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.444943769701724	-0.809807365020866	31	3	0.00465116279069767	645	8202	7855,89780,139285	FZD5,WNT3A,AMER1
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.444943769701724	-0.809807365020866	31	3	0.00465116279069767	645	8202	3159,11168,79902	HMGA1,PSIP1,NUP85
R-HSA-416700	Other semaphorin interactions	0.447147484426031	-0.804866796000179	19	2	0.00310077519379845	645	8202	5361,10507	PLXNA1,SEMA4D
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.447147484426031	-0.804866796000179	19	2	0.00310077519379845	645	8202	2778,10681	GNAS,GNB5
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.452901941918963	-0.792079640685812	56	5	0.00775193798449612	645	8202	9134,1027,5716,5720,5721	CCNE2,CDKN1B,PSMD10,PSME1,PSME2
R-HSA-114608	Platelet degranulation	0.455484811870423	-0.786392906701001	81	7	0.0108527131782946	645	8202	3920,808,5154,5265,801,22927,928	LAMP2,CALM3,PDGFA,SERPINA1,CALM1,HABP4,CD9
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.455484811870423	-0.786392906701001	81	7	0.0108527131782946	645	8202	23586,51191,3660,64135,83737,4792,84166	DDX58,HERC5,IRF2,IFIH1,ITCH,NFKBIA,NLRC5
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.455484811870423	-0.786392906701001	81	7	0.0108527131782946	645	8202	3065,5716,7088,6932,5720,5721,139285	HDAC1,PSMD10,TLE1,TCF7,PSME1,PSME2,AMER1
R-HSA-5362517	Signaling by Retinoic Acid	0.45903251130432	-0.778634240701603	44	4	0.0062015503875969	645	8202	56603,1382,5916,220	CYP26B1,CRABP2,RARG,ALDH1A3
R-HSA-382556	ABC-family proteins mediated transport	0.45903251130432	-0.778634240701603	44	4	0.0062015503875969	645	8202	215,9619,5243,20	ABCD1,ABCG1,ABCB1,ABCA2
R-HSA-211859	Biological oxidations	0.45937961155604	-0.777878370303976	194	16	0.0248062015503876	645	8202	56603,26873,2730,217,9060,2729,2950,4051,1543,57834,9061,191,113612,6820,10499,1545	CYP26B1,OPLAH,GCLM,ALDH2,PAPSS2,GCLC,GSTP1,CYP4F3,CYP1A1,CYP4F11,PAPSS1,AHCY,CYP2U1,SULT2B1,NCOA2,CYP1B1
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.466017683826698	-0.763531697450541	32	3	0.00465116279069767	645	8202	7046,9372,5045	TGFBR1,ZFYVE9,FURIN
R-HSA-68886	M Phase	0.469039732453273	-0.757067796739796	296	24	0.0372093023255814	645	8202	5347,11130,1058,57405,10112,5721,2491,9232,9493,5716,5720,83540,64900,55839,983,113130,699,1062,54820,9133,11065,9700,79902,55844	PLK1,ZWINT,CENPA,SPC25,KIF20A,PSME2,CENPI,PTTG1,KIF23,PSMD10,PSME1,NUF2,LPIN3,CENPN,CDK1,CDCA5,BUB1,CENPE,NDE1,CCNB2,UBE2C,ESPL1,NUP85,PPP2R2D
R-HSA-1483191	Synthesis of PC	0.474085298800089	-0.746368018202619	20	2	0.00310077519379845	645	8202	64900,23446	LPIN3,SLC44A1
R-HSA-2028269	Signaling by Hippo	0.474085298800089	-0.746368018202619	20	2	0.00310077519379845	645	8202	51421,60485	AMOTL2,SAV1
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.474085298800089	-0.746368018202619	20	2	0.00310077519379845	645	8202	5566,2172	PRKACA,FABP6
R-HSA-418217	G beta:gamma signalling through PLC beta	0.474085298800089	-0.746368018202619	20	2	0.00310077519379845	645	8202	10681,5330	GNB5,PLCB2
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.475744999643789	-0.742873283331342	70	6	0.00930232558139535	645	8202	23586,51191,4599,3434,11274,79902	DDX58,HERC5,MX1,IFIT1,USP18,NUP85
R-HSA-1169408	ISG15 antiviral mechanism	0.475744999643789	-0.742873283331342	70	6	0.00930232558139535	645	8202	23586,51191,4599,3434,11274,79902	DDX58,HERC5,MX1,IFIT1,USP18,NUP85
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.475744999643789	-0.742873283331342	70	6	0.00930232558139535	645	8202	5716,5720,11065,5721,983,4751	PSMD10,PSME1,UBE2C,PSME2,CDK1,NEK2
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	1528	CYB5A
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	10507	SEMA4D
R-HSA-1483115	Hydrolysis of LPC	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	5321	PLA2G4A
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	5228	PGF
R-HSA-400451	Free fatty acids regulate insulin secretion	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	5330	PLCB2
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	5330	PLCB2
R-HSA-73928	Depyrimidination	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	79661	NEIL1
R-HSA-110329	Cleavage of the damaged pyrimidine	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	79661	NEIL1
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	8309	ACOX2
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	217	ALDH2
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	4792	NFKBIA
R-HSA-196783	Coenzyme A biosynthesis	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	53354	PANK1
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	147111	NOTUM
R-HSA-194313	VEGF ligand-receptor interactions	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	5228	PGF
R-HSA-1614558	Degradation of cysteine and homocysteine	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	1491	CTH
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	3685	ITGAV
R-HSA-1483148	Synthesis of PG	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	5337	PLD1
R-HSA-163765	ChREBP activates metabolic gene expression	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	32	ACACB
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.480828748191966	-0.73224410513606	8	1	0.00155038759689922	645	8202	79661	NEIL1
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.486730134320494	-0.720045448463582	33	3	0.00465116279069767	645	8202	2041,2034,57167	EPHA1,EPAS1,SALL4
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.486730134320494	-0.720045448463582	33	3	0.00465116279069767	645	8202	9133,983,79902	CCNB2,CDK1,NUP85
R-HSA-933541	TRAF6 mediated IRF7 activation	0.486730134320494	-0.720045448463582	33	3	0.00465116279069767	645	8202	23586,3660,64135	DDX58,IRF2,IFIH1
R-HSA-163359	Glucagon signaling in metabolic regulation	0.486730134320494	-0.720045448463582	33	3	0.00465116279069767	645	8202	2778,5577,5566	GNAS,PRKAR2B,PRKACA
R-HSA-418597	G alpha (z) signalling events	0.494164491638141	-0.704886838194849	46	4	0.0062015503875969	645	8202	2778,5588,10681,8601	GNAS,PRKCQ,GNB5,RGS20
R-HSA-5632684	Hedgehog 'on' state	0.494359138120553	-0.704493025686847	84	7	0.0108527131782946	645	8202	5716,5720,156,5721,23288,83737,23432	PSMD10,PSME1,ADRBK1,PSME2,IQCE,ITCH,GPR161
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.499474565723936	-0.694198601661569	59	5	0.00775193798449612	645	8202	5716,5720,5566,5721,83737	PSMD10,PSME1,PRKACA,PSME2,ITCH
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.500212507775828	-0.692722255301815	21	2	0.00310077519379845	645	8202	10053,3105	AP1M2,HLA-A
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.500212507775828	-0.692722255301815	21	2	0.00310077519379845	645	8202	337876,79586	CHSY3,CHPF
R-HSA-500657	Presynaptic function of Kainate receptors	0.500212507775828	-0.692722255301815	21	2	0.00310077519379845	645	8202	10681,5330	GNB5,PLCB2
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.500212507775828	-0.692722255301815	21	2	0.00310077519379845	645	8202	4192,54492	MDK,NEURL1B
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	0.500212507775828	-0.692722255301815	21	2	0.00310077519379845	645	8202	3485,3489	IGFBP2,IGFBP6
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.500212507775828	-0.692722255301815	21	2	0.00310077519379845	645	8202	11065,983	UBE2C,CDK1
R-HSA-2187338	Visual phototransduction	0.510142460546906	-0.67306525786466	98	8	0.0124031007751938	645	8202	10681,3339,801,6385,808,5588,6382,10988	GNB5,HSPG2,CALM1,SDC4,CALM3,PRKCQ,SDC1,METAP2
R-HSA-156580	Phase II conjugation	0.510142460546906	-0.67306525786466	98	8	0.0124031007751938	645	8202	26873,2730,9060,2729,9061,191,6820,2950	OPLAH,GCLM,PAPSS2,GCLC,PAPSS1,AHCY,SULT2B1,GSTP1
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.519798760559373	-0.654313541234355	86	7	0.0108527131782946	645	8202	3920,808,5154,5265,801,22927,928	LAMP2,CALM3,PDGFA,SERPINA1,CALM1,HABP4,CD9
R-HSA-425561	Sodium/Calcium exchangers	0.521695901886042	-0.65067042429221	9	1	0.00155038759689922	645	8202	80024	SLC8B1
R-HSA-391908	Prostanoid ligand receptors	0.521695901886042	-0.65067042429221	9	1	0.00155038759689922	645	8202	5734	PTGER4
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.521695901886042	-0.65067042429221	9	1	0.00155038759689922	645	8202	760	CA2
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.521695901886042	-0.65067042429221	9	1	0.00155038759689922	645	8202	192670	AGO4
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.521695901886042	-0.65067042429221	9	1	0.00155038759689922	645	8202	760	CA2
R-HSA-112411	MAPK1 (ERK2) activation	0.521695901886042	-0.65067042429221	9	1	0.00155038759689922	645	8202	3572	IL6ST
R-HSA-446107	Type I hemidesmosome assembly	0.521695901886042	-0.65067042429221	9	1	0.00155038759689922	645	8202	3655	ITGA6
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.521695901886042	-0.65067042429221	9	1	0.00155038759689922	645	8202	2034	EPAS1
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.521695901886042	-0.65067042429221	9	1	0.00155038759689922	645	8202	760	CA2
R-HSA-2428933	SHC-related events triggered by IGF1R	0.521695901886042	-0.65067042429221	9	1	0.00155038759689922	645	8202	3480	IGF1R
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.521695901886042	-0.65067042429221	9	1	0.00155038759689922	645	8202	5045	FURIN
R-HSA-389513	CTLA4 inhibitory signaling	0.525489887819456	-0.643424331819916	22	2	0.00310077519379845	645	8202	7525,207	YES1,AKT1
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.525489887819456	-0.643424331819916	22	2	0.00310077519379845	645	8202	5270,2149	SERPINE2,F2R
R-HSA-432720	Lysosome Vesicle Biogenesis	0.526935122390169	-0.64067784543815	35	3	0.00465116279069767	645	8202	2799,1522,10053	GNS,CTSZ,AP1M2
R-HSA-194068	Bile acid and bile salt metabolism	0.526935122390169	-0.64067784543815	35	3	0.00465116279069767	645	8202	8309,10499,2172	ACOX2,NCOA2,FABP6
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.529664224564874	-0.635512011763164	61	5	0.00775193798449612	645	8202	10810,63916,3984,6850,4644	WASF3,ELMO2,LIMK1,SYK,MYO5A
R-HSA-201681	TCF dependent signaling in response to WNT	0.537313947340855	-0.621172723384279	229	18	0.027906976744186	645	8202	55366,207,8322,5721,139285,6662,5716,6932,5720,26108,83999,8323,51339,7088,3065,89780,7855,81847	LGR4,AKT1,FZD4,PSME2,AMER1,SOX9,PSMD10,TCF7,PSME1,PYGO1,KREMEN1,FZD6,DACT1,TLE1,HDAC1,WNT3A,FZD5,RNF146
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.544940814450725	-0.60707808755413	49	4	0.0062015503875969	645	8202	5716,5720,9902,5721	PSMD10,PSME1,MRC2,PSME2
R-HSA-199991	Membrane Trafficking	0.547058631968575	-0.603199294062037	256	20	0.0310077519379845	645	8202	1362,5563,10484,6272,207,54885,801,808,2495,1522,1294,90411,2799,10053,51422,5265,1075,3998,9882,4644	CPD,PRKAA2,SEC23A,SORT1,AKT1,TBC1D8B,CALM1,CALM3,FTH1,CTSZ,COL7A1,MCFD2,GNS,AP1M2,PRKAG2,SERPINA1,CTSC,LMAN1,TBC1D4,MYO5A
R-HSA-70895	Branched-chain amino acid catabolism	0.549889372610084	-0.598038161696064	23	2	0.00310077519379845	645	8202	36,64087	ACADSB,MCCC2
R-HSA-73980	RNA Polymerase III Transcription Termination	0.549889372610084	-0.598038161696064	23	2	0.00310077519379845	645	8202	4781,4784	NFIB,NFIX
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.549889372610084	-0.598038161696064	23	2	0.00310077519379845	645	8202	2805,4942	GOT1,OAT
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.549889372610084	-0.598038161696064	23	2	0.00310077519379845	645	8202	3065,7050	HDAC1,TGIF1
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.549889372610084	-0.598038161696064	23	2	0.00310077519379845	645	8202	11065,4751	UBE2C,NEK2
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.549889372610084	-0.598038161696064	23	2	0.00310077519379845	645	8202	9965,10817	FGF19,FRS3
R-HSA-211976	Endogenous sterols	0.549889372610084	-0.598038161696064	23	2	0.00310077519379845	645	8202	10499,1545	NCOA2,CYP1B1
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.556635073451092	-0.585845418129507	115	9	0.013953488372093	645	8202	3106,999,5819,3133,3134,3107,958,3105,945	HLA-B,CDH1,PVRL2,HLA-E,HLA-F,HLA-C,CD40,HLA-A,CD33
R-HSA-400253	Circadian Clock	0.559017934874223	-0.581573722488005	63	5	0.00775193798449612	645	8202	23411,2908,79365,10499,5465	SIRT1,NR3C1,BHLHE41,NCOA2,PPARA
R-HSA-74259	Purine catabolism	0.559350746669012	-0.580978548803144	10	1	0.00155038759689922	645	8202	7498	XDH
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.559350746669012	-0.580978548803144	10	1	0.00155038759689922	645	8202	57161	PELI2
R-HSA-209968	Thyroxine biosynthesis	0.559350746669012	-0.580978548803144	10	1	0.00155038759689922	645	8202	53905	DUOX1
R-HSA-419771	Opsins	0.559350746669012	-0.580978548803144	10	1	0.00155038759689922	645	8202	23596	OPN3
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.559350746669012	-0.580978548803144	10	1	0.00155038759689922	645	8202	79661	NEIL1
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.559350746669012	-0.580978548803144	10	1	0.00155038759689922	645	8202	490	ATP2B1
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.559350746669012	-0.580978548803144	10	1	0.00155038759689922	645	8202	983	CDK1
R-HSA-937039	IRAK1 recruits IKK complex	0.559350746669012	-0.580978548803144	10	1	0.00155038759689922	645	8202	57161	PELI2
R-HSA-74749	Signal attenuation	0.559350746669012	-0.580978548803144	10	1	0.00155038759689922	645	8202	8660	IRS2
R-HSA-418886	Netrin mediated repulsion signals	0.559350746669012	-0.580978548803144	10	1	0.00155038759689922	645	8202	219699	UNC5B
R-HSA-430116	GP1b-IX-V activation signalling	0.559350746669012	-0.580978548803144	10	1	0.00155038759689922	645	8202	5295	PIK3R1
R-HSA-399997	Acetylcholine regulates insulin secretion	0.559350746669012	-0.580978548803144	10	1	0.00155038759689922	645	8202	5330	PLCB2
R-HSA-1433617	Regulation of signaling by NODAL	0.559350746669012	-0.580978548803144	10	1	0.00155038759689922	645	8202	130399	ACVR1C
R-HSA-190377	FGFR2b ligand binding and activation	0.559350746669012	-0.580978548803144	10	1	0.00155038759689922	645	8202	2263	FGFR2
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.561273393915267	-0.577547158985397	50	4	0.0062015503875969	645	8202	5716,595,5720,5721	PSMD10,CCND1,PSME1,PSME2
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.561273393915267	-0.577547158985397	50	4	0.0062015503875969	645	8202	5716,595,5720,5721	PSMD10,CCND1,PSME1,PSME2
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.561273393915267	-0.577547158985397	50	4	0.0062015503875969	645	8202	5716,5720,1728,5721	PSMD10,PSME1,NQO1,PSME2
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.566679294575226	-0.56796175330972	142	11	0.0170542635658915	645	8202	3768,6196,10681,84254,6195,801,2902,808,1741,5566,5330	KCNJ12,RPS6KA2,GNB5,CAMKK1,RPS6KA1,CALM1,GRIN1,CALM3,DLG3,PRKACA,PLCB2
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.570824427900476	-0.56067359839385	77	6	0.00930232558139535	645	8202	5347,5716,5720,11065,5721,983	PLK1,PSMD10,PSME1,UBE2C,PSME2,CDK1
R-HSA-5358346	Hedgehog ligand biogenesis	0.573347783181972	-0.556262794935973	64	5	0.00775193798449612	645	8202	5716,5720,147111,27248,5721	PSMD10,PSME1,NOTUM,ERLEC1,PSME2
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.573347783181972	-0.556262794935973	64	5	0.00775193798449612	645	8202	5716,5720,11065,5721,9232	PSMD10,PSME1,UBE2C,PSME2,PTTG1
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.573392545362013	-0.556184726381219	24	2	0.00310077519379845	645	8202	8309,10499	ACOX2,NCOA2
R-HSA-5365859	RA biosynthesis pathway	0.573392545362013	-0.556184726381219	24	2	0.00310077519379845	645	8202	56603,220	CYP26B1,ALDH1A3
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.577282257970861	-0.549423950159275	51	4	0.0062015503875969	645	8202	54585,6102,27031,192668	LZTFL1,RP2,NPHP3,CYS1
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.577282257970861	-0.549423950159275	51	4	0.0062015503875969	645	8202	5716,5720,5721,7157	PSMD10,PSME1,PSME2,TP53
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.583722954589322	-0.53832880154029	78	6	0.00930232558139535	645	8202	688,8202,23097,10499,6837,5465	KLF5,NCOA3,CDK19,NCOA2,MED22,PPARA
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.583801988376098	-0.53819341464792	38	3	0.00465116279069767	645	8202	93973,8450,5886	ACTR8,CUL4B,RAD23A
R-HSA-69202	Cyclin E associated events during G1/S transition	0.587430876830593	-0.531996696344452	65	5	0.00775193798449612	645	8202	9134,1027,5716,5720,5721	CCNE2,CDKN1B,PSMD10,PSME1,PSME2
R-HSA-69541	Stabilization of p53	0.592954044217709	-0.522638380090825	52	4	0.0062015503875969	645	8202	5716,5720,5721,7157	PSMD10,PSME1,PSME2,TP53
R-HSA-879518	Transport of organic anions	0.594045420544986	-0.520799496978885	11	1	0.00155038759689922	645	8202	28231	SLCO4A1
R-HSA-2022923	Dermatan sulfate biosynthesis	0.594045420544986	-0.520799496978885	11	1	0.00155038759689922	645	8202	29940	DSE
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.594045420544986	-0.520799496978885	11	1	0.00155038759689922	645	8202	2184	FAH
R-HSA-5625970	RHO GTPases activate KTN1	0.594045420544986	-0.520799496978885	11	1	0.00155038759689922	645	8202	147700	KLC3
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.594045420544986	-0.520799496978885	11	1	0.00155038759689922	645	8202	113130	CDCA5
R-HSA-1266695	Interleukin-7 signaling	0.594045420544986	-0.520799496978885	11	1	0.00155038759689922	645	8202	5295	PIK3R1
R-HSA-189451	Heme biosynthesis	0.594045420544986	-0.520799496978885	11	1	0.00155038759689922	645	8202	2235	FECH
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.594045420544986	-0.520799496978885	11	1	0.00155038759689922	645	8202	5045	FURIN
R-HSA-982772	Growth hormone receptor signaling	0.595989298917529	-0.517532566914337	25	2	0.00310077519379845	645	8202	8660,9021	IRS2,SOCS3
R-HSA-210991	Basigin interactions	0.595989298917529	-0.517532566914337	25	2	0.00310077519379845	645	8202	481,3655	ATP1B1,ITGA6
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.595989298917529	-0.517532566914337	25	2	0.00310077519379845	645	8202	5321,10681	PLA2G4A,GNB5
R-HSA-2262749	Cellular response to hypoxia	0.595989298917529	-0.517532566914337	25	2	0.00310077519379845	645	8202	2034,54583	EPAS1,EGLN1
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.595989298917529	-0.517532566914337	25	2	0.00310077519379845	645	8202	2182,9524	ACSL4,TECR
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.595989298917529	-0.517532566914337	25	2	0.00310077519379845	645	8202	2034,54583	EPAS1,EGLN1
R-HSA-2559580	Oxidative Stress Induced Senescence	0.598778157764	-0.512864103781981	119	9	0.013953488372093	645	8202	9261,1031,7157,23466,5600,192670,4217,1032,2353	MAPKAPK2,CDKN2C,TP53,CBX6,MAPK11,AGO4,MAP3K5,CDKN2D,FOS
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.601257138869653	-0.508732584252774	66	5	0.00775193798449612	645	8202	147945,6737,4792,340061,23220	NLRP4,TRIM21,NFKBIA,TMEM173,DTX4
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.601257138869653	-0.508732584252774	66	5	0.00775193798449612	645	8202	9134,1027,5716,5720,5721	CCNE2,CDKN1B,PSMD10,PSME1,PSME2
R-HSA-425407	SLC-mediated transmembrane transport	0.604331401495086	-0.503632553544047	264	20	0.0310077519379845	645	8202	11046,64116,55343,4891,6542,6507,80024,6574,6549,84679,28231,8671,28965,10479,23446,6508,376497,57181,6558,79902	SLC35D2,SLC39A8,SLC35C1,SLC11A2,SLC7A2,SLC1A3,SLC8B1,SLC20A1,SLC9A2,SLC9A7,SLCO4A1,SLC4A4,SLC27A6,SLC9A6,SLC44A1,SLC4A3,SLC27A1,SLC39A10,SLC12A2,NUP85
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.608277272052463	-0.497124461410435	53	4	0.0062015503875969	645	8202	5716,5720,5721,60489	PSMD10,PSME1,PSME2,APOBEC3G
R-HSA-5658442	Regulation of RAS by GAPs	0.614817637775781	-0.486429579089355	67	5	0.00775193798449612	645	8202	5716,5720,5721,5922,5921	PSMD10,PSME1,PSME2,RASA2,RASA1
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.617676646198749	-0.481790184670665	26	2	0.00310077519379845	645	8202	4792,64127	NFKBIA,NOD2
R-HSA-912694	Regulation of IFNA signaling	0.617676646198749	-0.481790184670665	26	2	0.00310077519379845	645	8202	11274,9021	USP18,SOCS3
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.617676646198749	-0.481790184670665	26	2	0.00310077519379845	645	8202	2263,10817	FGFR2,FRS3
R-HSA-3238698	WNT ligand biogenesis and trafficking	0.617676646198749	-0.481790184670665	26	2	0.00310077519379845	645	8202	89780,9559	WNT3A,VPS26A
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.617676646198749	-0.481790184670665	26	2	0.00310077519379845	645	8202	7046,9372	TGFBR1,ZFYVE9
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.623242249621251	-0.472819992080979	54	4	0.0062015503875969	645	8202	10484,32,10499,5465	SEC23A,ACACB,NCOA2,PPARA
R-HSA-4641257	Degradation of AXIN	0.623242249621251	-0.472819992080979	54	4	0.0062015503875969	645	8202	5716,5720,5721,81847	PSMD10,PSME1,PSME2,RNF146
R-HSA-597592	Post-translational protein modification	0.625908825793237	-0.468550564187107	411	31	0.048062015503876	645	8202	2673,10484,93010,5329,79695,11282,56648,5045,29071,1294,1522,51809,90411,2517,2591,94025,6675,5265,22901,1075,79868,11320,2530,140766,6185,5476,3998,411,79902,170690,2650	GFPT1,SEC23A,B3GNT7,PLAUR,GALNT12,MGAT4B,EIF5A2,FURIN,C1GALT1C1,COL7A1,CTSZ,GALNT7,MCFD2,FUCA1,GALNT3,MUC16,UAP1,SERPINA1,ARSG,CTSC,ALG13,MGAT4A,FUT8,ADAMTS14,RPN2,CTSA,LMAN1,ARSB,NUP85,ADAMTS16,GCNT1
R-HSA-1475029	Reversible hydration of carbon dioxide	0.626012299291155	-0.468385260645087	12	1	0.00155038759689922	645	8202	760	CA2
R-HSA-156581	Methylation	0.626012299291155	-0.468385260645087	12	1	0.00155038759689922	645	8202	191	AHCY
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	0.626012299291155	-0.468385260645087	12	1	0.00155038759689922	645	8202	983	CDK1
R-HSA-390666	Serotonin receptors	0.626012299291155	-0.468385260645087	12	1	0.00155038759689922	645	8202	3352	HTR1D
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	0.626012299291155	-0.468385260645087	12	1	0.00155038759689922	645	8202	53354	PANK1
R-HSA-73621	Pyrimidine catabolism	0.626012299291155	-0.468385260645087	12	1	0.00155038759689922	645	8202	1890	TYMP
R-HSA-71384	Ethanol oxidation	0.626012299291155	-0.468385260645087	12	1	0.00155038759689922	645	8202	217	ALDH2
R-HSA-202670	ERKs are inactivated	0.626012299291155	-0.468385260645087	12	1	0.00155038759689922	645	8202	1846	DUSP4
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	0.626012299291155	-0.468385260645087	12	1	0.00155038759689922	645	8202	5557	PRIM1
R-HSA-388841	Costimulation by the CD28 family	0.628104548002411	-0.465048648658969	68	5	0.00775193798449612	645	8202	29126,7525,207,5295,5290	CD274,YES1,AKT1,PIK3R1,PIK3CA
R-HSA-15869	Metabolism of nucleotides	0.633236732559619	-0.456910941666666	82	6	0.00930232558139535	645	8202	131870,1890,122481,1633,7498,978	NUDT16,TYMP,AK7,DCK,XDH,CDA
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.63612562902379	-0.45235920523686	41	3	0.00465116279069767	645	8202	32,10499,5465	ACACB,NCOA2,PPARA
R-HSA-5620924	Intraflagellar transport	0.63612562902379	-0.45235920523686	41	3	0.00465116279069767	645	8202	79809,83658,26146	TTC21B,DYNLRB1,TRAF3IP1
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.637840978713679	-0.449666276370287	55	4	0.0062015503875969	645	8202	5716,5720,27248,5721	PSMD10,PSME1,ERLEC1,PSME2
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.637840978713679	-0.449666276370287	55	4	0.0062015503875969	645	8202	5716,5720,27248,5721	PSMD10,PSME1,ERLEC1,PSME2
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.637840978713679	-0.449666276370287	55	4	0.0062015503875969	645	8202	5716,5720,3315,5721	PSMD10,PSME1,HSPB1,PSME2
R-HSA-202424	Downstream TCR signaling	0.63841520264047	-0.448766419470194	96	7	0.0108527131782946	645	8202	5716,5588,5720,5721,4792,5295,5290	PSMD10,PRKCQ,PSME1,PSME2,NFKBIA,PIK3R1,PIK3CA
R-HSA-1483206	Glycerophospholipid biosynthesis	0.63841520264047	-0.448766419470194	96	7	0.0108527131782946	645	8202	5321,5337,64900,10555,9926,23446,1040	PLA2G4A,PLD1,LPIN3,AGPAT2,LPGAT1,SLC44A1,CDS1
R-HSA-182971	EGFR downregulation	0.638457666073599	-0.448699907863307	27	2	0.00310077519379845	645	8202	10253,30011	SPRY2,SH3KBP1
R-HSA-192105	Synthesis of bile acids and bile salts	0.638457666073599	-0.448699907863307	27	2	0.00310077519379845	645	8202	8309,10499	ACOX2,NCOA2
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.641111108345266	-0.444552501130355	69	5	0.00775193798449612	645	8202	5716,5720,11065,5721,983	PSMD10,PSME1,UBE2C,PSME2,CDK1
R-HSA-4641258	Degradation of DVL	0.652067058469875	-0.427607871930307	56	4	0.0062015503875969	645	8202	5716,5720,5721,51339	PSMD10,PSME1,PSME2,DACT1
R-HSA-3000178	ECM proteoglycans	0.652067058469875	-0.427607871930307	56	4	0.0062015503875969	645	8202	1299,3685,1605,4038	COL9A3,ITGAV,DAG1,LRP4
R-HSA-975634	Retinoid metabolism and transport	0.652511799898662	-0.426926055812923	42	3	0.00465116279069767	645	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-209560	NF-kB is activated and signals survival	0.655465543120786	-0.422409542955915	13	1	0.00155038759689922	645	8202	4792	NFKBIA
R-HSA-211227	Activation of DNA fragmentation factor	0.655465543120786	-0.422409542955915	13	1	0.00155038759689922	645	8202	3005	H1F0
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.655465543120786	-0.422409542955915	13	1	0.00155038759689922	645	8202	60559	SPCS3
R-HSA-350054	Notch-HLH transcription pathway	0.655465543120786	-0.422409542955915	13	1	0.00155038759689922	645	8202	84441	MAML2
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.655465543120786	-0.422409542955915	13	1	0.00155038759689922	645	8202	9254	CACNA2D2
R-HSA-74217	Purine salvage	0.655465543120786	-0.422409542955915	13	1	0.00155038759689922	645	8202	1633	DCK
R-HSA-140342	Apoptosis induced DNA fragmentation	0.655465543120786	-0.422409542955915	13	1	0.00155038759689922	645	8202	3005	H1F0
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.655465543120786	-0.422409542955915	13	1	0.00155038759689922	645	8202	4682	NUBP1
R-HSA-1483213	Synthesis of PE	0.655465543120786	-0.422409542955915	13	1	0.00155038759689922	645	8202	64900	LPIN3
R-HSA-190375	FGFR2c ligand binding and activation	0.655465543120786	-0.422409542955915	13	1	0.00155038759689922	645	8202	2263	FGFR2
R-HSA-175474	Assembly Of The HIV Virion	0.655465543120786	-0.422409542955915	13	1	0.00155038759689922	645	8202	5045	FURIN
R-HSA-351202	Metabolism of polyamines	0.656654038753461	-0.420597976427796	84	6	0.00930232558139535	645	8202	5716,2805,5720,1728,5721,6303	PSMD10,GOT1,PSME1,NQO1,PSME2,SAT1
R-HSA-2022854	Keratan sulfate biosynthesis	0.65834057046859	-0.418032897258603	28	2	0.00310077519379845	645	8202	93010,11046	B3GNT7,SLC35D2
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.65834057046859	-0.418032897258603	28	2	0.00310077519379845	645	8202	10053,3105	AP1M2,HLA-A
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.65834057046859	-0.418032897258603	28	2	0.00310077519379845	645	8202	10681,9254	GNB5,CACNA2D2
R-HSA-917977	Transferrin endocytosis and recycling	0.677337880292479	-0.389585045944171	29	2	0.00310077519379845	645	8202	533,261729	ATP6V0B,STEAP2
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.678396116120609	-0.388023919578897	72	5	0.00775193798449612	645	8202	3065,7050,7046,9372,5045	HDAC1,TGIF1,TGFBR1,ZFYVE9,FURIN
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.682602522558348	-0.381842547001639	14	1	0.00155038759689922	645	8202	127281	FAM213B
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.682602522558348	-0.381842547001639	14	1	0.00155038759689922	645	8202	139285	AMER1
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.682602522558348	-0.381842547001639	14	1	0.00155038759689922	645	8202	1478	CSTF2
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.682602522558348	-0.381842547001639	14	1	0.00155038759689922	645	8202	139285	AMER1
R-HSA-69166	Removal of the Flap Intermediate	0.682602522558348	-0.381842547001639	14	1	0.00155038759689922	645	8202	5557	PRIM1
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.682602522558348	-0.381842547001639	14	1	0.00155038759689922	645	8202	139285	AMER1
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.682602522558348	-0.381842547001639	14	1	0.00155038759689922	645	8202	139285	AMER1
R-HSA-190322	FGFR4 ligand binding and activation	0.682602522558348	-0.381842547001639	14	1	0.00155038759689922	645	8202	9965	FGF19
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.682602522558348	-0.381842547001639	14	1	0.00155038759689922	645	8202	139285	AMER1
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.682602522558348	-0.381842547001639	14	1	0.00155038759689922	645	8202	5557	PRIM1
R-HSA-69091	Polymerase switching	0.682602522558348	-0.381842547001639	14	1	0.00155038759689922	645	8202	5557	PRIM1
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.682602522558348	-0.381842547001639	14	1	0.00155038759689922	645	8202	139285	AMER1
R-HSA-877312	Regulation of IFNG signaling	0.682602522558348	-0.381842547001639	14	1	0.00155038759689922	645	8202	9021	SOCS3
R-HSA-69109	Leading Strand Synthesis	0.682602522558348	-0.381842547001639	14	1	0.00155038759689922	645	8202	5557	PRIM1
R-HSA-112315	Transmission across Chemical Synapses	0.690503005273434	-0.370334953827367	210	15	0.0232558139534884	645	8202	3768,217,6196,10681,84254,6195,801,2902,9254,808,6507,1741,2571,5566,5330	KCNJ12,ALDH2,RPS6KA2,GNB5,CAMKK1,RPS6KA1,CALM1,GRIN1,CACNA2D2,CALM3,SLC1A3,DLG3,GAD1,PRKACA,PLCB2
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.692467329590487	-0.367494219520198	59	4	0.0062015503875969	645	8202	5716,5720,5566,5721	PSMD10,PSME1,PRKACA,PSME2
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.692467329590487	-0.367494219520198	59	4	0.0062015503875969	645	8202	5716,5720,5566,5721	PSMD10,PSME1,PRKACA,PSME2
R-HSA-202403	TCR signaling	0.692583431527285	-0.367326569437863	115	8	0.0124031007751938	645	8202	5795,5721,4792,5295,5290,5716,5720,5588	PTPRJ,PSME2,NFKBIA,PIK3R1,PIK3CA,PSMD10,PSME1,PRKCQ
R-HSA-420092	Glucagon-type ligand receptors	0.695465699000132	-0.363173587310562	30	2	0.00310077519379845	645	8202	2778,10681	GNAS,GNB5
R-HSA-420029	Tight junction interactions	0.695465699000132	-0.363173587310562	30	2	0.00310077519379845	645	8202	1364,64398	CLDN4,MPP5
R-HSA-5683826	Surfactant metabolism	0.695465699000132	-0.363173587310562	30	2	0.00310077519379845	645	8202	10970,29995	CKAP4,LMCD1
R-HSA-5668914	Diseases of metabolism	0.69846403463395	-0.358871591039594	45	3	0.00465116279069767	645	8202	32,3417,64087	ACACB,IDH1,MCCC2
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.705167384989033	-0.349320078834487	60	4	0.0062015503875969	645	8202	5716,5720,11065,5721	PSMD10,PSME1,UBE2C,PSME2
R-HSA-3322077	Glycogen synthesis	0.707605132838154	-0.345869062853181	15	1	0.00155038759689922	645	8202	5236	PGM1
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.707605132838154	-0.345869062853181	15	1	0.00155038759689922	645	8202	167227	DCP2
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.707605132838154	-0.345869062853181	15	1	0.00155038759689922	645	8202	54492	NEURL1B
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.707605132838154	-0.345869062853181	15	1	0.00155038759689922	645	8202	139285	AMER1
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.707605132838154	-0.345869062853181	15	1	0.00155038759689922	645	8202	10499	NCOA2
R-HSA-391903	Eicosanoid ligand-binding receptors	0.707605132838154	-0.345869062853181	15	1	0.00155038759689922	645	8202	5734	PTGER4
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.707605132838154	-0.345869062853181	15	1	0.00155038759689922	645	8202	139285	AMER1
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.707605132838154	-0.345869062853181	15	1	0.00155038759689922	645	8202	207	AKT1
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.707605132838154	-0.345869062853181	15	1	0.00155038759689922	645	8202	139285	AMER1
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.707605132838154	-0.345869062853181	15	1	0.00155038759689922	645	8202	139285	AMER1
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.707605132838154	-0.345869062853181	15	1	0.00155038759689922	645	8202	54492	NEURL1B
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.707605132838154	-0.345869062853181	15	1	0.00155038759689922	645	8202	139285	AMER1
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.707605132838154	-0.345869062853181	15	1	0.00155038759689922	645	8202	9564	BCAR1
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.707605132838154	-0.345869062853181	15	1	0.00155038759689922	645	8202	139285	AMER1
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.707605132838154	-0.345869062853181	15	1	0.00155038759689922	645	8202	8322	FZD4
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.712743073431384	-0.338634269326532	31	2	0.00310077519379845	645	8202	10253,9965	SPRY2,FGF19
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.712743073431384	-0.338634269326532	31	2	0.00310077519379845	645	8202	3065,7050	HDAC1,TGIF1
R-HSA-196854	Metabolism of vitamins and cofactors	0.721138178732404	-0.326924511332131	90	6	0.00930232558139535	645	8202	5167,32,1528,53354,64087,316	ENPP1,ACACB,CYB5A,PANK1,MCCC2,AOX1
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.721138178732404	-0.326924511332131	90	6	0.00930232558139535	645	8202	5167,32,1528,53354,64087,316	ENPP1,ACACB,CYB5A,PANK1,MCCC2,AOX1
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.729191432739324	-0.315818985095627	32	2	0.00310077519379845	645	8202	79902,5902	NUP85,RANBP1
R-HSA-392518	Signal amplification	0.729191432739324	-0.315818985095627	32	2	0.00310077519379845	645	8202	5321,10681	PLA2G4A,GNB5
R-HSA-186712	Regulation of beta-cell development	0.729191432739324	-0.315818985095627	32	2	0.00310077519379845	645	8202	3280,207	HES1,AKT1
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.729191432739324	-0.315818985095627	32	2	0.00310077519379845	645	8202	10681,2149	GNB5,F2R
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.729228033022202	-0.31576879338639	105	7	0.0108527131782946	645	8202	1031,1027,6196,2353,11065,1032,6195	CDKN2C,CDKN1B,RPS6KA2,FOS,UBE2C,CDKN2D,RPS6KA1
R-HSA-1482922	Acyl chain remodelling of PI	0.730641005477217	-0.313833040440106	16	1	0.00155038759689922	645	8202	5321	PLA2G4A
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.730641005477217	-0.313833040440106	16	1	0.00155038759689922	645	8202	1522	CTSZ
R-HSA-193639	p75NTR signals via NF-kB	0.730641005477217	-0.313833040440106	16	1	0.00155038759689922	645	8202	4792	NFKBIA
R-HSA-1433559	Regulation of KIT signaling	0.730641005477217	-0.313833040440106	16	1	0.00155038759689922	645	8202	7525	YES1
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.730641005477217	-0.313833040440106	16	1	0.00155038759689922	645	8202	64127	NOD2
R-HSA-1295596	Spry regulation of FGF signaling	0.730641005477217	-0.313833040440106	16	1	0.00155038759689922	645	8202	10253	SPRY2
R-HSA-446353	Cell-extracellular matrix interactions	0.730641005477217	-0.313833040440106	16	1	0.00155038759689922	645	8202	54751	FBLIM1
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.730641005477217	-0.313833040440106	16	1	0.00155038759689922	645	8202	10476	ATP5H
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.730641005477217	-0.313833040440106	16	1	0.00155038759689922	645	8202	7046	TGFBR1
R-HSA-69183	Processive synthesis on the lagging strand	0.730641005477217	-0.313833040440106	16	1	0.00155038759689922	645	8202	5557	PRIM1
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	0.734575254958819	-0.308462831218622	77	5	0.00775193798449612	645	8202	9134,1027,3159,3005,7157	CCNE2,CDKN1B,HMGA1,H1F0,TP53
R-HSA-73847	Purine metabolism	0.744834097149304	-0.294593773791515	33	2	0.00310077519379845	645	8202	1633,7498	DCK,XDH
R-HSA-113510	E2F mediated regulation of DNA replication	0.744834097149304	-0.294593773791515	33	2	0.00310077519379845	645	8202	983,5557	CDK1,PRIM1
R-HSA-72187	mRNA 3'-end processing	0.744834097149304	-0.294593773791515	33	2	0.00310077519379845	645	8202	1478,65109	CSTF2,UPF3B
R-HSA-2033519	Activated point mutants of FGFR2	0.751864625270342	-0.285198990825079	17	1	0.00155038759689922	645	8202	2263	FGFR2
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.751864625270342	-0.285198990825079	17	1	0.00155038759689922	645	8202	11065	UBE2C
R-HSA-1839126	FGFR2 mutant receptor activation	0.751864625270342	-0.285198990825079	17	1	0.00155038759689922	645	8202	2263	FGFR2
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.751864625270342	-0.285198990825079	17	1	0.00155038759689922	645	8202	2902	GRIN1
R-HSA-622312	Inflammasomes	0.751864625270342	-0.285198990825079	17	1	0.00155038759689922	645	8202	598	BCL2L1
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	0.751864625270342	-0.285198990825079	17	1	0.00155038759689922	645	8202	60559	SPCS3
R-HSA-196299	Beta-catenin phosphorylation cascade	0.751864625270342	-0.285198990825079	17	1	0.00155038759689922	645	8202	139285	AMER1
R-HSA-69205	G1/S-Specific Transcription	0.751864625270342	-0.285198990825079	17	1	0.00155038759689922	645	8202	983	CDK1
R-HSA-1482801	Acyl chain remodelling of PS	0.751864625270342	-0.285198990825079	17	1	0.00155038759689922	645	8202	5321	PLA2G4A
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.751864625270342	-0.285198990825079	17	1	0.00155038759689922	645	8202	958	CD40
R-HSA-432142	Platelet sensitization by LDL	0.751864625270342	-0.285198990825079	17	1	0.00155038759689922	645	8202	5321	PLA2G4A
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.752354397462129	-0.284547792825728	49	3	0.00465116279069767	645	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.75969584908627	-0.274837124373278	34	2	0.00310077519379845	645	8202	2263,10253	FGFR2,SPRY2
R-HSA-177243	Interactions of Rev with host cellular proteins	0.75969584908627	-0.274837124373278	34	2	0.00310077519379845	645	8202	79902,5902	NUP85,RANBP1
R-HSA-69206	G1/S Transition	0.764131886233788	-0.269014878753307	109	7	0.0108527131782946	645	8202	9134,1027,5716,5720,5721,983,5557	CCNE2,CDKN1B,PSMD10,PSME1,PSME2,CDK1,PRIM1
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.76455105727432	-0.268466470657544	50	3	0.00465116279069767	645	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-169911	Regulation of Apoptosis	0.76455105727432	-0.268466470657544	50	3	0.00465116279069767	645	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-209776	Amine-derived hormones	0.771418359734151	-0.259524432954356	18	1	0.00155038759689922	645	8202	53905	DUOX1
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.771418359734151	-0.259524432954356	18	1	0.00155038759689922	645	8202	11065	UBE2C
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.771418359734151	-0.259524432954356	18	1	0.00155038759689922	645	8202	200576	PIKFYVE
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.771418359734151	-0.259524432954356	18	1	0.00155038759689922	645	8202	11065	UBE2C
R-HSA-1169091	Activation of NF-kappaB in B cells	0.773376045296382	-0.256989873528364	66	4	0.0062015503875969	645	8202	5716,5720,5721,4792	PSMD10,PSME1,PSME2,NFKBIA
R-HSA-180534	Vpu mediated degradation of CD4	0.77625535721914	-0.253273744348743	51	3	0.00465116279069767	645	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-69242	S Phase	0.777057524932781	-0.252240896692397	125	8	0.0124031007751938	645	8202	9134,595,5721,113130,5716,1027,5720,5557	CCNE2,CCND1,PSME2,CDCA5,PSMD10,CDKN1B,PSME1,PRIM1
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.783443245787759	-0.244056656583492	67	4	0.0062015503875969	645	8202	2673,5476,6675,79868	GFPT1,CTSA,UAP1,ALG13
R-HSA-5653656	Vesicle-mediated transport	0.784796892432513	-0.242330330432359	294	20	0.0310077519379845	645	8202	1362,5563,10484,6272,207,54885,801,808,2495,1522,1294,90411,2799,10053,51422,5265,1075,3998,9882,4644	CPD,PRKAA2,SEC23A,SORT1,AKT1,TBC1D8B,CALM1,CALM3,FTH1,CTSZ,COL7A1,MCFD2,GNS,AP1M2,PRKAG2,SERPINA1,CTSC,LMAN1,TBC1D4,MYO5A
R-HSA-1268020	Mitochondrial protein import	0.787477886579166	-0.238919989211007	52	3	0.00465116279069767	645	8202	9512,1678,10165	PMPCB,TIMM8A,SLC25A13
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.787477886579166	-0.238919989211007	52	3	0.00465116279069767	645	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.787477886579166	-0.238919989211007	52	3	0.00465116279069767	645	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.787477886579166	-0.238919989211007	52	3	0.00465116279069767	645	8202	2673,5476,6675	GFPT1,CTSA,UAP1
R-HSA-69610	p53-Independent DNA Damage Response	0.787477886579166	-0.238919989211007	52	3	0.00465116279069767	645	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-3000480	Scavenging by Class A Receptors	0.789433408356765	-0.236439795447026	19	1	0.00155038759689922	645	8202	2495	FTH1
R-HSA-69618	Mitotic Spindle Checkpoint	0.789433408356765	-0.236439795447026	19	1	0.00155038759689922	645	8202	11065	UBE2C
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.789433408356765	-0.236439795447026	19	1	0.00155038759689922	645	8202	6904	TBCD
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.789433408356765	-0.236439795447026	19	1	0.00155038759689922	645	8202	2571	GAD1
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.79315191438898	-0.231740506477456	68	4	0.0062015503875969	645	8202	9261,23411,79902,259217	MAPKAPK2,SIRT1,NUP85,HSPA12A
R-HSA-75109	Triglyceride Biosynthesis	0.79315191438898	-0.231740506477456	68	4	0.0062015503875969	645	8202	2182,9524,64900,10555	ACSL4,TECR,LPIN3,AGPAT2
R-HSA-202733	Cell surface interactions at the vascular wall	0.801183103525398	-0.221665764372662	99	6	0.00930232558139535	645	8202	7525,481,3685,3655,5295,5290	YES1,ATP1B1,ITGAV,ITGA6,PIK3R1,PIK3CA
R-HSA-210745	Regulation of gene expression in beta cells	0.806030677280931	-0.215633476057222	20	1	0.00155038759689922	645	8202	207	AKT1
R-HSA-190241	FGFR2 ligand binding and activation	0.806030677280931	-0.215633476057222	20	1	0.00155038759689922	645	8202	2263	FGFR2
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.806030677280931	-0.215633476057222	20	1	0.00155038759689922	645	8202	60559	SPCS3
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.808523316039956	-0.2125457617414	54	3	0.00465116279069767	645	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-68949	Orc1 removal from chromatin	0.811518980383014	-0.208847503042834	70	4	0.0062015503875969	645	8202	1027,5716,5720,5721	CDKN1B,PSMD10,PSME1,PSME2
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.811518980383014	-0.208847503042834	70	4	0.0062015503875969	645	8202	1058,55355,55839,2491	CENPA,HJURP,CENPN,CENPI
R-HSA-69052	Switching of origins to a post-replicative state	0.811518980383014	-0.208847503042834	70	4	0.0062015503875969	645	8202	1027,5716,5720,5721	CDKN1B,PSMD10,PSME1,PSME2
R-HSA-774815	Nucleosome assembly	0.811518980383014	-0.208847503042834	70	4	0.0062015503875969	645	8202	1058,55355,55839,2491	CENPA,HJURP,CENPN,CENPI
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	0.821321585778859	-0.196840546128113	21	1	0.00155038759689922	645	8202	5795	PTPRJ
R-HSA-211981	Xenobiotics	0.821321585778859	-0.196840546128113	21	1	0.00155038759689922	645	8202	1543	CYP1A1
R-HSA-379726	Mitochondrial tRNA aminoacylation	0.821321585778859	-0.196840546128113	21	1	0.00155038759689922	645	8202	57176	VARS2
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.821321585778859	-0.196840546128113	21	1	0.00155038759689922	645	8202	5566	PRKACA
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	0.821321585778859	-0.196840546128113	21	1	0.00155038759689922	645	8202	4792	NFKBIA
R-HSA-69186	Lagging Strand Synthesis	0.821321585778859	-0.196840546128113	21	1	0.00155038759689922	645	8202	5557	PRIM1
R-HSA-445144	Signal transduction by L1	0.821321585778859	-0.196840546128113	21	1	0.00155038759689922	645	8202	3685	ITGAV
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.821321585778859	-0.196840546128113	21	1	0.00155038759689922	645	8202	122481	AK7
R-HSA-6783310	Fanconi Anemia Pathway	0.82321758739287	-0.194534730024739	39	2	0.00310077519379845	645	8202	29089,55215	UBE2T,FANCI
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.82321758739287	-0.194534730024739	39	2	0.00310077519379845	645	8202	140766,170690	ADAMTS14,ADAMTS16
R-HSA-112316	Neuronal System	0.825849839881069	-0.19134231389885	289	19	0.0294573643410853	645	8202	3768,217,84254,6195,801,2902,9254,808,6507,5566,6196,27345,10681,3783,3790,56666,1741,2571,5330	KCNJ12,ALDH2,CAMKK1,RPS6KA1,CALM1,GRIN1,CACNA2D2,CALM3,SLC1A3,PRKACA,RPS6KA2,KCNMB4,GNB5,KCNN4,KCNS3,PANX2,DLG3,GAD1,PLCB2
R-HSA-69300	Removal of licensing factors from origins	0.828531967745891	-0.188099857771322	72	4	0.0062015503875969	645	8202	1027,5716,5720,5721	CDKN1B,PSMD10,PSME1,PSME2
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.833954938239408	-0.181575908971111	40	2	0.00310077519379845	645	8202	4781,4784	NFIB,NFIX
R-HSA-1251985	Nuclear signaling by ERBB4	0.833954938239408	-0.181575908971111	40	2	0.00310077519379845	645	8202	9542,3084	NRG2,NRG1
R-HSA-5675221	Negative regulation of MAPK pathway	0.833954938239408	-0.181575908971111	40	2	0.00310077519379845	645	8202	11221,1846	DUSP10,DUSP4
R-HSA-74158	RNA Polymerase III Transcription	0.833954938239408	-0.181575908971111	40	2	0.00310077519379845	645	8202	4781,4784	NFIB,NFIX
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.835408809472538	-0.17983408175975	22	1	0.00155038759689922	645	8202	65018	PINK1
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.835408809472538	-0.17983408175975	22	1	0.00155038759689922	645	8202	10681	GNB5
R-HSA-5205647	Mitophagy	0.835408809472538	-0.17983408175975	22	1	0.00155038759689922	645	8202	65018	PINK1
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.835408809472538	-0.17983408175975	22	1	0.00155038759689922	645	8202	2041	EPHA1
R-HSA-166208	mTORC1-mediated signalling	0.835408809472538	-0.17983408175975	22	1	0.00155038759689922	645	8202	6009	RHEB
R-HSA-162906	HIV Infection	0.837226325195163	-0.177660844572162	221	14	0.0217054263565891	645	8202	10053,5721,5902,5045,2963,5716,5720,3159,2958,292,11168,60489,79902,3105	AP1M2,PSME2,RANBP1,FURIN,GTF2F2,PSMD10,PSME1,HMGA1,GTF2A2,SLC25A5,PSIP1,APOBEC3G,NUP85,HLA-A
R-HSA-168325	Viral Messenger RNA Synthesis	0.844100031011207	-0.16948427125368	41	2	0.00310077519379845	645	8202	79902,2963	NUP85,GTF2F2
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.845361538861522	-0.167990886488661	58	3	0.00465116279069767	645	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.845361538861522	-0.167990886488661	58	3	0.00465116279069767	645	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.848386965703088	-0.164418419795898	23	1	0.00155038759689922	645	8202	60559	SPCS3
R-HSA-389948	PD-1 signaling	0.848386965703088	-0.164418419795898	23	1	0.00155038759689922	645	8202	29126	CD274
R-HSA-1482839	Acyl chain remodelling of PE	0.848386965703088	-0.164418419795898	23	1	0.00155038759689922	645	8202	5321	PLA2G4A
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.848386965703088	-0.164418419795898	23	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-428930	Thromboxane signalling through TP receptor	0.848386965703088	-0.164418419795898	23	1	0.00155038759689922	645	8202	10681	GNB5
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.848386965703088	-0.164418419795898	23	1	0.00155038759689922	645	8202	1478	CSTF2
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.848386965703088	-0.164418419795898	23	1	0.00155038759689922	645	8202	192670	AGO4
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.848386965703088	-0.164418419795898	23	1	0.00155038759689922	645	8202	5557	PRIM1
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.848386965703088	-0.164418419795898	23	1	0.00155038759689922	645	8202	54585	LZTFL1
R-HSA-69304	Regulation of DNA replication	0.851644900341221	-0.160585622668327	75	4	0.0062015503875969	645	8202	1027,5716,5720,5721	CDKN1B,PSMD10,PSME1,PSME2
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.853552300051196	-0.158348461470709	59	3	0.00465116279069767	645	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-73856	RNA Polymerase II Transcription Termination	0.85367944257226	-0.158199515644404	42	2	0.00310077519379845	645	8202	1478,65109	CSTF2,UPF3B
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.85367944257226	-0.158199515644404	42	2	0.00310077519379845	645	8202	10499,5465	NCOA2,PPARA
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	0.85367944257226	-0.158199515644404	42	2	0.00310077519379845	645	8202	1478,65109	CSTF2,UPF3B
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.860343244844001	-0.150423847450918	24	1	0.00155038759689922	645	8202	4792	NFKBIA
R-HSA-977606	Regulation of Complement cascade	0.860343244844001	-0.150423847450918	24	1	0.00155038759689922	645	8202	1604	CD55
R-HSA-5260271	Diseases of Immune System	0.860343244844001	-0.150423847450918	24	1	0.00155038759689922	645	8202	4792	NFKBIA
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.860343244844001	-0.150423847450918	24	1	0.00155038759689922	645	8202	6507	SLC1A3
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.862719239146573	-0.14766597206264	43	2	0.00310077519379845	645	8202	3065,7050	HDAC1,TGIF1
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.871244892296795	-0.137832179424679	44	2	0.00310077519379845	645	8202	8450,5886	CUL4B,RAD23A
R-HSA-446652	Interleukin-1 signaling	0.871244892296795	-0.137832179424679	44	2	0.00310077519379845	645	8202	57161,64127	PELI2,NOD2
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.871357992607849	-0.137702373245437	25	1	0.00155038759689922	645	8202	3768	KCNJ12
R-HSA-5669034	TNFs bind their physiological receptors	0.871357992607849	-0.137702373245437	25	1	0.00155038759689922	645	8202	970	CD70
R-HSA-977068	Termination of O-glycan biosynthesis	0.871357992607849	-0.137702373245437	25	1	0.00155038759689922	645	8202	94025	MUC16
R-HSA-1296059	G protein gated Potassium channels	0.871357992607849	-0.137702373245437	25	1	0.00155038759689922	645	8202	3768	KCNJ12
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.871357992607849	-0.137702373245437	25	1	0.00155038759689922	645	8202	5329	PLAUR
R-HSA-1482788	Acyl chain remodelling of PC	0.871357992607849	-0.137702373245437	25	1	0.00155038759689922	645	8202	5321	PLA2G4A
R-HSA-380994	ATF4 activates genes	0.871357992607849	-0.137702373245437	25	1	0.00155038759689922	645	8202	167227	DCP2
R-HSA-3295583	TRP channels	0.871357992607849	-0.137702373245437	25	1	0.00155038759689922	645	8202	7220	TRPC1
R-HSA-1296041	Activation of G protein gated Potassium channels	0.871357992607849	-0.137702373245437	25	1	0.00155038759689922	645	8202	3768	KCNJ12
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.881505246458649	-0.126124325422106	26	1	0.00155038759689922	645	8202	580	BARD1
R-HSA-1474165	Reproduction	0.881505246458649	-0.126124325422106	26	1	0.00155038759689922	645	8202	928	CD9
R-HSA-264876	Insulin processing	0.881505246458649	-0.126124325422106	26	1	0.00155038759689922	645	8202	4644	MYO5A
R-HSA-77387	Insulin receptor recycling	0.881505246458649	-0.126124325422106	26	1	0.00155038759689922	645	8202	533	ATP6V0B
R-HSA-1187000	Fertilization	0.881505246458649	-0.126124325422106	26	1	0.00155038759689922	645	8202	928	CD9
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.883091096864994	-0.124326916242049	96	5	0.00775193798449612	645	8202	5716,970,5720,958,5721	PSMD10,CD70,PSME1,CD40,PSME2
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.886852289454968	-0.120076838775586	46	2	0.00310077519379845	645	8202	2958,2963	GTF2A2,GTF2F2
R-HSA-73776	RNA Polymerase II Promoter Escape	0.886852289454968	-0.120076838775586	46	2	0.00310077519379845	645	8202	2958,2963	GTF2A2,GTF2F2
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.886852289454968	-0.120076838775586	46	2	0.00310077519379845	645	8202	2182,9524	ACSL4,TECR
R-HSA-167161	HIV Transcription Initiation	0.886852289454968	-0.120076838775586	46	2	0.00310077519379845	645	8202	2958,2963	GTF2A2,GTF2F2
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.886852289454968	-0.120076838775586	46	2	0.00310077519379845	645	8202	2958,2963	GTF2A2,GTF2F2
R-HSA-73893	DNA Damage Bypass	0.886852289454968	-0.120076838775586	46	2	0.00310077519379845	645	8202	8450,124739	CUL4B,USP43
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.886852289454968	-0.120076838775586	46	2	0.00310077519379845	645	8202	2958,2963	GTF2A2,GTF2F2
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.886852289454968	-0.120076838775586	46	2	0.00310077519379845	645	8202	2958,2963	GTF2A2,GTF2F2
R-HSA-3214841	PKMTs methylate histone lysines	0.889055388864737	-0.117595740724346	64	3	0.00465116279069767	645	8202	83852,84193,2122	SETDB2,SETD3,MECOM
R-HSA-611105	Respiratory electron transport	0.890014588246403	-0.116517425102194	81	4	0.0062015503875969	645	8202	4697,1345,55967,116228	NDUFA4,COX6C,NDUFA12,COX20
R-HSA-69239	Synthesis of DNA	0.893532001645013	-0.112573128969179	98	5	0.00775193798449612	645	8202	1027,5716,5720,5721,5557	CDKN1B,PSMD10,PSME1,PSME2,PRIM1
R-HSA-68874	M/G1 Transition	0.895488974758947	-0.110385369384133	82	4	0.0062015503875969	645	8202	5716,5720,5721,5557	PSMD10,PSME1,PSME2,PRIM1
R-HSA-69002	DNA Replication Pre-Initiation	0.895488974758947	-0.110385369384133	82	4	0.0062015503875969	645	8202	5716,5720,5721,5557	PSMD10,PSME1,PSME2,PRIM1
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.899464810314422	-0.105955347741556	28	1	0.00155038759689922	645	8202	8450	CUL4B
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	0.899464810314422	-0.105955347741556	28	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-381042	PERK regulates gene expression	0.899464810314422	-0.105955347741556	28	1	0.00155038759689922	645	8202	167227	DCP2
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE	0.899464810314422	-0.105955347741556	28	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-202040	G-protein activation	0.899464810314422	-0.105955347741556	28	1	0.00155038759689922	645	8202	10681	GNB5
R-HSA-73762	RNA Polymerase I Transcription Initiation	0.900691283424331	-0.104592717796355	48	2	0.00310077519379845	645	8202	3065,9014	HDAC1,TAF1B
R-HSA-5419276	Mitochondrial translation termination	0.905723960687546	-0.0990206985160995	84	4	0.0062015503875969	645	8202	28957,65080,51650,64960	MRPS28,MRPL44,MRPS33,MRPS15
R-HSA-5389840	Mitochondrial translation elongation	0.905723960687546	-0.0990206985160995	84	4	0.0062015503875969	645	8202	28957,65080,51650,64960	MRPS28,MRPL44,MRPS33,MRPS15
R-HSA-5368286	Mitochondrial translation initiation	0.905723960687546	-0.0990206985160995	84	4	0.0062015503875969	645	8202	28957,65080,51650,64960	MRPS28,MRPL44,MRPS33,MRPS15
R-HSA-69620	Cell Cycle Checkpoints	0.906010514370945	-0.0987043677405547	179	10	0.0155038759689922	645	8202	9134,5721,7157,5716,1027,5720,9133,580,11065,983	CCNE2,PSME2,TP53,PSMD10,CDKN1B,PSME1,CCNB2,BARD1,UBE2C,CDK1
R-HSA-68867	Assembly of the pre-replicative complex	0.906465082471346	-0.0982027685899524	67	3	0.00465116279069767	645	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	0.907397914966306	-0.0971742095659053	29	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	0.907397914966306	-0.0971742095659053	29	1	0.00155038759689922	645	8202	63971	KIF13A
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	0.907397914966306	-0.0971742095659053	29	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.907397914966306	-0.0971742095659053	29	1	0.00155038759689922	645	8202	10253	SPRY2
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	0.907397914966306	-0.0971742095659053	29	1	0.00155038759689922	645	8202	4603	MYBL1
R-HSA-180786	Extension of Telomeres	0.907397914966306	-0.0971742095659053	29	1	0.00155038759689922	645	8202	5557	PRIM1
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	0.907397914966306	-0.0971742095659053	29	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.907397914966306	-0.0971742095659053	29	1	0.00155038759689922	645	8202	2950	GSTP1
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.912019689975192	-0.0920936992557844	102	5	0.00775193798449612	645	8202	4697,1345,55967,10476,116228	NDUFA4,COX6C,NDUFA12,ATP5H,COX20
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	0.9129390094371	-0.0910862029875492	50	2	0.00310077519379845	645	8202	65109,79902	UPF3B,NUP85
R-HSA-112310	Neurotransmitter Release Cycle	0.9129390094371	-0.0910862029875492	50	2	0.00310077519379845	645	8202	6507,2571	SLC1A3,GAD1
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	0.914705922407247	-0.089152661641701	30	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-5656169	Termination of translesion DNA synthesis	0.914705922407247	-0.089152661641701	30	1	0.00155038759689922	645	8202	124739	USP43
R-HSA-68962	Activation of the pre-replicative complex	0.914705922407247	-0.089152661641701	30	1	0.00155038759689922	645	8202	5557	PRIM1
R-HSA-72086	mRNA Capping	0.914705922407247	-0.089152661641701	30	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	0.914705922407247	-0.089152661641701	30	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-3371556	Cellular response to heat stress	0.915061646800981	-0.0887638424231269	86	4	0.0062015503875969	645	8202	9261,23411,79902,259217	MAPKAPK2,SIRT1,NUP85,HSPA12A
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.919413975486932	-0.0840187950653992	87	4	0.0062015503875969	645	8202	3065,7088,6932,26108	HDAC1,TLE1,TCF7,PYGO1
R-HSA-5663205	Infectious disease	0.920992657148737	-0.0823032154527092	347	21	0.0325581395348837	645	8202	5721,5611,801,5045,808,5716,5720,2958,84168,292,11168,3105,10053,6136,6170,5902,928,2963,3159,79902,60489	PSME2,DNAJC3,CALM1,FURIN,CALM3,PSMD10,PSME1,GTF2A2,ANTXR1,SLC25A5,PSIP1,HLA-A,AP1M2,RPL12,RPL39,RANBP1,CD9,GTF2F2,HMGA1,NUP85,APOBEC3G
R-HSA-167287	HIV elongation arrest and recovery	0.921438017367511	-0.0818197668935766	31	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-1296065	Inwardly rectifying K+ channels	0.921438017367511	-0.0818197668935766	31	1	0.00155038759689922	645	8202	3768	KCNJ12
R-HSA-352230	Amino acid transport across the plasma membrane	0.921438017367511	-0.0818197668935766	31	1	0.00155038759689922	645	8202	6542	SLC7A2
R-HSA-167290	Pausing and recovery of HIV elongation	0.921438017367511	-0.0818197668935766	31	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-73772	RNA Polymerase I Promoter Escape	0.921438017367511	-0.0818197668935766	31	1	0.00155038759689922	645	8202	9014	TAF1B
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.921438017367511	-0.0818197668935766	31	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-70171	Glycolysis	0.921438017367511	-0.0818197668935766	31	1	0.00155038759689922	645	8202	2026	ENO2
R-HSA-5357905	Regulation of TNFR1 signaling	0.921438017367511	-0.0818197668935766	31	1	0.00155038759689922	645	8202	8567	MADD
R-HSA-180746	Nuclear import of Rev protein	0.921438017367511	-0.0818197668935766	31	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-977225	Amyloid formation	0.923565677939521	-0.0795133633664767	88	4	0.0062015503875969	645	8202	3339,26088,1471,5045	HSPG2,GGA1,CST3,FURIN
R-HSA-73886	Chromosome Maintenance	0.923977785108229	-0.0790672497201303	105	5	0.00775193798449612	645	8202	1058,55355,55839,2491,5557	CENPA,HJURP,CENPN,CENPI,PRIM1
R-HSA-69306	DNA Replication	0.927631359013453	-0.0751208675600172	106	5	0.00775193798449612	645	8202	1027,5716,5720,5721,5557	CDKN1B,PSMD10,PSME1,PSME2,PRIM1
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.927639520098156	-0.0751120698315612	32	1	0.00155038759689922	645	8202	10253	SPRY2
R-HSA-73863	RNA Polymerase I Transcription Termination	0.927639520098156	-0.0751120698315612	32	1	0.00155038759689922	645	8202	9014	TAF1B
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.927639520098156	-0.0751120698315612	32	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-5368287	Mitochondrial translation	0.931297441430587	-0.0711765667678804	90	4	0.0062015503875969	645	8202	28957,65080,51650,64960	MRPS28,MRPL44,MRPS33,MRPS15
R-HSA-5625740	RHO GTPases activate PKNs	0.931297441430587	-0.0711765667678804	90	4	0.0062015503875969	645	8202	10398,5585,103910,10499	MYL9,PKN1,MYL12B,NCOA2
R-HSA-162587	HIV Life Cycle	0.931572854002649	-0.0708808805091595	140	7	0.0108527131782946	645	8202	3159,2958,11168,79902,5902,5045,2963	HMGA1,GTF2A2,PSIP1,NUP85,RANBP1,FURIN,GTF2F2
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.93330376387061	-0.0690245535560261	54	2	0.00310077519379845	645	8202	65109,79902	UPF3B,NUP85
R-HSA-69190	DNA strand elongation	0.933352189561817	-0.0689726685890844	33	1	0.00155038759689922	645	8202	5557	PRIM1
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.933352189561817	-0.0689726685890844	33	1	0.00155038759689922	645	8202	580	BARD1
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.933352189561817	-0.0689726685890844	33	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-4085001	Sialic acid metabolism	0.933352189561817	-0.0689726685890844	33	1	0.00155038759689922	645	8202	5476	CTSA
R-HSA-391251	Protein folding	0.937640872925891	-0.06438826797186	55	2	0.00310077519379845	645	8202	63971,6904	KIF13A,TBCD
R-HSA-6784531	tRNA processing in the nucleus	0.937640872925891	-0.06438826797186	55	2	0.00310077519379845	645	8202	1478,79902	CSTF2,NUP85
R-HSA-113418	Formation of the Early Elongation Complex	0.9386145029196	-0.0633504240902261	34	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-390522	Striated Muscle Contraction	0.9386145029196	-0.0633504240902261	34	1	0.00155038759689922	645	8202	29767	TMOD2
R-HSA-1222556	ROS production in response to bacteria	0.9386145029196	-0.0633504240902261	34	1	0.00155038759689922	645	8202	533	ATP6V0B
R-HSA-5693537	Resolution of D-Loop Structures	0.9386145029196	-0.0633504240902261	34	1	0.00155038759689922	645	8202	580	BARD1
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.9386145029196	-0.0633504240902261	34	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.943461913013983	-0.0581992827530559	35	1	0.00155038759689922	645	8202	79661	NEIL1
R-HSA-73884	Base Excision Repair	0.943461913013983	-0.0581992827530559	35	1	0.00155038759689922	645	8202	79661	NEIL1
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	0.943461913013983	-0.0581992827530559	35	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.947927085778825	-0.0534776934205448	36	1	0.00155038759689922	645	8202	10810	WASF3
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.947927085778825	-0.0534776934205448	36	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.952040119066995	-0.0491481032016196	37	1	0.00155038759689922	645	8202	124739	USP43
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	0.952040119066995	-0.0491481032016196	37	1	0.00155038759689922	645	8202	580	BARD1
R-HSA-5674135	MAP2K and MAPK activation	0.955828744082211	-0.0451765199671812	38	1	0.00155038759689922	645	8202	8826	IQGAP1
R-HSA-166658	Complement cascade	0.955828744082211	-0.0451765199671812	38	1	0.00155038759689922	645	8202	1604	CD55
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.955828744082211	-0.0451765199671812	38	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-1296071	Potassium Channels	0.958043437416215	-0.0428621602686043	99	4	0.0062015503875969	645	8202	3768,27345,3783,3790	KCNJ12,KCNMB4,KCNN4,KCNS3
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	0.959318511368492	-0.0415321305983588	39	1	0.00155038759689922	645	8202	2915	GRM5
R-HSA-977444	GABA B receptor activation	0.959318511368492	-0.0415321305983588	39	1	0.00155038759689922	645	8202	3768	KCNJ12
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.959318511368492	-0.0415321305983588	39	1	0.00155038759689922	645	8202	580	BARD1
R-HSA-991365	Activation of GABAB receptors	0.959318511368492	-0.0415321305983588	39	1	0.00155038759689922	645	8202	3768	KCNJ12
R-HSA-68875	Mitotic Prophase	0.962075570010408	-0.0386622762973468	136	6	0.00930232558139535	645	8202	5347,64900,9133,983,55844,79902	PLK1,LPIN3,CCNB2,CDK1,PPP2R2D,NUP85
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.9625013559259	-0.038219804067008	101	4	0.0062015503875969	645	8202	4891,57181,64116,23446	SLC11A2,SLC39A10,SLC39A8,SLC44A1
R-HSA-168253	Host Interactions with Influenza Factors	0.962532961948152	-0.0381869672266868	40	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-5696400	Dual Incision in GG-NER	0.962532961948152	-0.0381869672266868	40	1	0.00155038759689922	645	8202	8450	CUL4B
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.962532961948152	-0.0381869672266868	40	1	0.00155038759689922	645	8202	2495	FTH1
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.963970898607311	-0.0366941729939533	83	3	0.00465116279069767	645	8202	93973,8450,5886	ACTR8,CUL4B,RAD23A
R-HSA-75893	TNF signaling	0.965493785212189	-0.0351156139937467	41	1	0.00155038759689922	645	8202	8567	MADD
R-HSA-70153	Glucose transport	0.965493785212189	-0.0351156139937467	41	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-192823	Viral mRNA Translation	0.966128192606476	-0.0344587490125206	84	3	0.00465116279069767	645	8202	6136,6170,5611	RPL12,RPL39,DNAJC3
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.966285833016801	-0.0342955951453017	64	2	0.00310077519379845	645	8202	5585,10499	PKN1,NCOA2
R-HSA-379724	tRNA Aminoacylation	0.968220964306854	-0.032294948842905	42	1	0.00155038759689922	645	8202	57176	VARS2
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.968220964306854	-0.032294948842905	42	1	0.00155038759689922	645	8202	580	BARD1
R-HSA-375280	Amine ligand-binding receptors	0.968220964306854	-0.032294948842905	42	1	0.00155038759689922	645	8202	3352	HTR1D
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	0.968543874575415	-0.0319614955861435	65	2	0.00310077519379845	645	8202	23411,9014	SIRT1,TAF1B
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.968543874575415	-0.0319614955861435	65	2	0.00310077519379845	645	8202	2958,2963	GTF2A2,GTF2F2
R-HSA-2980736	Peptide hormone metabolism	0.970082674156138	-0.030373980027869	86	3	0.00465116279069767	645	8202	1522,60559,4644	CTSZ,SPCS3,MYO5A
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.97073291015237	-0.0297039153129961	43	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-1296072	Voltage gated Potassium channels	0.97073291015237	-0.0297039153129961	43	1	0.00155038759689922	645	8202	3790	KCNS3
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.97073291015237	-0.0297039153129961	43	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-167169	HIV Transcription Elongation	0.97073291015237	-0.0297039153129961	43	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-167172	Transcription of the HIV genome	0.972631080003448	-0.0277504259365021	67	2	0.00310077519379845	645	8202	2958,2963	GTF2A2,GTF2F2
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.973046584975033	-0.027323320270049	44	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-75955	RNA Polymerase II Transcription Elongation	0.973046584975033	-0.027323320270049	44	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-112382	Formation of RNA Pol II elongation complex	0.973046584975033	-0.027323320270049	44	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	0.973374994796325	-0.0269858704309998	107	4	0.0062015503875969	645	8202	6185,60559,6136,6170	RPN2,SPCS3,RPL12,RPL39
R-HSA-73857	RNA Polymerase II Transcription	0.973374994796325	-0.0269858704309998	107	4	0.0062015503875969	645	8202	1478,65109,2958,2963	CSTF2,UPF3B,GTF2A2,GTF2F2
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.975709599532686	-0.0245902783057003	127	5	0.00775193798449612	645	8202	6136,6170,79902,5611,2963	RPL12,RPL39,NUP85,DNAJC3,GTF2F2
R-HSA-162599	Late Phase of HIV Life Cycle	0.975709599532686	-0.0245902783057003	127	5	0.00775193798449612	645	8202	2958,79902,5902,5045,2963	GTF2A2,NUP85,RANBP1,FURIN,GTF2F2
R-HSA-69473	G2/M DNA damage checkpoint	0.977816471017765	-0.0224332840032296	70	2	0.00310077519379845	645	8202	580,983	BARD1,CDK1
R-HSA-212436	Generic Transcription Pathway	0.978671129668504	-0.0215596176382582	553	32	0.0496124031007752	645	8202	5563,860,7067,7157,1345,7005,9668,7626,143686,1490,7181,10499,7068,7050,207,2908,3164,5465,84441,27244,6009,116228,51422,7761,619279,8013,3065,4929,29959,5916,55762,4306	PRKAA2,RUNX2,THRA,TP53,COX6C,TEAD3,ZNF432,ZNF75D,SESN3,CTGF,NR2C1,NCOA2,THRB,TGIF1,AKT1,NR3C1,NR4A1,PPARA,MAML2,SESN1,RHEB,COX20,PRKAG2,ZNF214,ZNF704,NR4A3,HDAC1,NR4A2,NRBP1,RARG,ZNF701,NR3C2
R-HSA-189200	Hexose transport	0.978948204241563	-0.0212765446525043	47	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-2299718	Condensation of Prophase Chromosomes	0.979323346995856	-0.0208934080454851	71	2	0.00310077519379845	645	8202	5347,983	PLK1,CDK1
R-HSA-73887	Death Receptor Signalling	0.98061324510598	-0.0195771427116394	48	1	0.00155038759689922	645	8202	8567	MADD
R-HSA-72163	mRNA Splicing - Major Pathway	0.981239413775007	-0.018938798453262	113	4	0.0062015503875969	645	8202	1478,65109,3188,2963	CSTF2,UPF3B,HNRNPH2,GTF2F2
R-HSA-390466	Chaperonin-mediated protein folding	0.98214678164119	-0.0180145096578138	49	1	0.00155038759689922	645	8202	63971	KIF13A
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	0.983272664689481	-0.0168688171456662	74	2	0.00310077519379845	645	8202	580,7157	BARD1,TP53
R-HSA-191859	snRNP Assembly	0.983559185172217	-0.0165774648526041	50	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-194441	Metabolism of non-coding RNA	0.983559185172217	-0.0165774648526041	50	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-72165	mRNA Splicing - Minor Pathway	0.983559185172217	-0.0165774648526041	50	1	0.00155038759689922	645	8202	2963	GTF2F2
R-HSA-429914	Deadenylation-dependent mRNA decay	0.983559185172217	-0.0165774648526041	50	1	0.00155038759689922	645	8202	167227	DCP2
R-HSA-3214858	RMTs methylate histone arginines	0.984418365349093	-0.0157043042505069	75	2	0.00310077519379845	645	8202	595,6595	CCND1,SMARCA2
R-HSA-5693606	DNA Double Strand Break Response	0.984418365349093	-0.0157043042505069	75	2	0.00310077519379845	645	8202	580,7157	BARD1,TP53
R-HSA-1221632	Meiotic synapsis	0.984418365349093	-0.0157043042505069	75	2	0.00310077519379845	645	8202	25777,23224	SUN2,SYNE2
R-HSA-168255	Influenza Life Cycle	0.985225241427025	-0.014884992451873	136	5	0.00775193798449612	645	8202	6136,6170,79902,5611,2963	RPL12,RPL39,NUP85,DNAJC3,GTF2F2
R-HSA-72172	mRNA Splicing	0.987639433559015	-0.0124375936336609	120	4	0.0062015503875969	645	8202	1478,65109,3188,2963	CSTF2,UPF3B,HNRNPH2,GTF2F2
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	0.988177621888622	-0.0118928181531246	54	1	0.00155038759689922	645	8202	8450	CUL4B
R-HSA-977443	GABA receptor activation	0.989113487612784	-0.0109462040814291	55	1	0.00155038759689922	645	8202	3768	KCNJ12
R-HSA-380108	Chemokine receptors bind chemokines	0.989975375488143	-0.0100752094071456	56	1	0.00155038759689922	645	8202	58191	CXCL16
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.990067208332309	-0.0099824509533804	143	5	0.00775193798449612	645	8202	4697,1345,55967,10476,116228	NDUFA4,COX6C,NDUFA12,ATP5H,COX20
R-HSA-212165	Epigenetic regulation of gene expression	0.990299761942302	-0.00974759184438455	124	4	0.0062015503875969	645	8202	3065,23411,9014,3720	HDAC1,SIRT1,TAF1B,JARID2
R-HSA-69481	G2/M Checkpoints	0.991148220725143	-0.00889118900956952	105	3	0.00465116279069767	645	8202	580,9133,983	BARD1,CCNB2,CDK1
R-HSA-927802	Nonsense-Mediated Decay (NMD)	0.991711887224633	-0.00832265014753589	106	3	0.00465116279069767	645	8202	6136,65109,6170	RPL12,UPF3B,RPL39
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	0.991711887224633	-0.00832265014753589	106	3	0.00465116279069767	645	8202	6136,65109,6170	RPL12,UPF3B,RPL39
R-HSA-156902	Peptide chain elongation	0.991822273581103	-0.00821134744474888	84	2	0.00310077519379845	645	8202	6136,6170	RPL12,RPL39
R-HSA-418555	G alpha (s) signalling events	0.991926263050596	-0.00810650606221667	127	4	0.0062015503875969	645	8202	2778,5144,10681,5734	GNAS,PDE4D,GNB5,PTGER4
R-HSA-168254	Influenza Infection	0.992113430106454	-0.00791783336876267	147	5	0.00775193798449612	645	8202	6136,6170,79902,5611,2963	RPL12,RPL39,NUP85,DNAJC3,GTF2F2
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.992240836047976	-0.00778942288897075	107	3	0.00465116279069767	645	8202	3065,23411,9014	HDAC1,SIRT1,TAF1B
R-HSA-72764	Eukaryotic Translation Termination	0.992392368452228	-0.00763671718576777	85	2	0.00310077519379845	645	8202	6136,6170	RPL12,RPL39
R-HSA-5696398	Nucleotide Excision Repair	0.993202643469152	-0.00682056378385469	109	3	0.00465116279069767	645	8202	93973,8450,5886	ACTR8,CUL4B,RAD23A
R-HSA-156842	Eukaryotic Translation Elongation	0.993879346966333	-0.00613946101446798	88	2	0.00310077519379845	645	8202	6136,6170	RPL12,RPL39
R-HSA-4839726	Chromatin organization	0.994232344195193	-0.00578435296481601	261	11	0.0170542635658915	645	8202	595,79960,6595,83852,84193,10362,3065,9643,23338,10499,2122	CCND1,JADE1,SMARCA2,SETDB2,SETD3,HMG20B,HDAC1,MORF4L2,JADE2,NCOA2,MECOM
R-HSA-3247509	Chromatin modifying enzymes	0.994232344195193	-0.00578435296481601	261	11	0.0170542635658915	645	8202	595,79960,6595,83852,84193,10362,3065,9643,23338,10499,2122	CCND1,JADE1,SMARCA2,SETDB2,SETD3,HMG20B,HDAC1,MORF4L2,JADE2,NCOA2,MECOM
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	0.994308639265462	-0.00570761824228244	89	2	0.00310077519379845	645	8202	6136,6170	RPL12,RPL39
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	0.994374059862839	-0.00564182534588045	63	1	0.00155038759689922	645	8202	8450	CUL4B
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.994447181872503	-0.00556829233229109	153	5	0.00775193798449612	645	8202	1478,65109,3188,79902,2963	CSTF2,UPF3B,HNRNPH2,NUP85,GTF2F2
R-HSA-6782135	Dual incision in TC-NER	0.994819904736765	-0.00519355847062685	64	1	0.00155038759689922	645	8202	8450	CUL4B
R-HSA-5685942	HDR through Homologous Recombination (HRR)	0.995230467709612	-0.00478094280586099	65	1	0.00155038759689922	645	8202	580	BARD1
R-HSA-72689	Formation of a pool of free 40S subunits	0.996049855106554	-0.00395796732239939	94	2	0.00310077519379845	645	8202	6136,6170	RPL12,RPL39
R-HSA-72306	tRNA processing	0.996049855106554	-0.00395796732239939	94	2	0.00310077519379845	645	8202	1478,79902	CSTF2,NUP85
R-HSA-3214815	HDACs deacetylate histones	0.996049855106554	-0.00395796732239939	94	2	0.00310077519379845	645	8202	3065,10362	HDAC1,HMG20B
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.996277262935465	-0.00372968369584106	68	1	0.00155038759689922	645	8202	580	BARD1
R-HSA-212300	PRC2 methylates histones and DNA	0.996844289986543	-0.00316069976654298	70	1	0.00155038759689922	645	8202	3720	JARID2
R-HSA-3214847	HATs acetylate histones	0.997035883934323	-0.00296851775793844	143	4	0.0062015503875969	645	8202	79960,9643,23338,10499	JADE1,MORF4L2,JADE2,NCOA2
R-HSA-392499	Metabolism of proteins	0.997056955691568	-0.00294738357920137	943	54	0.0837209302325581	645	8202	3489,3339,26088,79695,5611,10165,29995,51726,1522,94025,22901,1075,6170,79868,11320,2530,6904,1471,6185,3485,56005,3998,10130,10106,79902,4644,10970,2650,2673,10484,9512,93010,5329,56648,11282,5045,29071,63971,1294,51809,90411,167227,2517,2591,6136,6675,5265,1678,55062,140766,5476,60559,411,170690	IGFBP6,HSPG2,GGA1,GALNT12,DNAJC3,SLC25A13,LMCD1,DNAJB11,CTSZ,MUC16,ARSG,CTSC,RPL39,ALG13,MGAT4A,FUT8,TBCD,CST3,RPN2,IGFBP2,MYDGF,LMAN1,PDIA6,CTDSP2,NUP85,MYO5A,CKAP4,GCNT1,GFPT1,SEC23A,PMPCB,B3GNT7,PLAUR,EIF5A2,MGAT4B,FURIN,C1GALT1C1,KIF13A,COL7A1,GALNT7,MCFD2,DCP2,FUCA1,GALNT3,RPL12,UAP1,SERPINA1,TIMM8A,WIPI1,ADAMTS14,CTSA,SPCS3,ARSB,ADAMTS16
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.997391431432968	-0.00261197681039811	145	4	0.0062015503875969	645	8202	3065,9014,4781,4784	HDAC1,TAF1B,NFIB,NFIX
R-HSA-72766	Translation	0.997553354337289	-0.00244964359112083	146	4	0.0062015503875969	645	8202	6185,60559,6136,6170	RPN2,SPCS3,RPL12,RPL39
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.997732687788827	-0.00226988645531748	74	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.997732687788827	-0.00226988645531748	74	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	0.998111011242432	-0.00189077514683173	104	2	0.00310077519379845	645	8202	6136,6170	RPL12,RPL39
R-HSA-427413	NoRC negatively regulates rRNA expression	0.998111011242432	-0.00189077514683173	104	2	0.00310077519379845	645	8202	3065,9014	HDAC1,TAF1B
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	0.998230813337077	-0.00177075352196387	77	1	0.00155038759689922	645	8202	8450	CUL4B
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	0.998246211069368	-0.00175532861889445	105	2	0.00310077519379845	645	8202	6136,6170	RPL12,RPL39
R-HSA-211000	Gene Silencing by RNA	0.998359629350372	-0.00164171753068647	130	3	0.00465116279069767	645	8202	192670,4603,79902	AGO4,MYBL1,NUP85
R-HSA-157579	Telomere Maintenance	0.998371259549418	-0.00163006829030984	78	1	0.00155038759689922	645	8202	5557	PRIM1
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.99848865274869	-0.00151249048859767	107	2	0.00310077519379845	645	8202	3065,9014	HDAC1,TAF1B
R-HSA-2990846	SUMOylation	0.99850057240448	-0.00150055286205519	79	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-73864	RNA Polymerase I Transcription	0.998698004714011	-0.00130284361828078	109	2	0.00310077519379845	645	8202	3065,9014	HDAC1,TAF1B
R-HSA-72737	Cap-dependent Translation Initiation	0.998959552731897	-0.00104098890909325	112	2	0.00310077519379845	645	8202	6136,6170	RPL12,RPL39
R-HSA-72613	Eukaryotic Translation Initiation	0.998959552731897	-0.00104098890909325	112	2	0.00310077519379845	645	8202	6136,6170	RPL12,RPL39
R-HSA-1500620	Meiosis	0.999169129004604	-0.00083121636001666	115	2	0.00310077519379845	645	8202	25777,23224	SUN2,SYNE2
R-HSA-73777	RNA Polymerase I Chain Elongation	0.999288163212547	-0.000712090263555134	88	1	0.00155038759689922	645	8202	9014	TAF1B
R-HSA-418594	G alpha (i) signalling events	0.999572871945853	-0.000427219299318	236	7	0.0108527131782946	645	8202	2778,58191,2852,10681,3352,23596,8601	GNAS,CXCL16,GPER1,GNB5,HTR1D,OPN3,RGS20
R-HSA-5693607	Processing of DNA double-strand break ends	0.999662354480225	-0.000337702534857762	97	1	0.00155038759689922	645	8202	580	BARD1
R-HSA-5578749	Transcriptional regulation by small RNAs	0.999757687167896	-0.000242342194601439	101	1	0.00155038759689922	645	8202	79902	NUP85
R-HSA-375276	Peptide ligand-binding receptors	0.999893672674826	-0.0001063329783247	193	4	0.0062015503875969	645	8202	58191,2852,2149,1909	CXCL16,GPER1,F2R,EDNRA
R-HSA-372790	Signaling by GPCR	0.999910561052143	-8.94429477584382e-05	1230	66	0.102325581395349	645	8202	5321,5721,6195,8826,8601,2064,9542,5720,3709,5566,6710,27237,2915,3352,5154,6196,53358,5290,11221,5293,5144,221002,7074,2149,10125,10817,1604,207,8322,5734,5577,5588,1846,3710,29,8324,1909,8660,3084,50650,5922,1609,808,5716,9965,8323,58191,10681,156,23596,2065,89780,5330,9693,5295,801,2902,5921,8526,10235,2778,160851,2263,2852,7855,50649	PLA2G4A,PSME2,RPS6KA1,IQGAP1,RGS20,ERBB2,NRG2,PSME1,ITPR2,PRKACA,SPTB,ARHGEF16,GRM5,HTR1D,PDGFA,RPS6KA2,SHC3,PIK3CA,DUSP10,PIK3CD,PDE4D,RASGEF1A,TIAM1,F2R,RASGRP1,FRS3,CD55,AKT1,FZD4,PTGER4,PRKAR2B,PRKCQ,DUSP4,ITPR3,ABR,FZD7,EDNRA,IRS2,NRG1,ARHGEF3,RASA2,DGKQ,CALM3,PSMD10,FGF19,FZD6,CXCL16,GNB5,ADRBK1,OPN3,ERBB3,WNT3A,PLCB2,RAPGEF2,PIK3R1,CALM1,GRIN1,RASA1,DGKE,RASGRP2,GNAS,DGKH,FGFR2,GPER1,FZD5,ARHGEF4
R-HSA-73894	DNA Repair	0.999927598789159	-7.240383193506e-05	306	9	0.013953488372093	645	8202	79661,29089,93973,8450,7157,580,55215,124739,5886	NEIL1,UBE2T,ACTR8,CUL4B,TP53,BARD1,FANCI,USP43,RAD23A
R-HSA-500792	GPCR ligand binding	0.999946828255113	-5.31731585546549e-05	444	16	0.0248062015503876	645	8202	1604,8322,5734,8323,2915,8324,3352,1909,2778,58191,10681,23596,2852,89780,7855,2149	CD55,FZD4,PTGER4,FZD6,GRM5,FZD7,HTR1D,EDNRA,GNAS,CXCL16,GNB5,OPN3,GPER1,WNT3A,FZD5,F2R
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.99997635701601	-2.36432634902125e-05	129	1	0.00155038759689922	645	8202	580	BARD1
R-HSA-5693532	DNA Double-Strand Break Repair	0.999977216170365	-2.27840891901359e-05	162	2	0.00310077519379845	645	8202	580,7157	BARD1,TP53
R-HSA-5693538	Homology Directed Repair	0.999985656550358	-1.4343552510682e-05	135	1	0.00155038759689922	645	8202	580	BARD1
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.999997600049029	-2.39995385042544e-06	318	7	0.0108527131782946	645	8202	58191,2852,2149,3352,1909,23596,5734	CXCL16,GPER1,F2R,HTR1D,EDNRA,OPN3,PTGER4
R-HSA-74160	Gene Expression	0.999999989237661	-1.07623392972689e-08	1330	58	0.089922480620155	645	8202	5563,860,65109,5721,7067,7157,5716,5720,57176,1345,7005,9668,7626,143686,9014,1490,6170,7538,2963,5600,6185,4603,7181,79902,10499,7068,23411,7050,207,2908,3164,5465,192670,84441,2958,27244,4781,167227,6009,116228,4784,9261,51422,6136,3188,7761,8013,619279,1478,3065,4929,60559,3315,4306,55762,5916,29959,3720	PRKAA2,RUNX2,UPF3B,PSME2,THRA,TP53,PSMD10,PSME1,VARS2,COX6C,TEAD3,ZNF432,ZNF75D,SESN3,TAF1B,CTGF,RPL39,ZFP36,GTF2F2,MAPK11,RPN2,MYBL1,NR2C1,NUP85,NCOA2,THRB,SIRT1,TGIF1,AKT1,NR3C1,NR4A1,PPARA,AGO4,MAML2,GTF2A2,SESN1,NFIB,DCP2,RHEB,COX20,NFIX,MAPKAPK2,PRKAG2,RPL12,HNRNPH2,ZNF214,NR4A3,ZNF704,CSTF2,HDAC1,NR4A2,SPCS3,HSPB1,NR3C2,ZNF701,RARG,NRBP1,JARID2
R-HSA-388396	GPCR downstream signaling	0.999999999329864	-6.70135518790618e-10	928	31	0.048062015503876	645	8202	50650,207,1609,5295,8601,5734,5588,3709,3710,8526,27237,2915,29,3352,10235,1909,160851,2778,58191,156,10681,5290,23596,2852,5293,5144,7074,2149,5330,10125,50649	ARHGEF3,AKT1,DGKQ,PIK3R1,RGS20,PTGER4,PRKCQ,ITPR2,ITPR3,DGKE,ARHGEF16,GRM5,ABR,HTR1D,RASGRP2,EDNRA,DGKH,GNAS,CXCL16,ADRBK1,GNB5,PIK3CA,OPN3,GPER1,PIK3CD,PDE4D,TIAM1,F2R,PLCB2,RASGRP1,ARHGEF4
R-HSA-381753	Olfactory Signaling Pathway	0.999999999987928	-1.20718024060439e-11	381	0	0	645	8202
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.999999999992303	-7.69690180340682e-12	19	0	0	645	8202
R-HSA-110320	Translesion Synthesis by POLH	0.999999999992303	-7.69690180340682e-12	19	0	0	645	8202
R-HSA-190861	Gap junction assembly	0.999999999992303	-7.69690180340682e-12	19	0	0	645	8202
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999992303	-7.69690180340682e-12	19	0	0	645	8202
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.999999999992303	-7.69690180340682e-12	19	0	0	645	8202
R-HSA-1222499	Response of Mtb to phagocytosis	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-5602410	TLR3 deficiency - HSE	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-1839128	FGFR4 mutant receptor activation	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-163316	Mitochondrial transcription termination	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-2534343	Interaction With Cumulus Cells	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-3248023	Regulation by TREX1	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-169131	Inhibition of PKR	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-162589	Reverse Transcription of HIV RNA	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-1483076	Synthesis of CL	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-140180	COX reactions	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-162585	Uncoating of the HIV Virion	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-164525	Plus-strand DNA synthesis	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-164516	Minus-strand DNA synthesis	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-1222449	Mtb iron assimilation by chelation	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-1300645	Acrosome Reaction	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-5619084	ABC transporter disorders	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-5602415	UNC93B1 deficiency - HSE	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-2033515	t(4;14) translocations of FGFR3	0.99999999999248	-7.51976259039111e-12	1	0	0	645	8202
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-388479	Vasopressin-like receptors	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-500753	Pyrimidine biosynthesis	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-171052	LDL-mediated lipid transport	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-190370	FGFR1b ligand binding and activation	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-5660668	CLEC7A/inflammasome pathway	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-1566977	Fibronectin matrix formation	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-171319	Telomere Extension By Telomerase	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-193993	Mineralocorticoid biosynthesis	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-947581	Molybdenum cofactor biosynthesis	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-5626978	TNFR1-mediated ceramide production	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-173623	Classical antibody-mediated complement activation	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-187015	Activation of TRKA receptors	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-3065679	SUMO is proteolytically processed	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-177135	Conjugation of benzoate with glycine	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-73942	DNA Damage Reversal	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-428808	Na+-dependent glucose transporters	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-166662	Lectin pathway of complement activation	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-3000484	Scavenging by Class F Receptors	0.999999999993933	-6.0670858423539e-12	6	0	0	645	8202
R-HSA-166663	Initial triggering of complement	0.999999999994061	-5.93861202766121e-12	20	0	0	645	8202
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-916853	Degradation of GABA	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-205017	NFG and proNGF binds to p75NTR	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-168277	Influenza Virus Induced Apoptosis	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-168268	Virus Assembly and Release	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-1483101	Synthesis of PS	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-192905	vRNP Assembly	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-5652227	Fructose biosynthesis	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-141334	PAOs oxidise polyamines to amines	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-75102	C6 deamination of adenosine	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-844623	The IPAF inflammasome	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-75064	mRNA Editing: A to I Conversion	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-156582	Acetylation	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-141424	Amplification of signal from the kinetochores	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-190872	Transport of connexons to the plasma membrane	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-165160	PDE3B signalling	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-203754	NOSIP mediated eNOS trafficking	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-198765	Signalling to ERK5	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-351143	Agmatine biosynthesis	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-187042	TRKA activation by NGF	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-75094	Formation of the Editosome	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-5602566	TICAM1 deficiency - HSE	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-5602636	IKBKB deficiency causes SCID	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-77042	Formation of editosomes by ADAR proteins	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-111452	Activation and oligomerization of BAK protein	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-5662702	Melanin biosynthesis	0.999999999994537	-5.46332857426224e-12	2	0	0	645	8202
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-71288	Creatine metabolism	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-2485179	Activation of the phototransduction cascade	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-68689	CDC6 association with the ORC:origin complex	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-199983	Golgi to ER Retrograde Transport	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-199997	COPI Mediated Transport	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-3371378	Regulation by c-FLIP	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-1980148	Signaling by NOTCH3	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-5218900	CASP8 activity is inhibited	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-196757	Metabolism of folate and pterines	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-375281	Hormone ligand-binding receptors	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-211999	CYP2E1 reactions	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-193048	Androgen biosynthesis	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-71240	Tryptophan catabolism	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-69416	Dimerization of procaspase-8	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-196807	Nicotinate metabolism	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-1980150	Signaling by NOTCH4	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.999999999995497	-4.5024893955982e-12	11	0	0	645	8202
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.99999999999614	-3.86012758423189e-12	14	0	0	645	8202
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.99999999999614	-3.86012758423189e-12	14	0	0	645	8202
R-HSA-3371568	Attenuation phase	0.99999999999614	-3.86012758423189e-12	14	0	0	645	8202
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.99999999999614	-3.86012758423189e-12	14	0	0	645	8202
R-HSA-428540	Activation of Rac	0.99999999999614	-3.86012758423189e-12	14	0	0	645	8202
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.99999999999614	-3.86012758423189e-12	14	0	0	645	8202
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.99999999999614	-3.86012758423189e-12	14	0	0	645	8202
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.99999999999614	-3.86012758423189e-12	14	0	0	645	8202
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.99999999999614	-3.86012758423189e-12	14	0	0	645	8202
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.99999999999614	-3.86012758423189e-12	14	0	0	645	8202
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.99999999999614	-3.86012758423189e-12	14	0	0	645	8202
R-HSA-418885	DCC mediated attractive signaling	0.99999999999614	-3.86012758423189e-12	14	0	0	645	8202
R-HSA-5682910	LGI-ADAM interactions	0.99999999999614	-3.86012758423189e-12	14	0	0	645	8202
R-HSA-5675482	Regulation of necroptotic cell death	0.99999999999614	-3.86012758423189e-12	14	0	0	645	8202
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-265473	Trafficking of dietary sterols	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-5653890	Lactose synthesis	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-70350	Fructose catabolism	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-1483152	Hydrolysis of LPE	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-191650	Regulation of gap junction activity	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-111458	Formation of apoptosome	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-163282	Mitochondrial transcription initiation	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-193681	Ceramide signalling	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-977347	Serine biosynthesis	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-198745	Signalling to STAT3	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-190704	Oligomerization of connexins into connexons	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-110331	Cleavage of the damaged purine	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-352238	Breakdown of the nuclear lamina	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-1296067	Potassium transport channels	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-977442	GABA A (rho) receptor activation	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-217271	FMO oxidises nucleophiles	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-5602571	TRAF3 deficiency - HSE	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-73927	Depurination	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-190827	Transport of connexins along the secretory pathway	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-844615	The AIM2 inflammasome	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.999999999998088	-1.91162997974573e-12	3	0	0	645	8202
R-HSA-110312	Translesion synthesis by REV1	0.999999999998513	-1.48673418029691e-12	16	0	0	645	8202
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.999999999998513	-1.48673418029691e-12	16	0	0	645	8202
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.999999999998513	-1.48673418029691e-12	16	0	0	645	8202
R-HSA-1170546	Prolactin receptor signaling	0.999999999998513	-1.48673418029691e-12	16	0	0	645	8202
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.999999999998513	-1.48673418029691e-12	16	0	0	645	8202
R-HSA-5218859	Regulated Necrosis	0.999999999998513	-1.48673418029691e-12	16	0	0	645	8202
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.999999999998513	-1.48673418029691e-12	16	0	0	645	8202
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.999999999998513	-1.48673418029691e-12	16	0	0	645	8202
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.999999999998513	-1.48673418029691e-12	16	0	0	645	8202
R-HSA-190242	FGFR1 ligand binding and activation	0.999999999998513	-1.48673418029691e-12	16	0	0	645	8202
R-HSA-5663084	Diseases of carbohydrate metabolism	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-168799	Neurotoxicity of clostridium toxins	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-381183	ATF6-alpha activates chaperone genes	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-193692	Regulated proteolysis of p75NTR	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-3229121	Glycogen storage diseases	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-2474795	Diseases associated with visual transduction	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-2470946	Cohesin Loading onto Chromatin	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-549127	Organic cation transport	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-419812	Calcitonin-like ligand receptors	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-2453864	Retinoid cycle disease events	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-2562578	TRIF-mediated programmed cell death	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-1300644	Interaction With The Zona Pellucida	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-170660	Adenylate cyclase activating pathway	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-190873	Gap junction degradation	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999999076	-9.24152856953081e-13	10	0	0	645	8202
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.99999999999909	-9.10441345412972e-13	15	0	0	645	8202
R-HSA-209952	Peptide hormone biosynthesis	0.99999999999909	-9.10441345412972e-13	15	0	0	645	8202
R-HSA-901042	Calnexin/calreticulin cycle	0.99999999999909	-9.10441345412972e-13	15	0	0	645	8202
R-HSA-549132	Organic cation/anion/zwitterion transport	0.99999999999909	-9.10441345412972e-13	15	0	0	645	8202
R-HSA-205043	NRIF signals cell death from the nucleus	0.99999999999909	-9.10441345412972e-13	15	0	0	645	8202
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.99999999999909	-9.10441345412972e-13	15	0	0	645	8202
R-HSA-5358508	Mismatch Repair	0.99999999999909	-9.10441345412972e-13	15	0	0	645	8202
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	1.00000000000031	3.10683378541697e-13	18	0	0	645	8202
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	1.00000000000031	3.10683378541697e-13	18	0	0	645	8202
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	1.00000000000031	3.10683378541697e-13	18	0	0	645	8202
R-HSA-5654704	SHC-mediated cascade:FGFR3	1.00000000000031	3.10683378541697e-13	18	0	0	645	8202
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	1.00000000000031	3.10683378541697e-13	18	0	0	645	8202
R-HSA-73780	RNA Polymerase III Chain Elongation	1.00000000000031	3.10683378541697e-13	18	0	0	645	8202
R-HSA-5423646	Aflatoxin activation and detoxification	1.00000000000066	6.5820213850488e-13	22	0	0	645	8202
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	1.00000000000066	6.5820213850488e-13	22	0	0	645	8202
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	1.00000000000066	6.5820213850488e-13	22	0	0	645	8202
R-HSA-3371571	HSF1-dependent transactivation	1.00000000000066	6.5820213850488e-13	22	0	0	645	8202
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-164944	Nef and signal transduction	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-428643	Organic anion transporters	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-5619115	Disorders of transmembrane transporters	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-444821	Relaxin receptors	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-5358493	Synthesis of diphthamide-EEF2	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-177128	Conjugation of salicylate with glycine	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-72731	Recycling of eIF2:GDP	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-5632681	Ligand-receptor interactions	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-192456	Digestion of dietary lipid	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-193634	Axonal growth inhibition (RHOA activation)	1.00000000000117	1.17099664302957e-12	8	0	0	645	8202
R-HSA-194002	Glucocorticoid biosynthesis	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-156587	Amino Acid conjugation	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-110357	Displacement of DNA glycosylase by APEX1	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-196108	Pregnenolone biosynthesis	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-389661	Glyoxylate metabolism and glycine degradation	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-167590	Nef Mediated CD4 Down-regulation	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-1300642	Sperm Motility And Taxes	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-428890	Role of Abl in Robo-Slit signaling	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-428543	Inactivation of Cdc42 and Rac	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-70635	Urea cycle	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-2179392	EGFR Transactivation by Gastrin	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-189085	Digestion of dietary carbohydrate	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-390696	Adrenoceptors	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-419408	Lysosphingolipid and LPA receptors	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-193697	p75NTR regulates axonogenesis	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-159424	Conjugation of carboxylic acids	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-196025	Formation of annular gap junctions	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-447041	CHL1 interactions	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-201688	WNT mediated activation of DVL	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-159740	Gamma-carboxylation of protein precursors	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-3215018	Processing and activation of SUMO	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-1462054	Alpha-defensins	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-390450	Folding of actin by CCT/TriC	1.00000000000134	1.34291548942871e-12	9	0	0	645	8202
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-390648	Muscarinic acetylcholine receptors	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-75157	FasL/ CD95L signaling	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-5652084	Fructose metabolism	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-2161541	Abacavir metabolism	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-3000471	Scavenging by Class B Receptors	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-446205	Synthesis of GDP-mannose	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-167827	The proton buffering model	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-444209	Free fatty acid receptors	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-1614517	Sulfide oxidation to sulfate	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-2142850	Hyaluronan biosynthesis and export	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-197264	Nicotinamide salvaging	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-166187	Mitochondrial Uncoupling Proteins	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-114516	Disinhibition of SNARE formation	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-390651	Dopamine receptors	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-71032	Propionyl-CoA catabolism	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-187024	NGF-independant TRKA activation	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-111461	Cytochrome c-mediated apoptotic response	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-380095	Tachykinin receptors bind tachykinins	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-111463	SMAC binds to IAPs	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-561048	Organic anion transport	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-391906	Leukotriene receptors	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-203641	NOSTRIN mediated eNOS trafficking	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-68911	G2 Phase	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-426048	Arachidonate production from DAG	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-446199	Synthesis of Dolichyl-phosphate	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-167826	The fatty acid cycling model	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-209931	Serotonin and melatonin biosynthesis	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-111469	SMAC-mediated apoptotic response	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	1.00000000000291	2.91368148023081e-12	5	0	0	645	8202
R-HSA-379716	Cytosolic tRNA aminoacylation	1.000000000004	4.00283083173823e-12	24	0	0	645	8202
R-HSA-70268	Pyruvate metabolism	1.000000000004	4.00283083173823e-12	24	0	0	645	8202
R-HSA-937041	IKK complex recruitment mediated by RIP1	1.000000000004	4.00283083173823e-12	24	0	0	645	8202
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-71262	Carnitine synthesis	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-193144	Estrogen biosynthesis	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-173736	Alternative complement activation	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-1296061	HCN channels	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-75072	mRNA Editing	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-6783984	Glycine degradation	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-2473224	Antagonism of Activin by Follistatin	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-5603037	IRAK4 deficiency (TLR5)	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-888593	Reuptake of GABA	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-427975	Proton/oligopeptide cotransporters	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-1855191	Synthesis of IPs in the nucleus	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-1369007	Mitochondrial ABC transporters	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-75896	Plasmalogen biosynthesis	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-3000497	Scavenging by Class H Receptors	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-399710	Activation of AMPA receptors	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-389599	Alpha-oxidation of phytanate	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-209905	Catecholamine biosynthesis	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-209563	Axonal growth stimulation	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-417973	Adenosine P1 receptors	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-433692	Proton-coupled monocarboxylate transport	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-196819	Vitamin B1 (thiamin) metabolism	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-140179	Amine Oxidase reactions	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-428776	Class II GLUTs	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-165158	Activation of AKT2	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-173107	Binding and entry of HIV virion	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-75944	Transcription from mitochondrial promoters	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-1296025	ATP sensitive Potassium channels	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-390650	Histamine receptors	1.00000000000428	4.2772443098753e-12	4	0	0	645	8202
R-HSA-196071	Metabolism of steroid hormones and vitamin D	1.0000000000047	4.70458942542158e-12	36	0	0	645	8202
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	1.00000000000685	6.85430660824586e-12	27	0	0	645	8202
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	1.00000000000685	6.85430660824586e-12	27	0	0	645	8202
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-1839130	Signaling by activated point mutants of FGFR3	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-3371511	HSF1 activation	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-190373	FGFR1c ligand binding and activation	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-2168880	Scavenging of heme from plasma	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-174414	Processive synthesis on the C-strand of the telomere	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-1296346	Tandem pore domain potassium channels	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-176974	Unwinding of DNA	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-190239	FGFR3 ligand binding and activation	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-417957	P2Y receptors	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-2033514	FGFR3 mutant receptor activation	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-166786	Creation of C4 and C2 activators	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-844456	The NLRP3 inflammasome	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-381033	ATF6-alpha activates chaperones	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-389359	CD28 dependent Vav1 pathway	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-190372	FGFR3c ligand binding and activation	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-432047	Passive transport by Aquaporins	1.00000000001056	1.05599527790381e-11	12	0	0	645	8202
R-HSA-429947	Deadenylation of mRNA	1.00000000001074	1.07388294682833e-11	23	0	0	645	8202
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	1.00000000001074	1.07388294682833e-11	23	0	0	645	8202
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	1.00000000001074	1.07388294682833e-11	23	0	0	645	8202
R-HSA-191273	Cholesterol biosynthesis	1.00000000001074	1.07388294682833e-11	23	0	0	645	8202
R-HSA-201451	Signaling by BMP	1.00000000001074	1.07388294682833e-11	23	0	0	645	8202
R-HSA-5357786	TNFR1-induced proapoptotic signaling	1.00000000001172	1.17181803080281e-11	13	0	0	645	8202
R-HSA-428790	Facilitative Na+-independent glucose transporters	1.00000000001172	1.17181803080281e-11	13	0	0	645	8202
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	1.00000000001172	1.17181803080281e-11	13	0	0	645	8202
R-HSA-977441	GABA A receptor activation	1.00000000001172	1.17181803080281e-11	13	0	0	645	8202
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	1.00000000001172	1.17181803080281e-11	13	0	0	645	8202
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	1.00000000001172	1.17181803080281e-11	13	0	0	645	8202
R-HSA-209543	p75NTR recruits signalling complexes	1.00000000001172	1.17181803080281e-11	13	0	0	645	8202
R-HSA-209822	Glycoprotein hormones	1.00000000001172	1.17181803080281e-11	13	0	0	645	8202
R-HSA-2995410	Nuclear Envelope Reassembly	1.00000000001172	1.17181803080281e-11	13	0	0	645	8202
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	1.00000000001172	1.17181803080281e-11	13	0	0	645	8202
R-HSA-75892	Platelet Adhesion to exposed collagen	1.00000000001172	1.17181803080281e-11	13	0	0	645	8202
R-HSA-177504	Retrograde neurotrophin signalling	1.00000000001172	1.17181803080281e-11	13	0	0	645	8202
R-HSA-202433	Generation of second messenger molecules	1.00000000001414	1.414150500025e-11	32	0	0	645	8202
R-HSA-376176	Signaling by Robo receptor	1.00000000001414	1.414150500025e-11	32	0	0	645	8202
R-HSA-182218	Nef Mediated CD8 Down-regulation	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-174577	Activation of C3 and C5	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-3656225	Defective CHST6 causes MCDC1	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-111471	Apoptotic factor-mediated response	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-75158	TRAIL  signaling	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-196791	Vitamin D (calciferol) metabolism	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-3595177	Defective CHSY1 causes TPBS	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-166665	Terminal pathway of complement	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-190371	FGFR3b ligand binding and activation	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-429593	Inositol transporters	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-5619102	SLC transporter disorders	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-3595172	Defective CHST3 causes SEDCJD	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-427601	Multifunctional anion exchangers	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-2142789	Ubiquinol biosynthesis	1.00000000001598	1.5975804292062e-11	7	0	0	645	8202
R-HSA-1461957	Beta defensins	1.00000000001616	1.6164546390347e-11	42	0	0	645	8202
R-HSA-5334118	DNA methylation	1.00000000001671	1.67061227164146e-11	62	0	0	645	8202
R-HSA-975298	Ligand-gated ion channel transport	1.00000000001688	1.68753531986218e-11	26	0	0	645	8202
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	1.00000000001688	1.68753531986218e-11	26	0	0	645	8202
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	1.00000000001688	1.68753531986218e-11	26	0	0	645	8202
R-HSA-5656121	Translesion synthesis by POLI	1.00000000001799	1.79926794401097e-11	17	0	0	645	8202
R-HSA-5655862	Translesion synthesis by POLK	1.00000000001799	1.79926794401097e-11	17	0	0	645	8202
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1.00000000001799	1.79926794401097e-11	17	0	0	645	8202
R-HSA-140534	Ligand-dependent caspase activation	1.00000000001799	1.79926794401097e-11	17	0	0	645	8202
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	1.00000000001799	1.79926794401097e-11	17	0	0	645	8202
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	1.00000000001799	1.79926794401097e-11	17	0	0	645	8202
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	1.00000000001818	1.81776650524788e-11	28	0	0	645	8202
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	1.00000000001818	1.81776650524788e-11	28	0	0	645	8202
R-HSA-190828	Gap junction trafficking	1.00000000001818	1.81776650524788e-11	28	0	0	645	8202
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	1.00000000001818	1.81776650524788e-11	28	0	0	645	8202
R-HSA-399719	Trafficking of AMPA receptors	1.00000000001938	1.93801693960375e-11	30	0	0	645	8202
R-HSA-157858	Gap junction trafficking and regulation	1.00000000001938	1.93801693960375e-11	30	0	0	645	8202
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	1.00000000001938	1.93801693960375e-11	30	0	0	645	8202
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	1.0000000000212	2.12023567492263e-11	45	0	0	645	8202
R-HSA-171306	Packaging Of Telomere Ends	1.00000000002128	2.12839788984487e-11	49	0	0	645	8202
R-HSA-5654688	SHC-mediated cascade:FGFR1	1.00000000002154	2.15416974156646e-11	21	0	0	645	8202
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	1.00000000002154	2.15416974156646e-11	21	0	0	645	8202
R-HSA-156588	Glucuronidation	1.00000000002154	2.15416974156646e-11	21	0	0	645	8202
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	1.00000000002154	2.15416974156646e-11	21	0	0	645	8202
R-HSA-5620916	VxPx cargo-targeting to cilium	1.00000000002154	2.15416974156646e-11	21	0	0	645	8202
R-HSA-5673000	RAF activation	1.00000000002157	2.15653140731143e-11	25	0	0	645	8202
R-HSA-162588	Budding and maturation of HIV virion	1.00000000002157	2.15653140731143e-11	25	0	0	645	8202
R-HSA-1461973	Defensins	1.00000000002197	2.19712479203687e-11	51	0	0	645	8202
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	1.00000000002331	2.33131182462426e-11	48	0	0	645	8202
R-HSA-3214842	HDMs demethylate histones	1.00000000002331	2.33131182462426e-11	48	0	0	645	8202
R-HSA-76046	RNA Polymerase III Transcription Initiation	1.0000000000241	2.41039992468792e-11	35	0	0	645	8202
R-HSA-176187	Activation of ATR in response to replication stress	1.0000000000242	2.4197447051587e-11	37	0	0	645	8202
R-HSA-912446	Meiotic recombination	1.00000000002594	2.59384409272833e-11	84	0	0	645	8202
R-HSA-73728	RNA Polymerase I Promoter Opening	1.0000000000268	2.68038617230125e-11	60	0	0	645	8202
R-HSA-72702	Ribosomal scanning and start codon recognition	1.00000000003001	3.00126478738884e-11	55	0	0	645	8202
R-HSA-72649	Translation initiation complex formation	1.00000000003001	3.00126478738884e-11	55	0	0	645	8202
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	1.00000000003128	3.12810581502432e-11	56	0	0	645	8202
R-HSA-6782315	tRNA modification in the nucleus and cytosol	1.00000000003313	3.31308864685886e-11	39	0	0	645	8202
